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This thesis offers an ethnographic account of the work of a research institute called the 
South African Tuberculosis Vaccines Initiative (SATVI), which has been running 
tuberculosis (TB) vaccine trials in the Western Cape since 2001. The chapters show that 
SATVI has become deeply embedded in the local socioeconomic and healthcare 
landscape through the ground-level conduct of its vaccine trials. However, the 
significance of the trials in people’s lives goes beyond providing access to resources 
against the backdrop of withdrawing state structures. The focus is on how the trials have 
become entangled in people’s attempts to craft lives that they consider to be valuable, 
moral and respectable in conditions that have been rendered precarious by centuries of 
racialised domination, control and stereotyping.  
The thesis firstly shows that that the post-apartheid health system has retained residues 
of authoritarianism through the democratic transition and that TB control focuses 
attention upon individual behaviour and lifestyles through the neoliberal language of 
‘responsibility’. Against this backdrop, SATVI’s trials generated novel relationships and 
possibilities gravitating around the pursuit of the ‘greater good’ of a new TB vaccine and 
the bioethical ideal of the autonomous, rights-bearing ‘human subject’. Within these 
research relationships, participants not only felt valued, respected and included. 
Participants and research staff also engaged with health and wellbeing in ways that 
contest the common perception in the government clinics that residents are unwilling or 
unable to ‘take responsibly’ in matters of personal and community health. What emerges 
from this thesis is a moral economy surrounding trial participation that, firstly, challenges 
the bioethical construction of ‘vulnerability’. Secondly, it unsettles a tendency in social 
science research to emphasise the material dimensions of trial participation at the expense 
of a broader spectrum of imperatives and subject positions from which people approach 
and interpret medical science.   
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Chapter 1: 
Introduction 
I would like to begin with the story of Carina, a fictional young woman who lives in the 
Breede Valley of the Western Cape, South Africa. In this story, Carina makes a ‘brave 
choice’ to enrol her baby, Cookie, in a TB vaccine trial run by the South African 
Tuberculosis Vaccines Initiative (SATVI). SATVI is a research institute that has been 
conducting TB vaccine research in the Breede Valley since 2001 and has involved over 
20,000 infants, adolescents and adults in its research over the years (Hanekom et al. 
2012). The story of Carina was presented in a comic called Carina’s Choice (see 
Appendix 1), which was used as an educational tool in the build-up to an early efficacy 
trial involving nearly 3,000 infants between 2009 and 2012. It starts at the Kleynhans’ 
family home with Carina and her brother, Trevor (nicknamed Tupac). Tupac is a school-
age teenager, but frequently skips school to cause mischief with his ‘crew’. For the last 
few weeks, he has been coughing a lot:  
 
Chapter 1 
 
12 
 
Upon finding out that Tupac has been coughing, Vanessa (Tupac and Carina’s Mother), 
expresses her worry to Vernon (their father), and suggests that it might be TB. At first, 
Vernon reacts strongly and dismissively – hinting at the silence and stigma surrounding 
the disease (Abney 2011) – but after being reminded that many they know have had TB, 
subsequently he concedes that it might be a possibility: 
 
 
Vanessa says that it would be best to take Tupac to the doctor. However, Vernon, who 
has recently been laid off from his job at a fruit processing factory, says that they have no 
money for the doctor – or for anything else for that matter. Therefore, Vanessa suggests 
that they take him to a government clinic instead: 
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Carina, Cookie, Tupac and Vanessa take the long walk to the clinic and, after waiting in 
the queue, Tupac is called in by a uniformed nurse. As Tupac is being examined, he is 
uncooperative with the nurse and is scolded as a result: 
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It transpires that Tupac does not have TB, but rather a serious chest infection. However, 
the government nurse tells him that attending the clinic was the right thing to do, given 
the prevalence of TB in the region. Moreover, realising that Tupac is a smoker, the nurse 
strongly suggests that he quits the habit: 
 
As this is happening in the consultation room, Carina, back in the waiting room with her 
baby, is approached by a warm, smiling lady who introduces herself as Mandisa, an 
employee of SATVI: 
 
Mandisa explains to Carina that, although the Bacillus Calmette-Guérin (BCG) vaccine 
offers a degree of protection against TB, especially extra-pulmonary TB disease, SATVI 
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are working towards a new vaccine which offers greater protection against pulmonary TB 
as well as drug-resistant forms of the disease (e.g. multi drug- resistant [MDR] and 
extensively-drug-resistant [XDR] TB):  
 
Mandisa then says to Carina that developing such a new vaccine involves many years of 
clinical testing, and that SATVI are currently starting a large vaccine trial involving 
thousands of infants. Careful to emphasise that Cookie will not benefit directly from the 
new vaccine, Mandisa says that Carina and her baby can help SATVI develop a new 
vaccine that future generations will benefit from by choosing to take part. Wanting to 
contribute towards this ‘greater good’, Carina enthusiastically agrees: 
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A few months later, the Kleynhans family and friends are celebrating Cookie’s first 
birthday. There, one friend voices his suspicions about SATVI’s intentions. SATVI, he 
observes, has been active in the community for years, but so far, they have seen no new 
vaccine or tangible benefit. He suggests that SATVI might be giving people TB through 
the new vaccine. Moreover, he questions what SATVI are doing with Cookie’s blood. 
But Carina corrects the man’s ‘misconceptions’: 
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The conversation goes backwards and forwards, but eventually, and with the help of a 
member of SATVI’s ‘community advisory board’ (standing to the right of Vernon above), 
the man’s suspicions are put to rest. SATVI, the man comes to realise, is working in the 
community’s best interests and participants have numerous rights in the research. The 
story concludes with an optimistic look towards the future: 
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The comic Carina’s Choice is a useful device with which to begin this thesis because it 
offers a window into the socioeconomic and epidemiological context of the Breede Valley 
and also how SATVI conceives of its relationship with the region’s residents. The comic 
highlights the severity of the TB epidemic in South Africa and its close associations with 
poverty and unemployment (Farmer 2000; Benatar & Upshur 2010). It points out that 
most residents are reliant upon the government healthcare system, and hints at the strained 
relationship between the clinics and the people they serve, as depicted by the scene in 
which Tupac is scolded by the clinic nurse (Jewkes et al. 1998; Walker & Gilson 2004). 
It also introduces the Western Cape’s majority ‘coloured’ population1 and, moreover, 
some of the social challenges that are associated with poverty and which hardened into 
racial stereotypes in colonial and apartheid imaginings (Jensen 2008, p. 25; F. Ross 2015). 
This includes absent fathers (Cookie’s), young men tempted by gang life (Tupac) and 
women attempting to be ‘true homemakers’ with little money or support (Vanessa and 
Carina).  
 In terms of how the comic positions SATVI’s relationship with its study 
population, SATVI is unfamiliar to Carina prior to meeting Mandisa, who introduces the 
institute as standing outside of the local context of health seeking and delivery: 
representing not intervening upon the region’s TB epidemic. Accordingly, the encounter 
is oriented towards the ‘greater good’ of a new vaccine, with the comic careful to distance 
the trials from associations with healthcare or material gain. Moreover, any suspicions 
about the trials or SATVI’s intentions are construed as ‘misconceptions’, and indeed one 
of the comic’s primary aims as an educational tool was to align local understandings with 
the imperatives and epistemology of clinical science. However, based upon my fieldwork 
                                                 
1 This is one of the racial groups classified by the colonial and apartheid regimes, and will be 
described further on in this chapter.  
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at SATVI’s trials since between August 2014 and 2015, I would suggest that Carina’s 
Choice says more about the language of ‘global’ science and ethics than it does about 
how people actually view SATVI and its work. After over fifteen years of being one of 
the most active non-state presences in the Breede Valley, SATVI has come to hold far 
greater significance in people’s lives than if it were simply a neutral, distanced observer.   
This thesis is about the insertion of some of the largest contemporary TB vaccine 
trials into an impoverished post-apartheid setting which was also experiencing one of the 
most severe and divisive TB epidemics in the world. I show that despite an image of 
distance and objectivity characterising formal accounts of SATVI’s work (e.g. Carina’s 
Choice), the institute has become intricately entwined in the Breede Valley’s 
socioeconomic and healthcare landscape through enduring patterns of enrolment, follow 
up and referral through to the government clinics.2 Yet, the significance of SATVI in 
people’s lives is not only that the institute has introduced superior medical resources and 
expertise into the frame. In fact, my account diverges from others which depict the 
significance of medical research in the lives of African citizens primarily as a means of 
accessing scarce resources in the recesses of withdrawing states and ailing health systems 
(e.g. Geissler et al. 2008; Rottenburg 2009; Kamuya et al. 2014; Nguyen 2015). What 
emerged during my time with SATVI’s participants and staff was not that the trials had 
steamrolled over social life, purifying new forms of experimental subjectivity, but rather 
that they had become entangled in people’s efforts to craft lives that they considered to 
be valuable, moral and respectable on the peripheries of social and economic life (F. Ross 
2010, 2015).   
                                                 
2 As I will explain later, SATVI does not provide treatment for any conditions diagnosed during 
vaccine trials but rather refers them to their normal healthcare provider, usually a government 
clinic.   
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 The notion of ‘respectability’ has a long history in South Africa and carries 
particular weight in the Western Cape (F. Ross 2010). While it has its roots in dominant 
ideologies of proper personhood, ethnographies in Cape Town have shown that it has 
been used as a means of struggling back against the poverty, discrimination and 
stereotyping that have endured into post-apartheid South Africa (Salo 2003; Jensen 2008; 
F. Ross 2010, 2015). Building upon these studies, I position SATVI alongside other 
institutions, spaces and strategies in which people struggle back against the inscriptions 
of the state, with a particular focus on the landscape of health seeking and delivery. A key 
point of context for explaining how SATVI’s research features in people’s day-to-day 
lives is the highly-moralised nature of TB in both biomedical and popular discourse and 
the way that it partially deflects attention away from structural factors and on to individual 
behaviour and lifestyles. TB has, as I will show, become intimately connected to some of 
the practices associated with poverty that many residents resented most, including drugs, 
alcoholism, poor hygiene and gangsterism. One effect is a vicious cycle of responsibility 
and blame in both healthcare facilities and in low-income areas in which the disease finds 
greatest traction.  
 Against this backdrop, SATVI’s trials generated novel relationships and 
possibilities gravitating around the pursuit of the ‘greater good’ of a new TB vaccine and 
bioethical ideal of the autonomous ‘human subject’. Within these research relationships, 
participants not only felt valued, respected and as though they care about personal and 
community health, in contrast to their interactions with the state. Moreover, I found that 
during the day-to-day routines of the trials, both participants and staff were bringing their 
own beliefs, values and ideas about moral, respectable living to bear on their 
interpretations of the science and the ways in which it could be used it to pursue their 
hopes for better. I remain careful not to lose sight of the tensions, contradictions and often 
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futility of people’s world-building efforts in a context where life is often cruel and 
unpredictable (F. Ross 2010). This is reflected in the way the chapters oscillate between 
people’s self-perceptions and moral aspirations, on the one hand, and the multiple 
conditions, especially where TB is concerned, under which negative stereotypes resurface 
and are activated (in particular, the skollie [thug] and the ‘problem TB patient’). 
Nonetheless, what emerges from this account is a moral economy3 that, firstly, challenges 
the abstract tenets of formal research ethics and specifically the bioethical construction 
of ‘vulnerability’. Secondly, this moral economy unsettles a trend in social research to 
emphasise the material dimensions of trial participation at the expense of a broader 
spectrum of imperatives and subject positions from which people approach and interpret 
medical science.   
Globalised Clinical Trials 
Since the turn of the 21st century, there has been a greater acknowledgement of the 
widening health disparities between the global north and south and the failure of markets 
to address the needs of the world’s poorest (Farmer 1996; Lock & Nguyen 2010). In the 
wake of the civil society movement spearheaded by Médecins sans Frontiéres and Oxfam, 
a number of major pharmaceutical companies, governments and newly founded not-for-
profit organisations (e.g. the Gates and Rockefeller Foundations) began to direct 
substantial research and development (R&D) activity towards previously ‘neglected’ 
diseases, particularly HIV/AIDS, TB and malaria (Pecoul et al. 1999; Trouiller et al. 
2002; Hanson et al. 2012).4 The term ‘global health’ has come to refer to both the 
                                                 
3 I use Lorrain Daston’s (1995, p. 4-5) definition of a moral economy: “a web of affect-
saturated values that stand and function in a well-defined relationship to one another…but not 
always predictable in their details” (see also Daston & Galison 2007).  
4 Other diseases such as lymphatic filariasis and schistosomiasis remain neglected to the present 
day (Allen & Parker 2012).  
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increasingly transnational nature of health threats and the vast assemblages of 
government and non-governmental actors working to overcome them (Lock & Nguyen 
2010; Hanson et al. 2012). In the era of global health, research and development activity 
is increasingly conducted under the guise of product development partnerships. 
Supposedly combining the best of both worlds – public health interest and funding with 
private-sector efficiency – product development partnerships are now a prominent source 
of new drugs and vaccines. 
The research programme with which this thesis is interested is the pursuit of new 
and improved vaccines to combat TB. TB was labelled a ‘global emergency’ by the World 
Health Organisation (WHO) in 1993 and remains one of the most prevalent and deadly 
infectious diseases in the world. In 2015 alone, there were 10.4 million new cases of TB, 
1.4 million deaths from TB among HIV-negative individuals and 400,000 additional 
deaths among HIV-positive individuals (WHO 2016). Notably, 95% of positive TB 
diagnoses and 98% of TB-related deaths happen in developing countries, where the 
conditions under which the disease thrives – inadequate food security, unhygienic and 
crowded living conditions, and poor access to healthcare – are abundant (Benatar & 
Upshur 2010). The Bacillus Calmette-Guérin (BCG) vaccine has served as the only 
vaccine used on a global scale since its introduction in the former half of the 20th century. 
It has had a positive impact, and has been shown to reduce the risk of pulmonary TB in 
infants by upwards of 50% on average (although its efficacy is subject to regional 
variation (Colditz et al. 1994). However, it is widely thought to be insufficient as a self-
standing TB preventative, especially given the continuing proliferation of multi- and 
extensively drug-resistant strains of the disease (MDR and XDR). Thus, the goal at 
present is the production of a booster vaccine which will increase the overall efficacy of 
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the BCG vaccine or, alternatively, to find a self-standing vaccine that is sufficient to 
replace the BCG given at birth.   
Like all biomedical drugs and vaccines, those products that are destined for the 
humanitarian market must undergo extensive clinical trialling in order to attain approval 
from major regulatory bodies such as the US Food and Drug Administration (FDA). 
Consequentially, in a transition paralleling the ‘offshoring’ of clinical trials in the private 
sector (see Petryna et al. 2006; Petryna 2009; Sunder Rajan 2006), these products are 
increasingly tested in middle- and low-income countries in collaboration with host-
country NGOs and research institutes (Marks 1997; Hanson et al. 2012). Established in 
2001, SATVI is one of the largest research institutes running TB vaccine trials in Africa, 
in collaboration with Aeras Global Vaccine Foundation (a Gates Foundation-funded 
PDP), Oxford University and a variety of other northern institutions and companies (see 
Chapter 2).    
The trialling of drugs and vaccines on human subjects raises important questions 
of ethics. Since the atrocities committed under the Third Reich, various ethical guidelines 
have emerged and been gradually fine-tuned to ensure the protection of human subjects. 
These include the Nuremburg Code (1947), Declaration of Helsinki (1964), Belmont 
Report (1978) and, perhaps most significantly, the International Conference on 
Harmonisation and Good Clinical Practice (ICH GCP). Spearheaded by the US Food and 
Drug Administration (FDA), ICH GCP was introduced in 1995-1996 in order to 
synthesise existing norms, both scientific and ethical, into one “international ethical and 
scientific quality control standard for assuring the protection of subjects and quality of 
data” (Petryna 2009, p. 24). Good Clinical Practice (GCP) has a number of versions, 
having been adapted to be more relevant in the settings in which it is implemented (e.g. 
South Africa has its own version which was introduced in 2000 and updated in 2006). 
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Separate from the previous codes that it incorporates, today GCP is the industry standard 
for the regulation of human subject research and has largely succeeded in enabling a 
globalised network of standardised clinical trials.    
 GCP prescribes an array of measures, including high standards of care (and the 
minimisation of placebo-controlled trials), ensuring that the benefits outweigh the risks, 
and stringent monitoring and oversight. But with numerous examples etched into the 
popular memory of people being coerced into medical research, the bioethical principle 
that lies at the heart of research ethics is that of autonomy. The human subject, as Geissler 
(Geissler 2013, p. 18) explains, “is not a subject of control, compassion, or responsibility, 
not defined by a relation of inequality, but a free rational agent, whose participation in 
medical research is not derived from a logic of responsibility or care but of choice”. The 
practice that is primarily responsible for upholding this freedom is informed consent, the 
“sine qua non of human experimental research” (Sariola & Simpson 2011, p. 515). 
Informed consent involves the clear communication of information about research, which 
demonstrates that people are in a position to make rational, informed decisions whether 
to take part (see Molyneux & Geissler 2008; Sariola & Simpson 2011; Hoeyer & Hogle 
2014; De Vries & Henley 2015). Given the emphasis on autonomy, the ideal scenario 
(that informed consent is supposed to bring about) is one in which people take part for 
the ‘greater good’ that the research will bring about – be it a drug, vaccine or new 
knowledge – and not for the immediate benefits of participation. Situations to be avoided 
at all costs are expressed by telling phrases such as ‘undue inducement’ (where the 
material benefits are enough to sway people into participation against their better 
judgement) and ‘therapeutic misconception’ (where people believe the research is for 
their healthcare when it is not and could, to the contrary, cause them harm).  
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Conducting ‘ethical’ research is therefore a huge challenge in settings where 
people are incredibly poor, with low rates of scientific and health literacy, and where 
access to healthcare is severely compromised. In the language of bioethics, people living 
in poverty are considered, to varying degrees, to be ‘vulnerable’ – a key trope in bioethical 
discourse that features in research guidelines and has received critical attention in 
attendant scholarship (e.g. Kipnis 2001; Levine et al. 2004; Horn 2007; Tameris 2010; 
Ten Have 2016).5 Geissler (2013, p. 18) argues that while poverty is taken seriously in 
bioethical discourse, the priority afforded to autonomy (over distributive justice) means 
that material inequality should not be redressed by researchers but rather mitigated 
against. The possibility of ‘undue inducements’ and ‘misconceptions’ can in theory be 
neutralised through keeping material benefits in check and communicating clearly to 
participants about what the research is and what it is not. Consequently, with the 
exception of a minority of bioethicists who are interested in issues of distributive justice 
in medical research (Benatar 2002; London 2005; Macklin 2004; Pratt & Loff 2011; Pratt 
& Loff 2013), most bioethical debate has centred on how best to preserve the autonomy 
of vulnerable individuals by devising ever ‘stronger’ consent procedures (Hoeyer & 
Hogle 2014).  
Neoliberalism and Global Health 
Not satisfied with the assumptions upon which bioethical guidelines rest, an expanding 
body of anthropological literature has sought to put clinical trials back in the political and 
economic contexts from which they have been divorced. Analysing the ways that clinical 
                                                 
5 Kipnis (2001) offers a taxonomy of vulnerability. Kinds of vulnerability include: poverty and 
educational deprivation; cognitive (ability to understand and make choices), medical (having a 
disease for which no treatment exists), juridical (being under the legal authority of someone), 
deferential (accustomed to having decisions made for them) and infrastructural (whether 
research setting has the necessary capacity to carry out the research).      
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trials are ‘offshoring’ in the private sector, Petryna (2009) observes certain developing 
countries (e.g. Brazil and Poland) are being targeted for trials because of their relatively 
strong medical and research capacity, availability of poor trial participants with lack of 
access to healthcare and a legal system that is conducive to the conduct of clinical trials 
(see also Sunder Rajan 2006; Cooper 2008). A key part of this increasingly global trial 
assemblage is GCP. Because of its narrow focus on the researcher-subject relationship 
(as opposed to the broader socioeconomic contexts of this relationship), GCP enables the 
conduct of trials that might not be permissible in the developed world (see also Rennie 
2009; Douglas-Jones 2012; Simpson et al. 2015). Petryna (2009) uses the term 
‘experimentality’, a play on Foucault’s term ‘governmentality’, to capture the 
overarching logic of this highly profitable industry intent on enrolling the world’s poorest 
people into clinical trials.  
On first glance, it appears that the humanitarian market, which is not profit-driven 
and explicitly intended to reduce global health inequities, is separate from such processes. 
However, recent scholarship has situated clinical trials within a broader shift in power in 
Africa from national governments to an assortment of international non-state actors under 
the umbrella of ‘global health’. The backdrop for this argument is the neoliberal reforms 
imposed on many African nations during the 1980s that led to the withdrawal of the state 
from key functions, including healthcare. Into this space have moved a variety of actors 
– UN organisations, charities, NGOs, northern universities and research institutes – which 
often completely bypass state institutions. In contrast to imaginings of comprehensive, 
community-based care following independence in many African nations, these 
humanitarian interventions extend only to the minimal form of care required for survival 
(Prince 2014). Moreover, their territories are arranged in more of an “archipelago” pattern 
than providing even coverage, concentrated especially in regions with high burdens of 
Chapter 1 
 
27 
 
disease (Rottenburg 2009; Geissler 2014). Nonetheless, they have largely taken over the 
state’s responsibility for the provision of healthcare in a “new form of fragmented 
sovereignty” (Rottenburg 2009, p. 426).  
In the new era of global health, medical experiments and humanitarian 
interventions constitute a powerful form of social organisation in the everyday lives of 
Africans. Building upon previous work on “biosociality” (Rabinow 1996; see also 
Petryna 2005), Nguyen has coined the term “therapeutic citizenship” based on his work 
in West Africa to capture the way in which claims to resources essential for survival are 
contingent upon biological status, especially HIV and AIDS (Nguyen 2005, 2010, 2011). 
He argues that clinical trials “catalysed the formation of community-based organisations 
and self-help groups focused on gaining access to resources” that “became veritable 
therapeutic communities” (Nguyen 2011, p. 429). In self-help groups, people had to 
employ testimonials based upon Western confessional technologies, with members 
effectively competing with one another to demonstrate who made the best advocates in 
order to secure treatment (Nguyen 2010). Similar transformations of subjectivity have 
been observed by Robins (2006) in South Africa, who shows how, upon becoming 
members of the Treatment Action Campaign (TAC), people became “responsibilized 
citizens”, living “positively” in accordance with the demands of antiretroviral therapy. In 
a recent paper, Nguyen (2015) takes this argument yet further. Analysing Treatment as 
Prevention (TasP) trials, he goes so far as to suggest that these huge clinical trials are now 
so ubiquitous that they “herald the birth of experimental societies” (2015, p. 47), that is, 
entire populations that are governed from afar according to the inexorable logic of 
experimentality. 
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The Interface Between ‘Global’ and ‘Local’      
While the above scholars have drawn attention to the political economy of clinical trials 
and how they shape experimental subjectivities and social life, what they tend to be less 
attentive to is that ‘global’ scientific and ethical norms must contend with existing 
constellations of culture, history and politics (Sariola & Simpson 2011). Another line of 
anthropological enquiry has focused upon the dynamics of particular trial sites to 
highlight the creativity that is required for making ‘global’ research structures work in 
settings that are different to the global north, both culturally and economically. Issues 
explored include: establishing ethical review committees (McIntosh et al. 2008; Douglas-
Jones 2012); eliciting informed consent and maintaining ‘ethical’ relationships during 
clinical trials (e.g. Gikonyo et al. 2008; Geissler et al. 2008; Leach & Fairhead 2011; 
Kelly 2011; Sariola & Simpson 2011; Reynolds et al. 2013; Kingori 2013); ‘reimbursing’ 
participants for study visits (Geissler 2011); running community engagement projects 
(Marsh et al. 2008; Marsh et al. 2011); and working in contexts of medical paternalism 
(Simpson & Sariola 2012). 
 A number of these studies were conducted at large, northern-funded medical 
research institutes in Africa that make up the “archipelago” (Geissler 2014) of global 
health (e.g. the British MRC in The Gambia and KEMRI in Kenya). With SATVI sitting 
alongside these institutes in terms of size, scope and influence in the communities with 
which they work, it is useful to say something more about the social dynamics of African 
“trial communities” (Geissler et al. 2008). Standing out from the poverty and under-
resourced healthcare facilities around them, they have become a familiar part of the local 
context of health seeking and delivery, providing basic healthcare for participants – 
sometimes whole communities – that far surpasses that which their governments are able 
to provide (Geissler et al. 2008; Leach & Fairhead 2011; Kelly 2011; Kamuya et al. 2014). 
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Against this backdrop, for those on whom research is conducted, research is often not 
about the objective, disinterested collection of data for the ‘greater good’ but rather a 
means to access healthcare or material resources. As Geissler and colleagues observed 
during a British MRC vaccine trial in The Gambia, the moral economy of truth and 
objectivity prized by science had to coexist with another on the ground, involving 
“material contact and substantial transactions, notably of blood and medicine” (Geissler 
et al. 2008, p. 696; see also Lock & Nguyen 2010, p. 199).  
Because material transactions are not recognised by formal research ethics, 
considerable ethnographic attention has been paid to the work of frontline research staff, 
and especially fieldworkers. Speaking participants’ languages and knowing local values 
and customs, these actors are hired locally to perform ‘simple’ tasks, including obtaining 
informed consent and also some aspects of data collection (Molyneux et al. 2013). Yet, 
with allegiances to both research institutes and participants, it has been shown that their 
work is far from simple and that they play a creative, ethically-charged role balancing the 
objective requirements of protocols with the needs and expectations of participants and 
their communities (Geissler et al. 2008; Molyneux et al. 2010; Molyneux et al. 2013; 
Reynolds et al. 2013; Kingori 2013; Kamuya et al. 2014). ‘Relational ethics’ – the ethics 
of face-to-face encounters – has come to describe the work that these frontline researchers 
engage in: a necessary if obscured corollary to the distanced, abstract tenets of formal 
research ethics (Molyneux & Geissler 2008; Geissler et al. 2008; Molyneux et al. 2010; 
Posel & Ross 2015). Recently, Geissler (2013) has broadened this picture to suggest that 
an activity in which all research staff, from the lowest to the highest, implicitly engage is 
that of “unknowing” material difference. During research encounters, there are certain 
contexts in which difference can be “known”, for instance informal discussions in side 
corridors and after study visits. But in the formal protocols and practices of research, the 
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material inequalities between researchers and impoverished participants, between 
research institutes and government healthcare facilities, even between northern scientists 
and their African counterparts – these must all be conveniently “unknown” – in order to 
maintain the values of autonomy, distance and equal collaboration upon which 
transnational research is premised (Geissler 2013, p. 17). 
The ‘trial communities’ literature importantly highlights the creativity and 
relational work that is needed on the ground in order to make ‘global’ science and ethics 
operable in contexts of material inequality. However, its critique, while broadening the 
purview of research ethics in one respect (drawing attention to the wider political 
economic context of trials and the hidden work that is needed in such settings), is arguably 
also restricted in another. In seeking to unsettle the bioethical ideals of ‘autonomy’ and 
‘material independence’, the significance of trials in people’s lives is largely reduced to 
providing access to scarce medicines and resources against the backdrop of withdrawing 
state structures. This is similarly true of Nguyen’s (2005, 2011) notion of “therapeutic 
citizenship”, which refers to how people’s claims to resources for survival are being 
redirected through trials and humanitarian interventions on the basis of biological states. 
My worry is that the emphasis on the material dimensions of participation, described 
using state-citizen metaphors, is at the expense of a broader appreciation of the spectrum 
of roles, imperatives and subject positions from which people approach and interpret 
clinical trials. 
In a recent study, Brives (2013) expresses a similar concern. Her position is that 
while the category of the human subject has received considerable social scientific 
attention, the significance of trials for participants has tended to be reduced to their 
clinical benefits, with the effect that their lived realities tend to be “cut loose from the 
very practices that constitute the beating heart of the trial” (2013, p. 398). Analysing a 
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clinical trial in Burkino Faso involving HIV-positive mothers, Brives shows that the trial 
operated according to a very different logic to the rushed and under-resourced 
government healthcare context outside the trial environment. Specifically, much effort 
was made to engage the mothers one-on-one so that they adhered to the meticulous 
standards of the trial protocol (2013, p. 410). An unintended effect was that, in 
participating in their own objectification, this scientific way of being had significant 
ramifications for the mothers beyond the trial. For instance, for the women, what it meant 
to be a “good mother” emerged in conversation with supposedly mundane bio-scientific 
practices. Brives argues that: 
The mother-child pairs exist as research objects, yet not exclusively: they 
also exist as women, daughters/sons, employees, loved ones and so on. 
The trial might determine, in part, what choices the women make and 
impose numerous exigencies; yet, the women never emerge as passive 
objects, subjected to the authority of research. (2013, p. 412)  
In drawing attention to the ways in which the authority of research is challenged in 
everyday research practice, Brives’ observations suggest a line of critique that moves in 
another direction to much current anthropological scholarship. We arguably already have 
an established critique of the bioethical ideals of ‘autonomy’ and ‘equal collaboration’. 
Yet what has received considerably less critical attention is the (closely associated) 
bioethical construct of ‘vulnerability’.  
 The notion of vulnerability, as noted above, references ‘compromised autonomy’ 
in the context of bioethics and features prominently in research guidelines to justify 
additional protections to certain categories of participant (see Kipnis 2001). A growing 
body of bioethical and social science literature has problematised the category and its 
ever-expanding applications, especially in developing world settings where poverty and 
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‘vulnerability’ have become closely entwined (Chambers 1989; Levine et al. 2004; Furedi 
2008; Reynolds 2014; K. Brown 2015). Levine et al. (2004) argue that the bioethical use 
of vulnerability is both “too broad” and “too narrow”. It is too broad in the way that it is 
placed a priori over whole populations on the basis of socioeconomic status. This not only 
makes the term too nebulous to be meaningful but also reinforces negative stereotypes of 
the poor (ibid 2004, 47). Chambers argues that the category is generally imposed by 
policy makers under the assumption that “they know what poor people want and need” 
(usually income and consumption), positions them as defenceless, fragile and deficient, 
and reinforces an image of the “amorphous and undifferentiated mass of the poor” 
(Chambers 1989, p. 35). ‘Vulnerability’ is also too narrow in the way that it is focused 
solely on characteristics that bear on people’s capacity to freely choose. As Levine et al. 
(2004, p. 46) argue, this focus deflects attention away from other features of the 
institutional, social and economic context that can expose participants to harm. Moreover, 
it greatly limits our insights into what clinical trials might mean to those labelled 
‘vulnerable’.    
 By way of a response to the bioethical construction of vulnerability, this thesis 
strives to view ‘vulnerability’ not as an a priori and imposed category referencing 
‘compromised autonomy’, but rather as emergent in practices. I will show how 
vulnerability was interpreted and acted upon, both by clinical trial participants and 
research staff, in ways that might not be visible from the abstract perspective of bioethics. 
Taking ‘lived experiences’ of vulnerability as an empirical focus reveals an array of ways 
in which people felt vulnerable in their social and material environment; but it importantly 
allows us to see them not as not to be simply ‘fragile’ or’ ‘defenceless’ but rather 
innovative, dynamic and resilient in the ways in which they navigate complex 
sociomedical spaces (Beck & Nesmith 2001; F. Ross 2010; Reynolds 2014; Reynolds 
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2015; K. Brown 2015). Indeed, one of the primary reasons that SATVI’s trial 
environment was valued, I will show, is that people felt that they were treated as 
autonomous, rational and responsible in a way that they were not in other health settings. 
It is my hope that this approach will enable us to move beyond the narrow bioethical 
framing of the human subject that is captured between the poles of ‘vulnerability’ and 
‘autonomy’ and instead to gain a more holistic understanding of how medical research 
features in people’s lives in South Africa.  
Respectability in Post-Apartheid South Africa 
Despite the end of apartheid, South Africa remains highly segregated, still barely making 
inroads into centuries of racialised exclusionary policies that were initiated during the 
colonial period and further entrenched under apartheid. The Western Cape is unique case 
in relation to the rest of the South Africa. As within the country more generally, a sharp, 
racially-based distinction was drawn between ‘White’ and ‘Black’. However, this 
distinction was complicated in the case of those labelled ‘Coloured’6, who, on the basis 
of lighter skin than black people, were viewed with ambivalence: neither the antithesis of 
white civilization nor included within it. This ambivalence was reflected during apartheid 
when coloured people were situated, both hierarchically and spatially, in a sort of “buffer 
zone” between white and black people (Jensen 2008, p. 2). Cape Town and surrounds 
were declared a Coloured Labour Preference area in 1954, and black people were 
restricted from living permanently in the urban centres except under the most extreme of 
circumstances and relegated to the ethnic ‘homelands’ or otherwise forced into illegal 
                                                 
6 The denotations of racial groups in South Africa has shifted over time and been hotly 
contested. In this thesis, racial categories appear as they do in the South African census (2011). 
That is: ‘White’, ‘Coloured’, ‘Black African’ and ‘Indian’. I will not usually place inverted 
commas around them, although I am aware of the violent histories of these terms and the 
complexity of South African identity politics. Unless contextually appropriate, I will use first 
language rather than racial classification to describe participants.          
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squatter camps (F. Ross 2010, p. 2). In practice, however, living conditions were little 
better for coloured people during apartheid, and many of these people were eventually 
forced into illegal squatter camps alongside black people.  
 The notion of respectability has a long history in the Western Cape (R. Ross 1999; 
Salo 2003; Jensen 2008; F. Ross 2010). It is captured within the Afrikaans term 
ordentlikheid, which connotes “decency, respectability, reasonability, and proper 
conformity to the social norms of the elite” (2015, p. S98). Under colonial rule, 
‘respectability’ was an organising principle around which unequal social relations were 
built, and it came to be defined primarily in Christian terms, both legitimising racial 
divisions and providing a frame for “saving” Africans (R. Ross 1999; Hull 2009; F. Ross 
2015). While it is rooted in dominant notions of personhood, especially what it means to 
be a ‘proper’ woman, a number of ethnographic studies have shown that ordentlikhied 
has become an emic term in Afrikaans-majority townships in Cape Town, used to lend 
meaning to life in adverse circumstances and in the process taken on meanings not 
necessarily envisaged by the state (Salo 2003; Jensen 2008; F. Ross 2010). Fiona Ross 
(2010) conducted research in an informal settlement called The Park, the residents of 
which were awarded formal housing rights after apartheid. She shows that their hopes 
“crystallised around the notion of ordentlikheid” (ibid, p. 3) and examines the 
possibilities, tensions and contradictions surrounding their hopes to become recognised 
as decent and respectable people. Steffen Jensen (2008), in a township called Heideveld 
where poverty was less grinding, explores a broad array of ways in which men and women 
sought to attain dignity and respectability. This includes religion, community politics, 
sports, religion and even gang life.  
 Jensen (2008) importantly argues that claims to dignity and respectability in 
Heideveld were constructed in response to the stereotype of the skollie. The term literally 
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translates as ‘scavenger’. But in Cape Town it came to mean ‘thug’ or ‘hooligan’ and 
refers to someone who is poor, male and coloured, refuses to work, is a criminal, drinks 
and terrorises working people (ibid, p. 2). The skollie, Jensen argues, is closely entwined 
in the construction and governance of the coloured population. While coloured people 
were viewed as being some way closer to white civilization than black people, various 
commissions into coloured life (e.g. the Wilcocks Commission [1937]) framed them in a 
very negative light. With almost no regard for the poverty in which they were forced to 
live, they were portrayed as “lacking in commitment and moral fibre, and a general image 
of the coloured problem family in need of state attention was evoked” (ibid, p. 25). The 
most problematic member of this stereotypical family was the father, who undermined 
the mother’s “uphill battle to be a true homemaker” through being “absent, shirking his 
responsibilities and indulging in alcohol” (ibid, p. 25). Through his absence, the children 
were likely to go astray and become “antisocial, that is, skollies” (ibid, p. 25). Jensen 
argues that the skollie has been gradually objectified, acted upon and made real in the 
Foucauldian sense by successive governments and bureaucracies, and has endured 
through democratic transition into post-apartheid South Africa. Jensen (ibid, pp. 4-5) 
shows that today the skollie occupies an ambiguous place for township residents. One the 
one hand, he undermines positive coloured identities because people are associated with 
him through race; but on the other, people position their own morality and respectability 
by projecting the skollie elsewhere and on to others. Following Gramsci’s notion of dual 
consciousness (cited in Gutmann 1996), he explains that:  
Colouredness is split between individuals’ everyday sense of being 
themselves as persons who live normal and moral lives on the one hand, and 
on the other the colouredness, sustained by the full gamut of stereotypical 
framing and definition. These two forms of consciousness exist 
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simultaneously but not on an equal level. The form of consciousness based in 
governmental framing and definition might be repudiated, but it will never be 
entirely expunged. It can always return to undermine the sense of self. (2008, 
p. 8)  
The context in which I was working, like Ross (2010), is more heterogeneous in terms of 
racial and linguistic makeup than Heideveld (Chapter 2, p. 48), and therefore it would be 
misleading to overemphasise the coloured population and its challenges over those of 
others. Nonetheless, Jenson’s use of ‘dual consciousness’ resonates strongly with my own 
experiences with SATVI’s participants. Moreover, taken together, these ethnographic 
studies demonstrate the profound effects that the categorisations and interventions of the 
colonial and apartheid regimes have had on the lives of South Africans and that continue 
to threaten the conditions for being able to lead ordinary, respectable lives. Yet with 
considerable ingenuity this is precisely what many people have managed, however 
partially and temporarily. These ethnographies do much to draw attention to what it 
means to inhabit conditions that produce extreme vulnerability and the ways in which 
people not only find the means to survive but to recover from their circumstances the 
elementary particles of social life. 
TB, Morality and the Human Subject  
One might well ask what people’s attempts to craft moral, respectable lives has to do with 
the TB epidemic and SATVI’s research to produce a new TB vaccine. But one thing that 
will become clear is that TB is far from simply a biological organism, one that can be 
acted upon and researched as a brute biomedical fact. It is, in many ways, the archetypal 
disease of poverty (Farmer 2000), finding traction in exactly those spaces where life is at 
its most abject: cramped and overpopulated houses, lack of sanitation, malnutrition and 
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other infectious diseases (e.g. HIV). Moreover, in tandem with HIV and AIDS, with 
which TB is closely associated7, the disease is highly moralised in biomedical discourse 
through the neoliberal language of patient ‘responsibility’ (Compion 2008). The 
treatment of TB is framed as a matter of individual ‘adherence’ and, consequently, places 
blame for the continued proliferation of the disease upon sick individuals and their 
communities (Farmer 2000; Compion 2008; Harper 2006; Harper 2010). As Abney 
(2011) shows in a study of TB-related stigma in Khayelitsha, Cape Town, TB discourse 
is further moralised in local symbolic repertoires, closely associated with notions of ‘dirt’ 
– not only dirty places but dirty people and dirty practices. It is, I will suggest, closely 
tied to some of the practices that were viewed by residents as the biggest threats to a moral 
community, including alcoholism, drugs, poor hygiene and gangsterism.  
While in Jensen’s (2008) work the stereotypical figure of the skollie is the 
protagonist, in this thesis I introduce another stereotypical figure, one partially 
overlapping with that of the skollie (for the skollie often has TB – alluded to by the 
character Tupac in the comic Carina’s Choice) but distinct from him. This is the ‘problem 
TB patient’. Similar to the skollie, he is a product of governmental categorisation against 
which morality and respectability is set. The problem TB patient is not necessarily male, 
nor coloured, but almost certainly not white. He is likely to be seen drinking, smoking or 
doing drugs and practicing poor hygiene (e.g. spitting in the street). He might not yet have 
been diagnosed, but is visibly sick and refusing to go to the clinic for treatment, 
consequently spreading TB to the innocent, especially children and the elderly. Worse, 
he might have begun treatment but prematurely stopped – ‘defaulted’, in biomedical 
                                                 
7 HIV is largely responsible for the scale of the TB epidemic in South Africa because TB is one 
of the opportunistic infections to which HIV-positive people are highly susceptible. In the early 
2000s, the diagnosis and treatment of TB and HIV began to be integrated in government 
healthcare facilities (Compion 2008).   
Chapter 1 
 
38 
 
discourse – running the risk of developing and passing on drug-resistant strains of the 
disease. Unlike the skollie, the ‘problem TB patient’ is a stereotype produced through the 
health sector, and has not been a matter for the police since the end of apartheid when 
patients were afforded the right to refuse treatment (Patient Rights Charter 1996). Falling 
squarely under the jurisdiction of under-resourced government clinics, he is framed not 
as a criminal but rather as a threat to public health through his purported ‘irresponsibility’.   
TB is by no means the only challenge that the government clinics struggle with. 
For instance, HIV and AIDS, chronic diseases, other STDs and antenatal care all place a 
large strain on the clinics. Nonetheless, I will argue that given the magnitude of the TB 
epidemic and surging rates of ‘defaulting’, it is a key contributor to a common perception 
among government clinic staff that the communities they serve seem unwilling or unable 
to ‘take responsibility’ for their health. As alluded to by the interaction between Tupac 
and the nurse in Carina’s Choice, practices of scolding are commonplace occurrences in 
the government clinics. Although I am careful to articulate nurses’ side to the story 
(Chapter 4; see also Joyner et al. 2014), many residents felt that when entering a clinic 
they were immediately placed in the role of the irresponsible patient and that they were 
treated without respect and as on the bottom of a hierarchy similar to that during apartheid 
healthcare (Chapter 7). TB discourse, I will argue, is especially insidious in the way that 
it deflects attention away from structural determinants of disease and reproduces a cycle 
of blame both in healthcare facilities and in the communities in which the disease finds 
traction.  
 It is against this backdrop that many people were approached by one of SATVI’s 
fieldworkers and were asked whether they would like to take part in a TB vaccine trial 
(Chapter 5). In order to help explain what SATVI’s trials mean in such a context, the 
following chapters are constructed empirically around a schema that I have adapted from 
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Sariola and Simpson (2013). At the point at which people were enrolled into trials, they 
might be considered abjects: in my usage, people for whom the conditions for leading 
normal, healthy and respectable lives have been rendered precarious by centuries of 
discrimination and exclusion.8 However, because of the close association between 
poverty and TB, it is in this state that they become valuable “objects of research and 
experimentation – they are available bodies that provide measurements, samples and 
pathologies to be observed” (ibid, p. 42). In the process, they become “reconfigured as 
universal human subjects” (ibid, p. 42), that is, autonomous, rights-bearing individuals 
who have more power and inclusion in the decision-making process than in ‘normal’ 
healthcare relationships (for example between Tupac and the clinic nurse in Carina’s 
Choice) (see Chapter 3). 
Beginning with a history of SATVI, I will demonstrate that constructing a 
research environment gravitating around the remote authority of GCP and the universal 
human subject was a challenging undertaking in a deeply rooted culture of medical 
paternalism (Chapter 3; see also Simpson & Sariola 2012). Nonetheless, I will show that, 
at the time my fieldwork, most of SATVI’s research staff embraced the ‘flat’ nature of 
research relationships (Chapter 5) and, in turn, participants appreciated being made to 
feel valued, included and as though they genuinely care about their own health and that 
of others. Indeed, I will argue that one of the most important reasons that SATVI has 
become engrained in the local context of health seeking and delivery is because of how 
the research relationships starkly contrasted with the authoritarianism of the government 
clinics (Chapter 7).  
                                                 
8 Sariola and Simpson use the notion of abjection with Kristeva's (1982) conception in mind and 
to characterise self-poisoning patient-participants in Sri Lanka. I use this term tentatively 
because, like the term ‘vulnerable’, it is not necessarily something that participants would 
consider themselves to be. However, I believe that it is a useful starting point for highlighting 
why they tended to view SATVI in a very positive light.       
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 Moreover, within the more dialogical relationship generated by the research 
environment, the category of the human subject was not ‘universal’ (as it is viewed in 
bioethics) but rather a surprisingly open-ended signifier. As I will show, both participants 
and staff were projecting their own beliefs, values, self-perceptions and moral aspirations 
on to the category of the human subject and what it meant to take part in TB vaccine 
trials. Indeed, in the same moment that the trial protocols were shaping participants as 
standardised and commensurable bioscientific objects (Lock & Nguyen 2010; Brives 
2013), on the ground it was the moral subject that was the primary locus of knowledge 
and intervention. Importantly, the meaning-making that surrounded the human subject 
also spilled into understandings of the science itself (and how it could be used). One 
common understanding of SATVI’s trials, I will show, was in terms of donations of ‘clean 
blood’, which condenses a highly-moralised understanding of trial participation that 
collapses the distinction between object and subject altogether (Carsten 2013a). The 
idiom of ‘clean blood’, I will suggest, contrasts starkly with the way in which trial 
protocols construe participants’ scientific value in terms of a passive disposition to 
sickness, one in which participants are simply drawn from and representative of a ‘high-
burden community’. Rather, it reflects people’s desire and commitment to be set apart as 
moral, responsible and respectable individuals, sometimes leading to radical 
transformations in outlook and lifestyle that had profound effects on their lives beyond 
the confines of the trials (Chapter 6).  
At the same time that SATVI was seen as a place for the betterment of self and 
society, however, the figure that such moral personhood was defined against – the 
‘problem patient’, the skollie or others engaging in ‘dirty practices’ – was never far away. 
In fact, he was seen both by participants and research staff to be very much attracted to 
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the trials because of the promise of regular monetary ‘reimbursements’9 (cf. Geissler 
2011). From the perspective of research staff, the presence of people seemingly only there 
‘for the money’ was often taken as a unique opportunity to work with and on certain 
participants to instil in them with their own values. Yet for most research participants, 
this meant conscious efforts to distance and disassociate themselves from the monetary 
incentive. For instance, during interviews, it was striking how many people’s narratives 
of participation began with the phrase, “it’s not about the money, it’s about…”, usually 
followed by a reference to personal health and/or altruism (Chapter 6). Following Jensen 
(2008), I contend that one of the contradictions underlying SATVI’s entanglement in 
people’s attempts to frame themselves as valuable, moral and respectable was that it relied 
on pointing fingers at other people, reinforcing the very stereotypes and structures of 
dominance that they sought to escape. The limits and often futility of people’s attempts 
to dissemble the structural violence that shapes them are discussed most explicitly in 
Chapter 8. This chapter shows that, despite their self-perceptions as responsible, health-
seeking individuals, participants who were diagnosed with TB did not always attend a 
government clinic for treatment, prompting collaborations between clinic and SATVI 
staff to ‘track them down’. In fact, insofar as the government clinic staff were concerned, 
the subsidiary function of SATVI’s trials was to extend their reach into hard-to-reach, 
gangster-ridden settings and exert control over the elusive bodies therein.   
What ultimately emerges from this thesis is a different moral economy 
surrounding trial participation than, for instance, that of substantive transactions of blood 
and medicine identified by Geissler and colleagues (2008). The significance of SATVI’s 
trials in people’s lives, I will show, goes beyond providing access to scarce resources 
                                                 
9 These ‘reimbursements’ were R150 per study visit (approx. £9 at the time of writing). These 
are detailed further in Chapter 3, p. 87 and Chapter 5, p. 145.  
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against the backdrop of withdrawing state structures. In fact, people often expressed a 
sharp resistance to material gain, at least where money was concerned, as they struggled 
back against the state’s inscriptions. This moral economy instead incorporates values 
such as respectability, cleanliness, ‘good’ lifestyles and responsibility, and is partially 
defined in opposition to the associations between TB and ‘dirt’. Insofar as this thesis 
offers a critique of bioethics, therefore, it is not a critique of ‘autonomy’ and the language 
of ‘choice’. For in my experience, these mapped closely onto the way people did or 
wanted to view themselves. One thing that participants would object to, however, is being 
placed uncritically into the bioethical category of ‘vulnerable’. Participants, as I will 
show, experienced vulnerability in an array of social spheres, including the grinding 
effects of chronic poverty, the threat of gang violence or pressure to join gangs, disease 
and stigma, and the perceived indignities of their interactions with the state. But SATVI 
was not among them. In fact, the institute was a place in which people felt safe and, 
moreover, was a platform from which to confront or avoid other kinds of vulnerability. 
To apply this category a priori not only misses the ingenuity with which people build 
worlds on the peripheries of social and economic life and, specifically, how they interpret 
and appropriate medical science. It is potentially even harmful given how hard they 
worked to escape stereotypes of themselves. To resist one stereotype only to be reframed 
as ‘vulnerable’ – which, as Chambers (1989, p. 35) argues, sustains images of the 
“amorphous and undifferentiated mass of the poor” – seems a gross injustice. This 
ethnography is about how people attempt to build lives in post-apartheid South Africa 
and how clinical trials can become a part of their search for a better future – a situated 
moral project taking place under the radar of the bio-scientific pursuit of the ‘greater 
good’ of a new TB vaccine.  
  
Chapter 1 
 
43 
 
The Chapters  
Chapter 2 provides a description of the field site and study design. This includes 
information about SATVI’s trial site and post-apartheid Worcester, as well as sections on 
methodology and the ethics of fieldwork.  
Chapter 3 offers a history of SATVI. It shows showing how research capacity was built 
for some of the world’s largest TB vaccine trials against the backdrop of an emerging 
field of global health science and an enduring history of apartheid governance. Drawing 
on the memories of SATVI’s first team, I elaborate upon the statement made by SATVI’s 
first site manager that “we learned research by actually doing it”. This included building 
the site, establishing trust with government workers, adapting to a researcher-subject (as 
opposed to healthcare provider-patient) relationship, and learning GCP. While the chapter 
focuses upon SATVI’s first trial, “the BCG study”, it ends with an account of 
developments between that study and the present, especially the landmark infant trial 
between 2009 and 2012. 
Chapter 4 describes the context of TB control within the scope of SATVI’s operations 
from the perspective of government clinic staff and especially nurses. I show that the 
nurses were struggling with a dissonance between the post-apartheid imagining that 
people would ‘take responsibility for their own health’ and the reality of patients not 
attending the clinics when sick and ‘defaulting’ on treatment when they did. The ‘gap’ 
between the clinic and home was viewed as one of the main challenges of TB control. 
The chapter shows how nurses made sense of this gap and, making sure to keep in view 
the difficult position they were placed in, suggests why they often resorted to blaming 
and scolding patients. Ultimately, however, I show how TB is moralised, reproduces 
stereotypes of the poor and legitimises authoritarian nurse-patient relations in ways 
reminiscent of the apartheid era.    
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Chapter 5 focuses upon the recruitment activities of SATVI’s fieldworkers, which were 
concentrated in precisely the low-income regions that the government clinics struggle so 
much with. I show that there was a tension in the requirements of their work: to fill the 
trials, the fieldworkers had to follow the flows of material need (especially for money), 
but at the same time had to reconcile this with the principles of autonomy and ‘greater 
good’ that featured in the consent process. I show how the fieldworkers navigated 
community settings and dangerous gang territories and attempted during the consent 
encounter to make to make people feel valued and needed, simultaneously as research 
subjects and as people more generally.   
Chapter 6 focuses on how the role of participants in SATVI’s trials was understood and 
enacted by participants and staff. It argues that, in the same moment that trial protocols 
were shaping people as standardised and commensurable scientific objects, on the ground 
it was the moral subject that was the all-important object of knowledge and intervention 
as both participants and staff brought their own beliefs, values and ideas of proper 
personhood to bear on the category of the human subject. The chapter oscillates between 
two symbolic associations: between TB and ‘dirt’ (dirty places, people and practices), 
and between SATVI and ‘clean blood’, a prevalent understanding of the trials which 
collapsed the distinction between object and subject. The chapter renders visible an 
emergent moral economy unfolding between these two poles, with people at once framing 
themselves as moral and respectable individuals while at the same time locating the ever-
present figment of immoral personhood, the skollie or ‘problem patient’, in others. I 
reflect upon how the idiom of ‘clean blood’ differs from the scientific conception of 
participants’ value, and also upon the symbolic capital, stability and possibilities for new 
life trajectories that are offered by trials in a context characterised by instability and 
unpredictability.   
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Chapters 7 and 8 offer competing accounts of SATVI’s role in the local context of health 
seeking and delivery viz. a viz. government clinics. Chapter 7 takes the perspective of 
participants and shows how they constructed themselves as responsible, health-seeking 
individuals who have been deeply wronged by the government clinics. SATVI, I will 
show, was viewed as almost the diametric opposite of the clinics. Whereas the clinics 
were viewed as degrading and inhospitable environments in which they felt they were 
subjected to scolding, indignities and breaches of confidentiality, SATVI was perceived 
to be friendly and caring and confidential, treating them with dignity and respect and 
actively including them in the decision-making process. Consequently, while they 
understood fully that SATVI did not have the capacity to treat any diagnosed conditions, 
it was viewed as a preferable point of entry into the health system.   
Chapter 8, by contrast, casts SATVI as it appears from the perspective of government 
clinic staff, which is one of extending their reach into ‘difficult’ community settings and 
control over elusive bodies therein. It focuses on the interactions between SATVI and the 
government clinic nurses at the point at which many participants were diagnosed with TB 
and thus referred to the clinics for treatment, especially in the frequent even that 
participants resisted the transition from participant to patient. Here the governmental 
stereotype of the irresponsible and elusive patient was reactivated and worked upon, and 
raised the question of whether SATVI was responsible for these participant patients and 
for how long. This final chapter serves as a sobering reminder as to the limits of people’s 
abilities to cast off the structural violence that shapes them and highlights the magnitude 
of the challenges facing the health system in post-apartheid South Africa.  
The final chapter revisits Carina’s Choice to reflect upon the central themes of the 
thesis. This includes the significance of ‘global’ medical research in contexts 
characterised by precariousness, instability and abjection; the experiential dimension of 
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‘vulnerability’; and the particular moral economy that I found surrounding SATVI’s 
trials. I finally offer directions for future ethnographic research, both with SATVI and in 
the broader field of TB-related medical science. 
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Chapter 2: 
Field Site and Study Design 
SATVI and Post-Apartheid Worcester  
SATVI is based at the Institute of Infectious Disease and Molecular Medicine at the 
University of Cape Town (UCT). Established in 2001, SATVI has grown from a small 
research group of just five, originally named the “BCG research group” to a large institute 
with a staff complement of well over 100 people (explored in Chapter 3). Its field site, 
where I conducted my fieldwork between August 2014 and 2015, is located 110km from 
Cape Town away on the premises of Brewelskloof TB hospital in Worcester, a semi-rural 
town in the Breede Valley sub-district of the Cape Winelands. The field site – or “the 
Boiler House” as it is known – incorporates a main office building (Figure 1), a number 
of vaccine clinics scattered around the hospital10, a satellite lab (the main one is in Cape 
Town) and a pharmacy. SATVI also has a large fleet of branded vehicles for conducting 
enrolment home visits, participant site visits, and transporting samples between 
Worcester and the Cape Town lab. The staff complement of the field site is around 65, 
including doctors (principal investigators), nurses, fieldworkers (referred to as clinical 
research workers [CRWs]), drivers, lab technicians, pharmacists and admin workers. 
From its base at the hospital, SATVI has a wide scope of operations of 
approximately 40,000 km2 and a study population of 350,000, which includes Worcester, 
other smaller towns and the numerous farms in the Breede Valley. Since the first trial, 
SATVI has enrolled well over 20,000 infants, adolescents and adults into TB vaccine 
trials and related studies over the years and this number is steadily rising. The majority 
                                                 
10 These vaccine clinics are isolated from the main hospital wards for the purposes of infection 
control. A description of how SATVI’s research spaces are arranged is provided in Chapter 2, 
which explores the social dynamics of capacity building.   
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of the institute’s trial activities at the time of my fieldwork were concentrated in the town 
of Worcester itself, which has around 100,000 residents. 
  
Worcester, as with the Western Cape more generally, remains divided along racial lines 
despite the freedom of movement since the end of apartheid. The town is divided by a 
long road called Durban Street, which historically separated those labelled ‘white’ from 
‘non-white’ under apartheid. North of the road is inhabited primarily by the town’s more 
affluent residents, which includes the majority of town’s white, primarily Afrikaans-
speaking population (14%). South of the road, in the town’s less affluent suburbs, live the 
majority of the town’s residents, the largest proportion of whom are coloured, Afrikaans-
speaking people (60%). Finally, on the outskirts of the town lies the primarily black 
township of Zwelethemba (25%), most of whom speak isiXhosa. There has been 
considerable movement and mixing between these historically divided populations, 
Figure 1: SATVI’s project office or “the Boiler House” 
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especially after apartheid.11 Nonetheless, there remains a stark difference in the 
distribution of health and wealth between the north and south of the town. The majority 
live below the poverty line, there is a high rate of unemployment and many households 
entirely dependent upon meagre social grants (Appendix 3 includes socioeconomic 
indicators for the Breede Valley and the social grants available to South African citizens).  
Brewelskloof hospital is situated in the north of Worcester in the middle of one of 
its wealthiest suburbs, ironically named Panorama. This is an odd place for such a 
hospital, given that TB disproportionately affects the poor. The hospital’s location is 
partially because it predates most of the houses in the area and was chosen for being an 
appropriate location distanced from the town centre. The hospital and the residents of the 
suburb’s large houses have a mutual lack of interest in one another, with TB 
circumnavigating the suburb and others like it with uncanny precision. Meanwhile, 
Worcester’s low-income suburbs are home to one of the most severe TB burdens in the 
world, even by the Western Cape’s standards, which has the highest burden in the 
country. Compion (2008, p. 28) observes that the Western Cape’s TB burden is a “unique 
epidemic within an epidemic”, one which is driven by a combination of “rapid 
urbanisation and poor housing conditions, poor nutrition, overcrowding, unemployment, 
a short supply of nursing staff and clinics, as well as numerous social issues like 
alcoholism, drug abuse and domestic instability” (see also Health Systems Trust 2004). 
Worcester is no different. In addition to high rates of chronic poverty, the town has the 
fourth largest gangsterism rate in the Western Cape, high levels of alcoholism and 
substance abuse and government clinics that are stretched to breaking point with the 
                                                 
11 For example, Zwelethemba has many coloured residents, especially in its poorest areas 
(usually because of migration and it being easiest to settle in Zwelethemba with little or no 
money). At the same time, many black people live in the primarily coloured suburbs. Moreover, 
many black and coloured people who benefitted most after apartheid live north of Durban 
Street.    
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volume of patients and prevalence of infectious disease. TB and poverty are particularly 
prevalent in the low-income suburbs of Avian Park, Roodewal, Riverview and the 
township of Zwelethemba. It is no coincidence that it is in these areas, too, where most 
of SATVI’s recruitment activity is concentrated (Figure 2).  
 
Known colloquially to local residents as the ‘TB people’, SATVI is a familiar presence 
in these areas of Worcester. In fact, having conducted many vaccine trials on a variety of 
age groups, it is not uncommon to find whole families who have taken part in a trial or 
are currently involved in one. Because of its humble origins as a group of only five 
individuals, SATVI is sometimes referred to by the institute’s members as a ‘family 
business’. However, today it is probably more accurately described as a family business 
in the sense of entire household participation. “SATVI – something for all the family”, 
was the way one of SATVI’s doctors jokingly put it.          
Figure 2: SATVI’s recruitment hotspots 
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 SATVI is as large and influential as other research institutes that have been the 
focus of anthropological investigation (e.g. Geissler et al. 2008; Molyneux et al. 2013; 
Reynolds 2013). However, because of the comparative strength of healthcare in South 
Africa, SATVI, like many other medical research institutes working within the country, 
are able to lean more heavily on government healthcare facilities than some other 
locations in Africa (Barsdorf et al. 2010), where research institutes are often required to 
provide basic healthcare for participants and even their communities during clinical trials 
(Geissler et al. 2008; Geissler & Molyneux 2011). While SATVI performs regular 
diagnostics and health checks as part of the screening and two-to-three-year follow-up 
phases of vaccine trials, the institute provides no treatment for any conditions, TB or 
otherwise, that are picked up along the way. Rather, participants are referred to their 
normal healthcare provider, usually a government clinic, which is then responsible for 
further diagnostics and treatment (Barsdorf et al. 2010). SATVI is, therefore, highly 
dependent upon the government clinics when running vaccine trials, departing somewhat 
from the imagining of an isolated island of ‘global’ medical research operating 
independently of state structures. For this reason, in addition to involving participants and 
research staff in my project, it was important that I conducted research in the government 
clinics that SATVI works with.  
Study Design  
The fieldwork for my PhD project took place between August 2014 and August 2015. 
Most of this time was spent in Worcester, where I lived for a year, but also with occasional 
visits to SATVI’s headquarters in Cape Town. The project builds upon previous research 
with the institute which was conducted for a month in June 2011 as part of an 
undergraduate honours research project and the same again in June 2012 as part of my 
Master’s research (Dixon 2012; Dixon 2013). As a result, when I started designing my 
Chapter 2 
 
52 
 
PhD research, I already had a preliminary sense of the lay of the land, which helped 
immensely with research design. More importantly, I already had a very good working 
relationship with Dr Michele Tameris, a senior research officer based at SATVI’s field 
site who helped supervise my previous research projects. With Michele’s assistance, I 
was able to navigate the labyrinth of scientific and ethical review boards to gain approval 
for the study. Michele is the official Principal Investigator on this project, an aspect of 
the research which will be discussed further under Ethics.  
The only participants in my honours and Master’s research were SATVI’s 
research staff (although, following them around, I inevitably came into contact with many 
other people involved in the trials). This project, however, aimed to provide a more 
comprehensive and historically informed account of how SATVI featured in the lives of 
those affected by their long-standing programme and therefore engaged a much broader 
range of local stakeholders. This included three broad groups: SATVI’s research staff (n 
= 40); vaccine trial participants (65 adults and 33 adolescents, n = 98); and government 
healthcare professionals (n = 20). Regarding the latter, I focused upon the healthcare 
facilities with which SATVI has worked most closely over the years. This included three 
clinics: Worcester Community Day Centre (CDC), Worcester’s largest clinic near the 
centre of town; Empilisweni clinic, located in the Xhosa-majority township of 
Zwelethemba (where the opening vignette was set); and De Doorns clinic, a more rural 
clinic nestled between a host of farms approximately 20 km from Worcester. It also 
included the staff of Brewelskloof Hospital. 
 My fieldwork was conducted in the context of four main clinical trials, which I 
followed throughout the year. The first was a Phase I adult trial which I shall call the 
Adult Safety Trial. This trial involved 66 TB-negative, healthy adults (of which I 
interviewed 26) and was designed to test the safety profile of a vaccine candidate. The 
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second was a Phase IIb trial, referred to as the Adolescent Trial. The trial involved 990 
TB-uninfected, HIV-negative adolescents (of which I interviewed 33), and was designed 
to test a vaccine’s capacity prevent TB infection. The third was a Phase IIb, multisite trial, 
which I refer to as the Adult Efficacy Trial. It involved 3,500 TB-infected, HIV-negative 
adults in total (of which I interviewed 27), and was an early efficacy trial to prevent active 
TB disease. The fourth, the most sensitive study, was a Phase I trial involving HIV-
exposed infants (i.e. whose mothers were all HIV-positive; I interviewed 12 of the 
mothers). While the protocols of the trials differed according to their participants and 
aims, their routines were all fairly similar. Therefore, Appendix 2 provides an overview 
of the structure of these vaccine trials, from screening to final visit usually two to three 
years later.  
The overarching methodology used in this study is that of ethnography. SATVI 
has been highly supportive of qualitative research, and has even conducted a number of 
studies themselves, some in collaboration with applied anthropologists (Mahomed et al. 
2008; Abrams et al. 2011). Nonetheless, it was a steep learning curve for both me and my 
informants to conduct ethnography in a setting where people are more used to the 
hypothetico-deductive methods of clinical trials (Bosk 2007; Bernard 2011). It has also 
been Michele’s thankless task to rein me in from time to time when my ethnographic 
instinct to explore and follow up on findings began to go beyond the scope of the 
predefined study protocol (see Ethics section). That said, it has undoubtedly been worth 
it; ethnography has proved ideally suited to getting beneath the neatness of the forms, the 
seeming commensurability of values and the formal accounts of SATVI’s work to 
uncover the ‘messiness’ of clinical trials on the ground.  
The two research methods that I used within a broad ethnographic methodology 
were (i) participant observation and (ii) interviews (semi-structured and unstructured). 
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These featured differently in my research depending upon the social setting and who I 
was interacting with. Thus, in the following two sub-sections I provide some further 
details on how I gathered my data and how they added value to the project.   
(i) Participant Observation  
Participant observation is designed to capture people’s day-to-day routines and 
experiences, enabling the researchers to determine what people actually do as opposed to 
just say (Hammersley 1992; Bernard 2011). It was my intention to ground my account of 
SATVI’s work in “thick description” (Geertz 1973) in order to foster an appreciation of 
the everyday realities within which clinical research is embedded. Because much of the 
participant observation took place in medical settings, the ‘participant’ in ‘participant 
observation’ strictly does not refer to my participation in medical practices but rather in 
the social dynamics of the setting: engaging in dialogue, asking questions, responding to 
questions – in short, not attempting to disengage from observed social phenomena unless 
contextually appropriate (Hammersley 1992; Bosk 2008; Bernard 2011).  
Only SATVI’s research staff and government healthcare professionals were 
directly involved in participant observation in the sense that I asked them as part of the 
informed consent process. The routines I engaged in were, firstly, going out into 
community settings with SATVI’s fieldworkers as they recruited participants. Secondly, 
I observed the morning vaccine clinic sessions at the trial site – not the consultations 
themselves (which were conducted behind closed doors) but rather in the waiting areas, 
where the staff were trying to channel people into the right rooms and make things run 
smoothly. I also observed the research staff as they went about their routines (but not 
involving contact with participants), for instance doing the paperwork. Finally, I spent 
time observing the routines of the government clinic nurses, primarily in the ‘TB 
departments’.  
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In consultation with Michele, we decided that it would not be appropriate, either 
pragmatically or ethically, for me to ask participants or patients to be the focus of 
participant observation. Nonetheless through spending time with research or healthcare 
facility staff, I inevitably came into contact with both. In fact, while I did not imagine 
being party to nurse-patient interactions in the government clinics at first, I realised 
quickly that because there were fuzzy boundaries between public and private in the 
government clinics regarding TB – for instance, the doors were almost always open and 
with up to three patients in there at once – it was very difficult to spend time with the 
nurses and not witness these. As we will see in Chapter 7, this methodological 
consideration is part and parcel of the reason why many people find government clinics 
so unpleasant and SATVI so attractive.  
(ii) Interviews  
Almost all of the participants in my study were interviewed, sometimes two or three times 
in the case of the members of the research team I grew closest to. There were a number 
of reasons why interviews were a valuable complement to participant observation. Firstly, 
they allowed me to shed additional light upon the events I witnessed while observing. 
Allowing for a greater degree of reflection than is possible in the day-to-day hustle of 
participant observation, interviews not only helped me to understand what has transpired, 
but also enabled a deeper exploration of meanings, beliefs and attitudes (Greener 2011; 
Bernard 2011). Secondly, they offered a means of drawing out phenomena related to the 
project that are not within the scope of participant observation (e.g. history). Thirdly, it 
was the only method that it was appropriate to use with participants.  
 The majority of the interviews were semi-structured. One of the reasons for this 
was because the University of Cape Town’s Human Research Ethics Committee wanted 
to have a good idea in advance of the kinds of questions that I would be asking people in 
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order to assess whether or not the line of questioning was ethically appropriate. By the 
time that I started the project, I had several interview schedules, each tailored to the 
different groups that I would be interviewing. While it is challenging trying to anticipate 
the questions that I wanted to ask before even starting the project, having these schedules 
turned out to be very useful. For especially in the case of trial participants and government 
nurses, interviews had to be made to fit around busy study visits and chaos of government 
healthcare delivery, which meant that the interviews were sometimes rushed and did not 
lend themselves to an unstructured interview format. The interviews with participants 
ranged from 15-40 minutes; with stops and starts, interviews with government healthcare 
staff were between 30 minutes and an hour and a half; and interviews with SATVI’s 
research staff were anything from 40 minutes to two and a half hours. It was these 
interviews with SATVI staff that were more likely to be unstructured, especially follow-
up interviews where all planned themes had been addressed.  
During interviews with participants, an Afrikaans or Xhosa translator was always 
present, both for the consent process and for the interviews themselves. Through the 
project, I had the help of several different translators, some of them SATVI’s fieldworkers 
when they had time to spare, other times with externally sourced ones whom I was able 
to find with the help of SATVI. The extent to which the translators needed to translate 
the proceedings varied immensely depending on the individual. Some informants were 
perfectly fluent in English but most struggled and on occasion switched between English 
and their home language; sometimes the entire conversation needed translating. 
Interestingly, it was not just matters of language in which the translators were highly 
beneficial. They played an important part in making participants feel comfortable, added 
to the conversations and often picked up on things that I simply missed. The translators 
are very much responsible for my development as an interviewer, as well as the 
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development of the interview schedules, for I had regular prolonged discussions with 
them between interviews about what had been said, the themes that were emerging and 
how we could improve. Invariably, I asked permission to tape record and transcribe 
interviews. In the small minority of cases where my participants did not feel comfortable 
with the use of a tape recorder, I took notes instead. Interview recordings were destroyed 
once transcribed.  
Ethical Considerations  
This project was designed in accordance with the American Anthropological 
Association’s (AAA) Statement of Ethics: Principles of Professional Responsibility 
(AAA 2012) and Anthropology Southern Africa’s Ethical Guidelines and Principles of 
Conduct for Anthropologists (Anthropology Southern Africa 2005) These codes implore 
anthropologists to carefully consider the structural circumstances informing ethnographic 
encounters and, moreover, to remain aware that ethical conduct is a process that begins 
the moment research is conceived and continues after ethical clearance is granted. Ethical 
approval for the project was attained through three channels. Firstly, in Durham it 
received approval from the Department of Anthropology’s Ethics Committee. In South 
Africa, the project went through UCT’s Human Research Ethics Committee in the Faculty 
of Health Sciences. Finally, in order to conduct research in government healthcare 
facilities, I attained approval from the Western Cape Department of Health.  
 Conducting ethnography in medical settings is a challenge and one that has been 
debated fairly extensively (Bosk 2007; Molyneux et al. 2009; Macdonald & Spiegel 
2013). The challenge stems at least partially from the different epistemological 
backgrounds. Medical research ethics procedures are designed with clinical trials and 
similar studies in mind, where everything that is going to be done can be stated in 
advance; its regulatory structure seeks to anticipate and control researchers’ actions 
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without leaving any stone unturned. The inductive and exploratory approach of 
ethnography thus sits uncomfortably with medical research ethics, because it means 
placing trust in the ethnographer that they will behave ‘ethically’ in response to particular 
situations (Simpson 2011). Indeed, this is precisely the kind of relational ethics that 
ethnographers have shown that frontline clinical research staff must engage in on the 
ground (e.g. Molyneux & Geissler 2008).  
In order to attain approval from University of Cape Town’s ethics committee, I 
had to make several methodological compromises. For instance, as discussed above, I 
had to provide detailed interview schedules in advance and state exactly where and with 
whom I would be spending time. I was, of course, more than happy to make these 
concessions and learned much about the rationale behind medical ethics through the 
fieldwork. Nonetheless, as mentioned above, Michele and I have had to work much out 
along the way. Michele, as the principal investigator, bore responsibility for any 
indiscretions I might have made and thus, on occasions, when I had my anthropology 
‘hat’ on and wanted to go off ‘exploring’ Michele was the one to sit me down and have a 
long think about whether what I was proposing was consistent with protocol. Can I go 
here? Can I ask participants this and that? Can I speak to this person or that person? These 
were things which struck me as necessary and unproblematic at the time but which, in 
fact, required careful consideration to remain true to the study’s protocol. It was not lost 
on me that that participants in SATVI’s vaccine trials must have been going through a 
similar journey, contending with the trials’ protocols, wondering what was expected of 
them and how to comport themselves. This is something that I try to bring out in the 
following chapters.   
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 In addition to the above considerations, below I detail how I adapted the major 
ethical tenets of human subject research to suit my project: (i) harms and benefits, (ii) 
informed consent, and (iii) privacy and confidentiality.  
(i) Harms and Benefits 
Ethnography does not pose the threat of physical harm to participants in the way that, say, 
clinical trials might. Nevertheless, ethnography is an intensive research methodology, 
involving not only prolonged but also affective interactions between anthropologists and 
research participants (Hammersley 1992; Bernard 2011). This form of engagement has 
the potential to make participants feel uncomfortable or even distressed if conducted 
insensitively or without due consideration of participants’ right to privacy. 
Participant observation was the most intensive method used. Consequently, the 
time frames of participant observation were arranged in consultation with participants 
with the explicit aim of ensuring that they were comfortable with my presence at all times 
and felt empowered to alter or terminate any agreed upon time frames. Another potential 
source of discomfort I was on the lookout out for were questions during interviews that 
asked participants to relate beliefs, attitudes, meanings or experiences. I made it clear 
during the consent process that that they could refuse to answer any questions they did 
not feel comfortable answering, whether in the course of my participant observation, 
interviews or focus groups. In the event that the research drew out experiences that caused 
significant distress (for instance, regarding illness of a relative), I had the measure in place 
to refer participants to an appropriate counselling service. Fortunately, nothing of the sort 
occurred and most were comfortable throughout.   
Participants were not remunerated for taking part, although South African health 
policy does permit this in certain circumstances where appropriate (Anthropology 
Southern Africa 2005). I did, however, almost invariably bring snacks and drinks with 
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me for participants during in interviews. In the case of adolescents, I made sure to bring 
sandwiches along. Interestingly, most of the adolescents did not eat or drink anything 
during the interviews but instead stashed them in their bags for later consumption and 
sharing back home. I do not believe this constituted any kind of ‘undue inducement’, and 
it felt the least I could do for giving me a portion of their afternoons.     
(ii) Informed Consent  
Informed consent was elicited in accordance with the AAA’s Statement of Ethics (2012). 
All participants were made aware that they could interrupt or withdraw their participation 
at any time with absolutely no repercussions. Although not required by AAA (2012) in 
all instances – which holds that informed consent should be adapted to context – I did use 
informed consent forms (Appendix 4). This is because the project took place in a medical 
environment where consent forms are standard practice and is contextually appropriate. 
In addition, I treated informed consent not as a once-off event but rather as an ongoing 
process during which I will maintained an open-ended dialogue with participants.  
In order to ensure that linguistic barriers did not impede the consent process, 
Afrikaans and/or Xhosa interpreters were used where necessary, and informed consent 
forms were made available in English, Afrikaans and Xhosa. In the case of adolescents, 
it was parents/legal guardians from whom consent was elicited, with the adolescents 
providing informed assent on a separate form. A final consideration for trial participants 
was that they were made fully aware that I was not a member of SATVI and that 
participation my project did not have any bearing on their clinical trial participation. 
Understandably, this was often a deep concern for participants who did not want to be 
interviewed.  
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(iii) Privacy and Confidentiality 
Assuring that participants’ privacy was respected and that data remained as confidential 
as possible was a key priority for me. As was discussed above, ethnographic research 
methods are particularly intensive and it was therefore important to put measures in place 
to ensure that participants do not feel that their privacy is being intruded upon. 
Throughout the fieldwork’s duration, all raw data remained confidential, with field notes 
and the tape recorder kept on my person and laptop password protected at all times while 
in the field. The only people who had access to the raw data were myself and my 
supervisors, including Michele. However, in order to protect employees lower down 
SATVI’s organisational hierarchy, Michele, who is a member of management, did not 
have access to any raw data pertaining to SATVI’s research staff. This was conveyed 
carefully to SATVI’s research staff during the consent process, who I am sure would 
otherwise have worried that the information they imparted to be would be immediately 
shared with SATVI’s management. Michele has acted as a supervisor in all other 
capacities.   
The kinds of data that were kept as hard-copy during the project were field notes 
taken in the course of participant observation and notes taken in interviews where 
participants did not wish tape recorders to be used. Electronic data included typed-up 
field notes and interview notes, interview and focus group tape recordings, and interview 
and focus group transcriptions. During the fieldwork, electronic data were stored on a 
password-protected laptop and an external hard-drive. In all raw data, participants’ names 
and identifying characteristics were removed. Moreover, after being transposed into 
electronic form, all tape recordings and field notes were destroyed.  
In all publications and other outputs from this PhD project, the majority of 
participants will be assigned pseudonyms. Pseudonyms have proved tricky in the case of 
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certain individuals. It was only towards the end of the fieldwork that it was decided that 
it would be appropriate for SATVI’s name to be used. But in doing so, for those with 
more unique roles, it is almost impossible to maintain their anonymity if anyone were to 
probe on the internet. Fortunately, these individuals are the higher-ranking members of 
the institute, and are happy for their names to appear unmasked. In the case of those lower 
down the institutional hierarchy, for instance nurses and fieldworkers, there are sufficient 
numbers that their identities can be protected through the use of pseudonyms.    
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Chapter 3: 
“We Learned Research by Actually Doing It”: A 
History of SATVI  
In her ethnography Scrambling for Africa, Joanna Crane observes that, with the advent 
of “global health science” at the beginning of the 21st century, Africa went from being a 
continent largely excluded from advancements in biomedicine to “an area of central 
concern and knowledge production” (Crane 2013, p. 6). Previously ‘neglected’ diseases 
were suddenly hot on the global health agenda – especially malaria, HIV and TB – and 
with it, scientific opportunity to participate in the trialling of new biomedical products 
was rife, both for scientists in the global north and ‘local’ collaborators. A number of 
factors common to other developing world settings make African nations conducive to 
the conduct of clinical trials: infectious diseases are highly prevalent; ‘standards of care’ 
are lower; and populations are comparatively ‘treatment naïve’ – all of which enable 
smaller sample sizes and make it easier to demonstrate efficacy (Petryna 2009; Crane 
2013; Geissler 2013). Under-resourced healthcare systems also make it more likely 
people will consent to take part (Biehl & Petryna 2013; Geissler 2014). Moreover, as 
Petryna (2009) argues, “ethical variability” in regulatory standards makes it possible to 
conduct trials in precisely these kinds of impoverished, under-resourced environments, 
whereas in the global north they might not be permissible (see also Angell 1997; 
Wendland 2008; Nguyen 2010).  
 At the same time, the conditions that make the continent scientifically valuable 
are precisely those in which it is challenging to conduct rigorous clinical science. In order 
to be inserted into the slipstream of ‘global’ knowledge production, researchers must 
conform to the scientific and ethical standards laid out in international guidelines, 
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especially GCP (see Chapter 1, p. 23). Nothing short of unfaltering compliance with these 
guidelines guarantees the reputability of results with regulatory agencies (e.g. the FDA) 
and journal audiences (Simpson 2012, p. 557). With the infrastructure, technology, 
expertise and oversight required to meet these standards often severely below-par in 
developing world settings, significant ‘capacity building’ and ‘community engagement’ 
initiatives are usually needed in order that local conditions can be leveraged to participate 
in the global knowledge economy. This includes building or upgrading research sites, 
clinics and labs; engaging local stakeholders; (re)training staff; ensuring supply lines and 
cold-chains12; and sometimes even establishing ethical review committees (ERCs) 
(Sariola & Simpson forthcoming; Geissler & Molyneux 2011; Crane 2013).  
 Today, Africa is punctuated with large medical research sites that have been 
around for years if not decades. They have considerable power and influence and 
hundreds of high-impact publications that have led to new products. Yet in Africa, as in 
developing world contexts more generally, we have relatively few sustained accounts of 
what goes into establishing such sites in the first place and how the conditions and social 
relationships for globally reputable clinical research are constructed and maintained. This 
chapter joins with a modest number of accounts which explore this from the perspective 
of ‘local’ collaborators, whose efforts to attract externally sponsored clinical trials are 
often driven by more situated concerns, for instance healthcare, social and economic 
development than their northern counterparts (Sariola & Simpson forthcoming; Petryna 
2009; Petty & Heimer 2011; Crane 2013; Okwaro & Geissler 2015). It should be noted 
that the power differential between SATVI and its northern partners is not as pronounced 
as at some of the research sites explored by anthropologists in Africa (e.g. Okwaro & 
                                                 
12 The cold chain is a supply chain in which the temperature is rigorously controlled to make 
sure that the vaccine remains at the required temperature.  
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Geissler 2015). This is partially because academic medicine in South Africa has 
historically been well-resourced in comparison with the healthcare facilities upon which 
the majority of South Africans depend (Coovadia et al. 2009). Nonetheless, the 
researchers who founded SATVI needed to undergo a radical process of what Simpson 
and Sariola have referred to as “epistemic development”, that is, what they needed to 
learn and to accomplish in order for them to “participate, gain credibility and, indeed, 
compete in the game of global scientific research” (Sariola and Simpson forthcoming; see 
also Crane 2012). It is the social dynamics of this developmental process that I focus upon 
in this chapter.  
 More specifically, in this chapter I demonstrate that the history of SATVI is one 
of learning by doing. With so many international guidelines in circulation today, most 
influential among which is GCP, there always seems to be the assumption that the 
knowledge about how to conduct clinical trials, especially their ethical dimensions, is 
already in place, that it is fixed and requires only application. Anything that even slightly 
diverges comes across as irresponsible, if not raising the possibility of malpractice. Yet, 
while taking on the appearance of a closed system which covers all bases, GCP has 
travelled widely and been received and interpreted in very different settings to the 
Western contexts in which it was initially developed. From the perspective of local 
collaborators, international research guidelines do not simply fill a space that was until 
then left vacant, but have to be negotiated with pre-existing ways of doing things. 
Moreover, even local adaptations of research guidelines (e.g. South African GCP) do not 
offer all the answers.  
When SATVI was established in 2001, funding for large clinical trials in Africa 
was on the rise, GCP was only just beginning to gain traction in South Africa, and the 
legacies of apartheid were still (and indeed still are) resonating loudly. Against this 
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backdrop, the researchers who founded SATVI committed to conducting a huge TB 
vaccine trial in a region with no previous exposure to field research with very little 
research experience themselves. By taking us into the microcosm of ‘the BCG trial’, I 
will show that the epistemic capacity for research was not secured in advance and then 
applied; rather it was an ongoing inductive, iterative and error-driven exercise that meant 
working with, through and often against the hard-set social relations of apartheid. As 
Dennis – SATVI’s first site manager and one of the main protagonists of this chapter – 
put the matter, “we learned research by actually doing it”. This chapter therefore 
contributes towards an arguably much-needed de-fetishising of GCP; to look beyond the 
obsessive drive towards rule-following in global health research by showing the 
ingenuity, creativity and experimentation that underlies one of Africa’s largest and 
reputable TB vaccine trial sites. This is, moreover, a useful point of entry into our 
exploration of SATVI’s trials, highlighting the origins and longevity of a number of the 
challenges and that have endured through to the present. These challenges include, most 
notably, conducting research in a context of medical paternalism and, secondly, 
maintaining the delicate line between research and care.  
  While most of this chapter is focused upon the BCG trial, the final section fast-
forwards through the developments between the end of the trial and the present day. This 
is so that the necessary context is in place to turn to the events surrounding SATVI’s trials 
as they were unfolding during my fieldwork. It is unfortunately beyond the scope of this 
chapter to devote more attention to these subsequent developments, for every study and 
every milestone was an important part of SATVI’s growth and reveals something more 
about SATVI’s current shape. Nonetheless, the BCG trial was viewed as a rite of passage 
into the game of global scientific research and thus warrants detailed exploration. Let us 
turn to the relationship between two leading paediatricians, where it all began.   
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A Meeting of ‘Local’ and ‘Global’ Agendas  
SATVI began its life as an idea – a debate in fact – between two leading experts in 
paediatrics and infectious disease in the Western Cape. These were Professors Grant 
Hennessey and Maurice Kibel, colleagues at the Red Cross Children’s Hospital in Cape 
Town, the main paediatrics teaching hospital of the University of Cape Town (UCT). 
Professor Kibel, the senior of the two, had moved down from Zimbabwe in 1979 in order 
to fill a novel Chair in Child Health that had been established at UCT/Red Cross. The aim 
of this chair (one of three set up throughout South Africa in total, funded by the Stella 
and Paul Loewenstein Trust) was to bridge the gap, both metaphorical and spatial, 
between teaching hospitals and community-based medicine – “grassroots paediatrics” as 
Maurice referred to it. This attempt can be located within a broader historical trend (albeit 
a stunted and uncoherent one) towards the prioritisation of primary healthcare provision, 
involving the Gluckman Commission in the 1940s, Alma Ata in 1978 and the drive for 
equitable access to healthcare as the apartheid regime decayed through the 1980s and 
early 1990s. Grant arrived on the scene a couple of years afterwards, taking up a post at 
UCT/Red Cross under Maurice. Through the 1980s and 1990s they worked together 
closely as mentor-mentee, where they encountered a lot of TB and, in particular, 
childhood TB. 
The debate that these professors were having during the late 1990s had to do with 
the method of administering BCG, which, given to infants at birth, was (and still is) the 
only available vaccine to protect against TB. The BCG has been shown to offer up to 80% 
protection against TB meningitis and miliary disease, but protection against ‘normal’ 
pulmonary disease is more variable, with protection waning towards the equator. As of 
the year 2000, Japan and South Africa were the only countries with large BCG 
vaccination programmes that still used the ‘percutaneous’ method of administering the 
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vaccine, rather than the intradermal method recommended by the WHO (Hawkridge et 
al. 2008). The percutaneous method involves a multi-puncture device that one applies 
pressure to, which drops a measured amount of BCG into the skin. The merits of this 
method are that it is cheaper and also has fewer side effects (Nicol et al. 2002; Hawkridge 
et al. 2008). The downside, however, is that there are more variables to consider, such as 
how much ‘pressure’ one should apply, and how much BCG would actually enter the 
skin. So how effective was it? Nobody really knew, and Grant and Maurice were at the 
forefront of the debates surrounding its relative merits (e.g. Nicol et al. 2002). In order to 
fall in line with WHO recommendations, South African national policy was transitioning 
around 1999-2000 towards the intradermal method, but an important condition that came 
out of these negotiations was that further research was needed. And it was then that Grant 
decided that it was time to do a large-scale clinical trial (phase IV) to compare the efficacy 
of the intradermal versus percutaneous methods of administration. 
Involving around 12,000 newborns, such a study would dwarf any BCG study that 
had been performed since the mid-20th century. Where could this trial be conducted? And 
how would it be funded? Fortunately, Grant and Maurice, partially due to the latter’s 
mandate to get academic medicine more in touch with primary healthcare, had been 
providing outreach and support for a number of years in a semi-rural sub-district of the 
Cape Winelands called the Breede Valley. Practice included monthly ward rounds at the 
regional TB hospital, Brewelskloof, improving the standards of care in primary healthcare 
clinics, and also organising lectures and symposia for healthcare professionals in the 
region. In short, they were well known and respected by the district health authorities for 
the work they were doing. The Breede Valley had a number of attributes that made it 
highly suited for a large-scale BCG trial. Firstly, it has an astonishingly high burden of 
TB among the ‘coloured’ and ‘black’ communities, even by South African standards 
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(1,500 per 100,000 compared with the national average of 1,000 per 100,000). Secondly, 
it had comparatively strong public healthcare facilities, crucial for recruitment, record 
surveillance, and follow-up care for participants. Thirdly, it was a fairly discrete 
geographical area, with a stable rural population, and in easy reach of Cape Town 
(approximately 110 km). Because of Grant and Maurice, the district health authorities 
were “keen to get involved”, as Grant put it.   
 In terms of funding, there was a meeting of agendas. Grant originally sought 
funding from the WHO and UNICEF, but they did not have the resources available at the 
time. However, as Grant explained to me, “the world was talking about new vaccines 
because of the escalation of TB”, especially since the WHO declared TB a global 
emergency in 1993.13 One US-based NGO very much at the forefront of the push for new 
TB vaccines was Sequela (which became Aeras), itself funded by the recently established 
Gates Foundation. At the time that the professors were seeking funds for the BCG trial – 
the year 2000 – Sequela was fortuitously looking for a site in the developing world to 
build capacity to conduct large, high-quality trials on promising TB vaccine candidates. 
Grant was, in other words, at the right place and the right time and “the rest was history”, 
as he put it. The agreement was that Sequela would fund the proposed BCG trial in order 
to build research capacity in the Breede Valley, after which Grant and his research group 
would turn their eyes to new vaccines. As Grant put it, the trial had four aims: (i) to 
answer a research question, (ii) to develop capacity for new vaccine research, (iii) to 
develop partnerships with the health services and (iv) to develop trust between themselves 
and the community at large. This is the story of how SATVI was established.        
  
                                                 
13 As discussed in Chapter 1, the BCG is not deemed sufficient as a self-standing TB 
preventative. 
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Networks and Relationships  
For the purposes of orienting the following exploration, the proposal for the BCG trial 
design was (very roughly) as follows. Pregnant women were approached at the Midwives 
Obstetrics Units in the Breede Valley – Worcester, Robertson, Ceres, De Doorns and 
Rawsonville – and asked whether they would like to enrol their baby into the study. For 
those that gave their consent, their babies were vaccinated with BCG at the hospital within 
24 hours of birth with either the intradermal or percutaneous method of administration 
(which was randomised by week across all Obstetrics Units). Then, the babies were 
followed up ‘actively’ for three months for adverse events, with every baby being visited 
by the study team at least once. They were also followed up ‘passively’ for two years via 
their public clinics, where babies were seen regularly in their first years of life. This meant 
that in the event that a participating infant was brought to the clinic with signs of TB, the 
clinic nurses called the study team, who took them for an independent series of 
diagnostics (over a 48-hour period) that constituted the data for the trial. For those infants 
who developed TB during the trial, it was not SATVI’s responsibility to treat them, unlike 
in many trial sites in Africa where public healthcare facilities are much weaker (Fairhead 
et al. 2006; Geissler et al. 2008). Rather, they were referred back to their local clinic for 
treatment (or admitted to Brewelskloof children’s ward in severe cases). At the end of the 
trial, all of the data were analysed to determine whether there was a significant difference 
in the number of TB cases between those who had been vaccinated using the intradermal 
method and those that had been vaccinated using the percutaneous method.     
Aside from the process of securing ethical approval (from UCT’s human research 
ethics committee), a huge amount of preparatory work was needed before the BCG trial 
could get off the ground. As reciprocation for the support given by the Department of 
Health, Grant started off with a small research team based in Cape Town running a 
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training programme in 2000 for nurses in the Western Cape on how to administer the 
BCG vaccine intradermally (which, as discussed above, was gradually being rolled out 
nationwide at the time). The motivation for this was that nurses were often administering 
it incorrectly, leading to adverse events. To this end, two of Grant’s study nurses, Anita 
and Mary, visited all of the Midwives Obstetrics Units in the Western Cape, including 
Ceres, Robertson and Worcester, which was where the infants for the BCG study were 
going to be enrolled from. While this was for the good of healthcare in the region on one 
level, this also helped to ensure that, when the BCG trial got underway, the vaccines 
would be administered properly by the government facility nurses. Moreover, this initial 
work helped to build trust within the healthcare facilities for when the BCG trial started.  
 At the same time that this training programme was taking place, the work of 
setting up the trial site in Worcester began. Grant and Dr Toby Hardy – the doctor 
appointed to the post of medical officer for the BCG trial and who quickly became Grant’s 
‘right hand man’ – conducted much of the networking at the level of district upper 
management. This included liaising with the district manager, Dr Franz Kruger. Dr 
Kruger gave them permission to establish a site on the premises of Brewelskloof hospital, 
allowed them to admit participants to the hospital for diagnostics and gave them use of 
the old Matron’s flat in the nurses’ home in which to work. He also gave them 
progressively larger spaces in the hospital from which to work as SATVI expanded (to 
be discussed later). In addition to the trial site itself, Grant gained permission from Dr 
Kruger and other key players in the Department of Health to gain access to the region’s 
government facilities (Midwives Obstetrics Units and clinics), and Dr Kruger sent 
directives to the facility staff to cooperate with the research team during the BCG study. 
As Grant expressed to me, without the support of the Department of Health, and Franz 
Kruger in particular, “we couldn’t have got it [the BCG study] going”.  
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 While this networking at the upper-managerial level was crucial, there was still 
much work to be done developing relationships and trust ‘on the ground’. This was 
important because, as several people related to me, while some medical research had been 
conducted in the Breede Valley, this had mainly been conducted with hospital in-patients 
rather than at the primary healthcare level. Certainly, nothing on the scale that the BCG 
trial proposed to achieve had been conducted, which would involve many healthcare 
facilities and 12,000 infants in the region. “This was a major move into the community”, 
as Grant put it. Some of the most important work in this regard was performed by Dennis, 
SATVI’s first site manager. A lab technician by training, Dennis was from the area and 
had pre-existing relationships with the healthcare facilities in the region and their staff. 
Whenever I spoke about the formative years of SATVI with its staff, Dennis’s name 
almost invariably came up. For example, Toby, reflecting upon Dennis’s importance in 
SATVI’s early years, said: 
Because he’s from that area, and he’s absolutely fluent in Afrikaans and 
English, he could make those connections and he was very well 
accepted...You could walk through Worcester and every second person 
would greet him.  
It was Dennis who was regularly visiting the Midwives Obstetrics Units and government 
clinics, greeting and remembering people (“baby kissing”, as one person jokingly put it), 
setting up meetings with the facility managers to keep them informed of developments, 
and in general making sure that SATVI was an active and known quantity in the region 
right from the outset. He was, in many ways, SATVI’s first ‘face’ in the area. Moreover, 
with Grant’s blessing, he also gave several ‘gifts’ to the healthcare facilities, including 
putting fridges in the Obstetrics Units (which, during the study, would be used to store 
BCG vaccines but afterward the fridges reverted to ownership of the clinic), TVs and 
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other useful items. This relational work would become especially important once SATVI 
started relying upon government health facility staff during the BCG study.  
SATVI’s First Community Advisory Board 
It must be noted that, while SATVI’s ‘community engagement’ activities were quickly 
aimed at the wider community, the lion’s share of that work in the formative years 
involved mainly healthcare facility staff. This is particularly demonstrated by the 
establishment of SATVI’s first community advisory board, which Dennis and Toby were 
charged with. Community advisory boards are the most common form of ‘community 
engagement’ and have received considerable attention in bioethical literature (Marsh et 
al. 2008; Pratt 2013; Kamuya, Marsh, et al. 2013). One issue that comes to the fore in 
relation to community advisory boards is: what is ‘the community’? Moreover, is the 
advisory board representative of it? The ethical imperative underlying this is that the 
views of all stakeholders in research should have a say in how it is conducted and how it 
can be shaped to fit local values and cultural sensibilities. Dennis and Toby advertised 
the advisory board to the general public via a local newspaper. However, the 
overwhelming subscription was by healthcare workers. As Toby expressed this to me: 
That [the community advisory board] was quite tricky because...the first 
one was very heavily dominated by people from the health services, so 
they were all happy to be part of this effort, and they were good people 
don’t get me wrong, but ...You’d have the matron of here, the 
superintendent from there, et cetera. There weren’t that many actually 
bona fide community reps. So, they were representing not the community 
but the health services!  
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In a similar vein, Dennis said to me: “the core of our community was the health facility 
people”. This very much reflected the relationship between healthcare staff and patients 
that had been inherited from apartheid, which had only elapsed six years previously. This 
was one in which healthcare staff were the ones who made medical decisions on the part 
of patients. As Toby put it, “in the old regime this is how healthcare worked: the doctors 
were right, the nurses were right, you did what you were told – very authoritarian”. As a 
result of this paternalism, the advisory board was very permissive when asked whether 
aspects of the trial were appropriate. For instance, Toby said to the board members, “we 
want to approach the mums when they’re pregnant, then visit them again at birth, et cetera 
– will this be acceptable? And as health professionals, some of them said ‘yes they’ll 
sign’. It was as simple as that”.  
With so little input from lay community members, Dennis interestingly saw it as 
his responsibility to take on the role of the “community’s conscience”, as he put it. This 
was certainly for the BCG study, but he also maintained this self-appointed role 
throughout SATVI’s formative years. He looked carefully at research proposals, 
considered the risks and benefits, what was culturally appropriate and inappropriate and 
his input was fed into protocol designs. One notable example that Dennis related to me 
was an immunology sub-study that was proposed to take place within the BCG trial itself, 
involving HIV-exposed babies (i.e. with HIV-positive mothers).14 Not only was the study 
incredibly sensitive (especially given that antiretrovirals were not yet available); it also 
involved regular blood draws from the babies. Dennis, in this case, was the one who 
considered the “agony and pain” of the children and the mothers who had to look on, 
limiting the volume of blood that the scientists were permitted to take at any one time. 
                                                 
14 This study was scientifically value in and of itself, like the BCG study. However, a subsidiary 
function was to build capacity for immunology, central to TB vaccine research.  
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This might seem like a highly problematic response to the challenge of a highly partial 
community advisory board, only adding another layer of paternalism onto the situation, 
another person claiming to know what is best for the ‘vulnerable’. However, what this 
shows, I believe, is that people will always find ways of acting ethically, of doing what 
they believe is morally necessary, even if the only place to turn seems to be one’s own 
virtue ethics, as was the case for Dennis. In subsequent years, the advisory board became 
considerably better represented by lay people. However, this was all built upon the 
lessons learnt during of these formative years and from grappling with challenges of 
representation in a post-apartheid setting.    
Staffing and GCP Training  
A couple of months before the BCG study was due to start, other members of the field 
team were hired. The main appointments were three professional nurses: Lydia, a nurse 
with several years of experience working in TB in the Eastern Cape; Sophie, previous 
facility manager of Empilisweni clinic in Zwelethemba; and Lorna, a nurse from the town 
of Ceres. These nurses were to perform the bulk of day-to-day study tasks. While Dennis 
and Toby would take care of randomising the vaccines, the nurses were to: transport the 
vaccines to the Midwives Obstetrics Units; ensure the ‘cold chain’ was maintained; record 
the data; monitor the facility nurses as they administered the vaccines; follow up on 
adverse events, TB suspects and other illnesses; and perform certain TB-related 
diagnostics in the CV ward. It was thought at first that the nurses could also perform the 
consent process in the Obstetrics Units with pregnant mothers. However, this quickly 
appeared untenable. Thus, approximately twenty fieldworkers15, most of whom were 
previously HIV counsellors, were hired to perform the bulk of the informed consent 
                                                 
15 As discussed in Chapter 2, the fieldworkers are referred to at SATVI as ‘clinical research 
workers'. I use the more generic term for the sake of consistency with existing literature.   
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processes (although nurses did perform some), much like field workers who have been 
written extensively about in other African research contexts (Geissler et al. 2008; 
Molyneux et al. 2013).      
 Other members of the study team were drawn from four groups. Firstly, there 
were the nurses who had been conducting the training course all over the Western Cape, 
who were to stay based in Cape Town but serve as internal monitors for the trial and also 
help train the on-site staff. Secondly were the immunology team members, who were less 
important for the BCG study but central to the HIV sub-study and subsequent trials. 
SATVI’s main laboratory was based in Cape Town; however, an on-site lab was 
established for less technologically intensive work. Thirdly was Brewelskloof hospital’s 
paediatrician Dr Gilbert. While not directly a member of SATVI, he agreed to be part of 
the diagnostic team for infants brought into the hospital with suspected TB. Toby 
mentioned the following of Dr Gilbert and his contributions:   
[Dr Gilbert] was an excellent resource, because even then he’d been at 
Brewelskloof for about ten years, so he knew paediatric TB on the clinical 
side backwards, and he would do the ward rounds, read the Mantouxs, 
read the X-rays, and make a judgement. And he wasn’t employed by us, 
so he could make an unbiased call whether this was a case or not.  
(We will hear more about Dr Gilbert in Chapter 8; see also Dixon 2012, forthcoming 
regarding the diagnosis of childhood TB in research contexts). Finally, there were the 
various administration workers and support staff at the trial site and in Cape Town. This, 
in effect, was SATVI’s first team. In the years that followed, SATVI expanded rapidly 
from this initial few to nearly 200. However, it all started with this small group of 
individuals.  
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 A significant challenge for this first study team was that almost every member 
was accustomed to working in clinic and hospital environments, and almost none of them 
had any prior experience of conducting research. As Margaux, one of SATVI’s first lab 
technicians, put it: “Most had clinical backgrounds as nurses or doctors, and had little 
knowledge of research, as research was a foreign concept, especially for this area”. Toby 
made a similar point: “It was new for the nurses, but it was new for me as well”. In order 
to train the team in how to rigorously produce clinical data, a great deal of training (and 
retraining) was needed. GCP was fairly new at the time, having come about in 1996, but 
in South Africa as elsewhere, it quickly became a key document in shaping the conduct 
and oversight of research practice (Petryna 2009:37; Simpson & Sariola 2012). Toby 
explained to me that, in the beginning, they relied largely upon external GCP trainers. 
But as the years went by, it was decided that it would be more economical to develop 
their own in-house GCP-accredited training and quality assurance department. This work 
was spearheaded by a research coordinator called Monica in collaboration with some 
international partners, particularly George Washington University.  
What was interesting, however, was that while the impression I gained from 
SATVI’s management was that everybody was trained in GCP before the BCG trial 
started, speaking to the nurses it became apparent that the training they received at the 
beginning was not couched explicitly in the language of GCP. Lydia said to me that:   
We had a little bit of training, but not GCP training. Every Friday, we’d 
have something called ‘supervision’, where we’d go and meet with 
different groups of consenters, a different group each time…and this was 
the forum through which we taught them how to do the consents, with no 
knowledge of GCP… We needed to do GCP but we just didn’t know it at 
the time.  
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GCP was more as a “buzzword from the US”, as Anita put it, which gradually took on 
pertinence as the trial went on and largely in response to challenges encountered along 
the way. Perhaps more importantly, every single person, regardless of their thoughts on 
GCP, expressed that they were all very much leaning ‘on the job’. As lab technician 
Margaux put this: “This was a tiny team, doing an enormous study, with absolutely no 
knowledge of clinical research. We were winging it”. Therefore, it is useful to dive 
straight in and highlight how, as with SATVI’s first community advisory board, this 
“enormous study” put everyone on a steep learning curve in which GCP functioned not 
so much as a clear set of rules pathing the way so much as a dim torchlight on an 
exploratory potholing expedition.    
Trial and Error 
The first baby was vaccinated on the 23rd March 2001, to the relief and delight of the 
study team. This moment, and all significant enrolment milestones after that, were relayed 
to Grant in Cape Town and celebrated. Enrolment was very steady; in fact, as Toby said 
to me, one thing they certainly did not have a problem with was persuading pregnant 
women to enrol their baby into the study (cf. Reynolds et al. 2013). Of all mothers-to-be 
approached, “only a handful refused”, he explained. Nonetheless, the team encountered 
numerous challenges along the way that they had to deal with in a largely ad hoc fashion. 
Many of these had to do with the handling of vaccines, the maintenance of the ‘cold 
chain’, and the recording of participant and other relevant data – things which were 
crucial to ensuring the scientific success of the BCG trial and indeed for the broader effort 
to develop research capacity at the site (Petty & Heimer 2011; Crane 2012). However, 
the challenges that I focus on here, as they are the most relevant to the following chapters, 
are those relating to the face-to-face encounters between the study team and participants.   
Chapter 3 
 
79 
 
(i) Informed Consent 
The first challenge stemmed precisely from the realisation that so few mothers-to-be were 
refusing to take part, casting the spotlight on the consent process. As was discussed in 
Chapter 1, informed consent has a long history in medical research (see section entitled 
‘globalised clinical trials’). Designed to uphold the bioethical principle of autonomy, 
informed consent involves the clear communication of information about research so that 
people can make rational, informed decisions to take part. The problem, similar to the 
one regarding the establishment of SATVI’s first community advisory board, was that the 
BCG study was being implemented in a context with a deeply entrenched culture of 
medical paternalism (cf. Simpson & Sariola 2012; Sariola and Simpson forthcoming). 
Lydia explained to me that, when SATVI’s team were enrolling participants from the 
Midwives Obstetrics Units, they were introduced by the facility nurses as researchers 
from the University of Cape Town and there was an intention for them not to resemble 
the government facility nurses. “They tend to say yes to anybody in a uniform”, as Lydia 
put it. But despite this, during Dennis’s first internal audit of the consent process, things 
went “horribly wrong”, as Lydia put it, with a paternalistic attitude underlying a 
consenter’s interaction with the mother.16 Dennis recounted the incident: 
When I was doing the monitoring for the consent, and this happened 
particularly in the Xhosa/black language consents...We listened to the 
nurse doing the consents, and you’d have someone translating it back to 
you. We were so, so intrigued and concerned, because we heard something 
to the effect of “you must do this study because it is good for you”. We’ve 
                                                 
16 Field workers performed the majority of the informed consent processes. However, especially 
in the beginning of the BCG trial when there were not so many field workers, nurses performed 
quite a few of the informed consents.  
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seen this on many occasions, it’s a short-cut. They basically breeze 
through the consent form and say “you can read the rest later, but sign now 
because it’s in your interests”. And it was very much a thing of the 
command that the nurse had with their patients. 
Sparking a sudden realisation that something was fundamentally wrong, this incident was 
recounted to me as a sort of myth of origin for the ‘need’ for GCP, resulting more intense 
training and oversight of the consent process. As Lydia said, “GCP training got quite a 
lot more intense after that one. It was a turning point”. Based on my experiences during 
fieldwork, I would suggest that this really was a turning point and that the research team 
were highly motivated to include participants and make them feel that it was their 
informed, autonomous decision whether or not to take part. More generally, as we will 
see in Chapters 5, 6 and 7, both participants and research staff came to value the more 
open and communicative relationship that was engendered by the research environment 
and the possibilities to which it gave rise.  
 It might have been the verbal component of the consent process that made for the 
best horror story as to what could go wrong with consent. However, speaking to the team, 
it became clear that they learned quickly that what mattered most to the regulators as 
evidence for conformity to GCP was the quality of documentation (Petryna 2009; 
Simpson et al. 2014). Mary, who had some prior knowledge of GCP as a trainer, did some 
more online research and found that they needed to look very carefully at the quality of 
data, case report forms, but especially the informed consent forms. It subsequently 
became Anita’s job to regularly take a 10% sample of the consent forms, check that they 
were being filled in correctly and, in the event that there was an error rate of over 20%, 
they would do a wider audit and, if the need was found, Mary conducted further training 
with the staff. Reflecting upon the steep learning curve, Anita said, “It’s completely 
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different today, we wouldn’t dare...I mean if I think about it now, I’m quite horrified, it’s 
just the way it was”.  
The following chapter, which focuses upon the activities of the field workers in 
community settings, explores the informed consent process in greater detail. The 
experiences of SATVI’s first team just underline that GCP was not simply a stable source 
of guidance from the beginning but was learned on the job, an undertaking made more 
complex in the context of medical paternalism in which it was applied.   
(ii) The Case Verification Ward  
To the dismay of the study team, they actually missed the suspected first case of childhood 
TB, because the public clinic nurses forgot to inform them and thus the baby was put on 
treatment before the study-related diagnostics could be performed. “There was no 
surveillance back then”, reflected Lydia – referring to the surveillance department that 
was later developed to pre-empt this kind of occurrence. Despite missing the first TB 
case, others quickly followed and there was a steady stream of participants. Moreover, 
once the HIV immunology sub-study started sometime in 2002, they were going out and 
actively doing screening for TB in participating infants and many potential TB cases were 
identified this way. In fact, the volume of participants was enough that it outstripped what 
the hospital’s general ward could handle.  
Fortunately, the district manager Dr Kruger, with whom Grant was on good terms 
(discussed above), had an unused ward in the hospital which he allowed SATVI to make 
use of. Moreover, Lydia had been liaising with the hospital’s matron for the purposes of 
training, and the matron actually ‘lent’ SATVI some nurses who worked in the study ward 
on their off days (which they were happy to do as they got paid overtime). The space was 
named the case verification (CV) ward, named after the purpose for which it was used, 
that is, diagnosing cases of childhood TB. It was designed and decorated by Anita and 
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Lydia, who ordered lots of things to furnish the ward including cots for the babies, beds 
for the mothers, mattresses and bedside trollies. They also made a play area, bought toys 
and painted a mural on the wall for the children, who were anything up to two years old 
when they came to the ward. Importantly, they sourced all of the items needed to furnish 
ward from local retailers. This not only helped consolidate SATVI’s already positive 
relationships with the Breede Valley constituents by stimulating the local economy. It 
also turned out to be a good opportunity to spread the word about the BCG trial further, 
with several mothers-to-be agreeing to take part in the study as a result.  
When they started admitting infants, they assumed at first that the mothers would 
come with food, nappies and other basics for both the baby and for themselves. However, 
they realised quickly how naïve this assumption was, especially given the poverty in 
which most participants lived. Thus, they had to ensure that the ward was equipped to 
sustain the infants and their mothers during their stay. A similar story was true of transport 
to the site. With most of the mothers being unable to get to the hospital by themselves, 
SATVI started with a modest two or three cars to fetch them from their homes and take 
them back afterwards. However, this quickly expanded and, in subsequent years, SATVI 
had around 30 vehicles that required fleet management. “Things kept coming up”, 
commented Anita, leading to the rapid and largely ad hoc expansion of the site. This just 
demonstrates how many things are needed to run a large clinical trial in a resource-poor 
environment – things are not easily anticipated at the beginning. Fortunately for SATVI, 
perhaps, they had both the funding and the local support to satisfy the trial’s large 
appetite.    
(iii) Taking the Nurse out of the Nurse 
One challenge that emerged strongly during the BCG trial was the distinction between 
research and care, a subject which has received considerable attention in the social 
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scientific literature on clinical trials (Easter et al. 2006; Timmermans & McKay 2009; 
Wadmann & Hoeyer 2014; Zvonareva, Kutishenko, et al. 2015; Zvonareva, Engel, et al. 
2015). Now with SATVI, the distinction between the two is, at least theoretically, clearer 
than in some research contexts, because SATVI’s remit does not extend as far as 
providing treatment for diagnosed TB cases (see also Barsdorf et al. 2010). Nonetheless, 
during the BCG trial this became far more of a challenge than anticipated at the outset, 
and Dennis was, as with everything else, at the forefront of efforts to reconcile conflicting 
roles and imperatives relating to care.   
 Dennis explained to me that the use of nurses to conduct study data was an 
exercise in carefully selecting which skills were put to the service of data collection and 
which were to be filtered out. They needed the nurses to perform diagnostics, draw blood 
and record data – things which they had been trained to do – but at the same time they 
needed to put aside their instincts for caring. Dennis explained:    
The work that they’re doing now is not caring but rather it’s data collection. 
Maybe they draw blood, which isn’t data, but it’s still data isn’t it…They’re 
just using their knowledge of nursing to collect data the right way – that’s 
why we use them. 
The telling phrase he used describe the task at hand was: “you have to take the nurse out 
of the nurse, you had to put the research nurse there”.  
Dennis was aware from the outset that this would not a be a straightforward 
undertaking, and that the divide between research and care had to be, as he put it, 
“continuously managed…It had to be engineered very subtly – you cannot just tell a nurse 
that you can’t be a nurse”. Nonetheless, the task proved even more difficult than even he 
had imagined. This became especially clear during the HIV-exposed neonate sub-study. 
This study was, as Dennis observed, “a very sad study”, and because of its sensitivity 
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(discussed briefly above regarding the first community advisory board), there were 
incentives offered for taking part. This included ‘transport money’ (see Geissler 2011), a 
“little parcel of baby goodies” and also baby formula (since they wanted the mothers to 
avoid breastfeeding). However, Dennis recounted doing stock checking one day:  
But when I was doing stock checking, I realised there was less than there 
should be. I realised that one of the nurses was giving more to the people 
than she should have, but because there’s only so much a baby can take it 
meant that they were passing it down into the community. So, I had to deal 
with this, because from an ethics point of view, and from an ordinary 
management point of view, we couldn’t have this going on. And she said 
to me, “[Dennis] but I’m a nurse, I can see the need, what must I do?” In 
that moment, I realised that you can’t take the nurse out of the nurse.    
Dennis, in other words, realised that when it came to caring, his initial commitment to 
‘taking the nurse out of the nurse’ was simply not possible. Indeed, the phrase ‘taking the 
nurse out of the nurse’ indicates the futility of the exercise, making one wonder what 
would even be left if it was achieved.  
 Even Dennis was, in several cases, left in doubt as to whether they could or should 
step back from getting involved in the care of participants. For example, they had one 
participating infant who was suspected of having TB and thus flagged as needing to attend 
the CV ward. However, when a study nurse went to collect the mother, it turned out that 
she had been thrown out of her house because it became known that she had contracted 
HIV, made worse by the fact she was not from one of the region’s ethnic groups. She 
came to SATVI destitute, with no house and as a result the study team “put her up” for a 
couple of days in the ward with her baby over and above the 48 hours that she would 
usually have stayed. In the end, she died in the ward. Dennis said to me it was these 
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incidents that begged the questions: Who is responsible? Who must be accountable? 
Dennis, reminding me that with so little community representatives on the advisory board 
he acted as the “community’s conscience” (see above), said to me that SATVI ended up 
arranging several funerals for infant participants who died during the study. This was 
because he felt that it was the morally appropriate thing to do in the circumstances.   
The complicated relationship between research and care will, in various ways, be 
addressed in several of the following chapters (6, 7 and 8). There I will show that the new 
ways of being and relating that are attendant upon the production of knowledge do not 
simply amount to the stripping away of care. To the contrary, the experiences of Dennis 
and the nursing staff suggest that, in face-to-face encounters, one can never fully ‘take 
the nurse out of the nurse’ nor devise an a priori set of rules regarding how to manage the 
delicate line between clinical research and care.  
Developments Since the BCG Trial 
By commencing our exploration of SATVI’s trials at the very beginning, with a small 
group of individuals who committed themselves to run a massive trial which vastly 
outstripped their initial experience and capacity, I have shown that much of the 
knowledge needed to participate in the global knowledge economy took place ‘on the 
job’. Yet a lot has happened since then as the research institute has moved towards the 
trialling of new TB vaccines. Indeed, much of the momentum driving the BCG trial 
forwards was the knowledge that this trial was only the beginning and that much more 
was soon to come. The years following the BCG trial was also “a time of great 
innovation”, as SATVI’s first epidemiologist put it. In the remainder of this chapter, I 
give a sense of these developments to put us in a position to pick up on the issues raised 
in this chapter as they manifested during my fieldwork. I divide this into three sections: 
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early phase studies on new vaccines; other preparatory studies; site development; and the 
landmark phase IIb infant trial. 
(i) Phase I and IIa Trials 
At the time that Aeras (then Sequela) agreed to fund the BCG trial as a stepping stone 
towards trialling new TB vaccines, they had no particular vaccine candidates in mind. 
Rather, they were at the stage of ‘shopping around’ the various research institutes that 
were developing new TB vaccines to decide which to take forwards. The way that TB 
vaccine candidates are introduced into clinical testing is firstly through phase I and IIa 
(safety and immunogenicity) trials in settings where there is very little TB, which is 
because of factors related to the immune reaction to the vaccines. The UK, Europe or the 
United States are therefore appropriate locations. Subsequently, they are trialled in 
medium-prevalence countries, for instance Eastern Europe and West Africa. Only after 
this can they be trialled in high-prevalence countries such as South Africa, before finally 
being ready to commence early-efficacy trials (in high-burden countries).   
Among the candidates that Sequela were interested in was MVA85A, a vaccine 
developed by Professor Helen McShane and colleagues at Oxford University. So 
promising was this vaccine candidate that the immune response generated by the vaccine 
was on “another order of magnitude” to other candidates, as Toby described it. Around 
the same time that the BCG trial was being run in Worcester, Professor McShane was 
conducting safety trials in Oxford and The Gambia. Thus, by the time that MVA85A was 
ready to be trialled in a high-prevalence country, SATVI already had most of the 
necessary infrastructure and expertise in place. In 2006, early phase trials began at 
SATVI. Involving between 35 and 50 participants in each trial, MVA85A was 
progressively trialled on healthy adults, then adolescents, then children and then finally 
infants. TB-infected and HIV-infected persons were also included these safety trials. 
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MVA85A was not the only vaccine trialled at this time, and SATVI in fact trialled 5 
different vaccine candidates in 11 different protocols by 2012 (Hanekom et al. 2012). 
However, MVA85A, delivering on its initial promise, was the one which fared best in 
these early trials.  
 In terms of the ground-level conduct of these trials, several factors are worthy of 
mention and bear upon the happenings at the time of my fieldwork. During the BCG 
study, pregnant women were approached in antenatal clinics in the region to be asked if 
they would like their babies to be a part of the trial. By contrast, in these initial safety 
studies, SATVI started recruiting in community settings, thus commencing the active 
presence in Worcester’s low-income suburbs that endures to the present day. Moreover, 
because these new TB vaccines were unlicensed products, SATVI had to obtain approval 
from South Africa’s Medicines Control Council. This was a very difficult process, and 
Anita – internal monitor on the BCG trial and who became the regulatory affairs officer 
– explained that it took months of work and the help of an independent contract research 
organisation to get the first safety trial underway. One requirement of the Medicines 
Control Council was that participants be ‘reimbursed’ R150 per site visit (Appendix 2).17 
This is a standard in South Africa, and interestingly has not changed (e.g. in response to 
inflation) since 2005 when the first early phase trials got underway. As we will see, one 
of the things that SATVI is known for today in the Breede Valley is monetary 
contributions, and the reason that I put ‘reimbursements’ in inverted commas will become 
clear in the following chapters.  
  
                                                 
17 These ‘reimbursements’ were R150 per study visit (approx. £9 at the time of writing). These 
will be discussed further in Chapter 4. 
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(ii) Other Preparatory Studies 
In addition to testing the safety and immunogenicity profiles of new vaccines, many other 
preparatory studies needed to be conducted before efficacy trials could go ahead. Firstly, 
SATVI’s researchers needed to determine the incidence of TB, that is, the probability of 
TB developing over a specific time frame. This is because the incidence determines how 
large a sample is needed to demonstrate a statistically significant level of protection over 
and above the BCG vaccine (the standard of care). The statistics for adults were readily 
available from the Department of Health. However, for adolescents and infants, this was 
not known precisely. Therefore, SATVI conducted two large-scale epidemiological 
studies over a two-year period, one involving nearly 4,786 neonates, the other involving 
nearly 6,363 adolescents, which would lay the groundwork for efficacy studies.  
 In addition to determining the incidence, these epidemiological studies were also 
used as a platform for a variety of other preparatory work. In the case of infants, there 
was need to conduct a study on how to best diagnose TB in efficacy trials. The diagnosis 
of childhood TB is highly challenging because unlike in older children, adolescents and 
adults, there is no single definitive test for TB (sputum culture is definitive in these other 
age groups). Therefore, they needed to find a ‘diagnostic algorithm’ that used a variety 
of tests and examinations as inputs and gave a yes/no as an output (Hatherill et al. 2010). 
In addition, the adolescent cohort study or “ACS”, as it was colloquially known, was used 
to test the effectiveness of the quantiFERON blood test for latent TB, which was more 
reliable and pragmatic than the tuberculin skin test (requiring one rather than two site 
visits) but had never been tested in a high-prevalence setting. In the screening and follow-
up for all subsequent trials, the quantiFERON blood test was used, and I am convinced 
that this is one of the reasons that SATVI has developed a reputation for being in the 
business of collecting blood from participants (see especially Chapter 6). Finally, these 
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studies were used to study participant retention, that is, how many were likely to drop out 
of trials. “We needed to see if they were prepared to go the distance”, as Dr Mahomed 
put this.  
(iii) Site Development 
As was the case during the BCG trial, the rapid influx of studies and funding fuelled the 
rapid expansion of the site, occupying more and more spaces on the premises of 
Brewelskloof Hospital. Fortunately, the good relations between the hospital and SATVI 
endure to the present day, and the hospital has been highly generous to the institute in 
allowing it to flow into almost all unused areas. From being situated in the Matron’s flat 
during the BCG trial, SATVI then moved to the hospital Superintendent’s home around 
the back of the hospital. Then, when SATVI outgrew that, the only space that the hospital 
had left was an old boiler house, which was large but almost dilapidated – not to mention 
that it was believed to be haunted. Not deterred, they fully renovated the place and this is 
where the main offices remain today, with the vacated buildings becoming vaccine clinics 
for specific studies. The old superintendent’s house, for example, is now referred to as 
the Trials House, and has been used for adolescent studies in recent years, including the 
Adolescent Trial during my fieldwork (Figures 3 and 4).      
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                                Figure 4: The Trials House (Inside)18 
                                                 
18 Figure 2 depicts basic medical observations being conducted, for instance blood pressure, 
weight and height. Medical histories and procedures (e.g. blood draws) were performed behind 
closed doors to respect participants’ rights to privacy and confidentiality. 
Figure 3: The Trials House (Outside) 
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What is interesting is that as SATVI expanded and the studies came and went, the 
buildings and clinics retained traces and memories of older studies. The Adult Safety 
Trial run during my fieldwork, for instance, was being conducted in the “ACS building”, 
named after the adolescent epidemiological study (literally, adolescent cohort study) that 
many of the research staff had fond memories of (Figure 5 and 6). 
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Figure 5: The ACS Building (Outside) 
Figure 6: The ACS Building (Inside) 
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Moreover, the large clinic space in the main hospital building is no longer called the Case 
Verification Ward but rather, as of 2012, the Vaccine Trials Clinic19, and is the home of 
the Adult Efficacy Trial that was conducted during my fieldwork (Figures 7 and 8). 
However, almost every single member of staff still refers to it as the “CV ward”.    
 
 
 
 
 
 
                                                 
19 The name change is down to the fact that the ward is now used for screening, vaccination and 
follow-up rather than for ‘case verification’, a term that is specific to the diagnosis of TB in 
children which is a much longer process than for adults (Hatherill et al. 2010).  
Figure 7: The Vaccine Trials Clinic  
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Finally, SATVI’s main office space is colloquially referred to as “the Boiler House” (see 
Chapter 2, p. 47). This name has a double meaning: firstly, taking after its original 
purpose for the hospital and, secondly, describing SATVI’s field site in relation to the 
Cape Town headquarters. Whereas the headquarters is where all ‘thinking’ happens, the 
field site is, at least theoretically, the place where things are simply ‘done’. What I would 
suggest is that this second meaning is something that is most apparent to those working 
at the headquarters, from whose perspective a line between thinking and doing is sharpest. 
What this chapter and indeed the rest of this thesis draws attention to, however, is the 
creativity and innovation and that underlies the outward appearance of simple rule-
following. 
  
Figure 8: The Vaccine Trials Clinic (Waiting Area) 
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(iv) The Trial of MVA85A  
By 2009, SATVI had all the necessary infrastructure in place to begin efficacy trials on 
new TB vaccines, with MVA85A first in line. In one of the most eagerly anticipated 
vaccine trials on a new TB vaccine since the BCG trials of the mid-20th century (Aronson 
& Palmer 1946; Rosenthal et al. 1961) approximately 2,800 HIV-negative infants were 
enrolled into a phase IIb (early efficacy) trial that ran between 2009 and 2012 (Tameris, 
Hatherill, et al. 2013; Tameris, McShane, et al. 2013). The excitement was palpable 
among the research team, not only the scientists but all those who had seen this vaccine 
emerge through its early stages as the most promising. It was sometime after enrolment 
had been completed that I emerged on the scene and conducted both my undergraduate 
(2011) and Master’s research (2012). This involved mainly spending time with the field 
workers conducting home visits and with the nurses in the case verification ward, and my 
focus, at least towards the latter stages of my research (see Methods, Chapter 1), was on 
the ways that these staff balanced the fine line between research and care (Dixon 2013).  
 To the dismay of everyone involved – from researchers in Oxford and South 
Africa, to Aeras who partially funded it, to the field team – the trial failed to demonstrate 
the efficacy of MVA85A. Despite all its promise and the strength of the immune reactions 
that it generated in the early phase studies, this did not translate into clinical protection. 
The grief was experienced most profoundly by those, for instance my supervisor Michele 
and Helen McShane, who had invested so much time and even emotion in this vaccine. 
What was arguably even worse was that it was not entirely clear that the trial failed 
because the vaccine did not work. For it was suspected that the intensity of case finding 
among the study cohort might have picked up cases of TB too early, including cases that 
would have ‘self-resolved’. Thus, the worry was that the effects of the vaccine had been 
‘washed away’. The problem was that there was simply no way that they could know, 
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leaving the researchers feeling desperately frustrated and with great difficulty letting go. 
As Toby, put it: “I was shattered when the MVA results came out…It was just so bitterly 
disappointing”.  
Against the backdrop of and in response to this ‘failure’, when writing up my 
Master’s research, part of what I was trying to do was suggest the kinds of ‘success’ that 
went on beneath the failure. If the trial’s epistemological goals were undermined by its 
immediate effects, then this testifies to just how significant the trial, and SATVI’s 
research programme more generally, was as a public health intervention (Dixon 2012, 
Dixon forthcoming). This was a question that I wanted to take much further as part of my 
PhD research. My fieldwork commenced just as more trials were getting underway – for 
after all, there is very little time for mourning in the trials industry – and yet everyone 
was still feeling a profound sense of liminality. Having been caught in the momentum 
leading up to the anticipated trial of MVA85A, people were suddenly thinking: what have 
we been doing all this time? This was, in a sense, an ideal time to be asking people about 
the history of SATVI and to conduct an ethnography of the institute’s ground-level 
operations. I hope that the remainder of this thesis will help to satisfy this curiosity.  
Conclusions 
In this chapter, I have described the multifaceted work that went into capacitating a 
comparatively ‘research-naïve’ healthcare landscape for the world’s largest 
contemporary TB vaccine trials. While GCP and other international guidelines are 
important for ‘good’ scientific and ethical practice, they tend to assume that the norms, 
values and practices that it enshrines are fixed in advance, a closed system that covers all 
possible eventualities in research practice. However, my aim has been to contribute to an 
arguably much needed de-fetishising of GCP by casting an eye back to a time when the 
guidelines were still gaining a foothold in South Africa and where, against the enduring 
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social forms of apartheid governance, SATVI’s first team embarked upon a massive 
clinical trial with very little experience of how to do field research. From the perspective 
of these actors, there was not the comfort or stability of having everything prepared in 
advance and a simple application of pre-existing principles. Rather, learning to participate 
in the game of global scientific research was experienced as an inductive, iterative 
exercise in which error was as important a driver of growth and learning as success.  
 During the fascinating conversations that I had with SATVI’s founding 
researchers, a number of them expressed that they had thought about writing the history 
of SATVI themselves. While a small number of publications have discussed the 
development of the site (Mahomed et al. 2010; Tameris 2010; Hanekom et al. 2012), they 
have not been able to provide the level of detail or depth of analysis that I have here. 
Perhaps the most important aspect of site development that these other publications were 
unable to convey, but which was spoken about most passionately by the first research 
team, was the pioneering spirit with which they entered the unfamiliar game of global 
scientific research and the sense of accomplishment that came from demonstrating that 
large field trials were actually possible in this particular setting. In the rush to produce 
the next ground-breaking scientific finding, these other successes often tend to fall by the 
wayside. It is my hope that this chapter does justice to innovation and endeavour that 
went into the founding of one of Africa’s largest TB vaccine trial sites.  
Aside from making a self-standing contribution to accounts of capacity building 
(Sariola & Simpson forthcoming; Petty & Heimer 2011; Crane 2012; Douglas-Jones 
2012), the main purpose of this chapter going forward has been to highlight the origins 
of the themes and challenges that will emerge in the following chapters. Most important 
among these is the transition that SATVI’s staff – who trained as doctors, nurses, HIV 
counsellors and more – had to undergo in order to become credible researchers. This 
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includes, firstly, the move from a ‘normal’ healthcare relationship, in which the purpose 
of interactions was to cure sicknesses, to a research relationship, where one had to ‘step 
back’ from care and into the distanced and disinterested position where people are 
scientific objects and the aim is the production of clinical data. Secondly, it includes a 
simultaneous power inversion from a culture of medical paternalism in which decisions 
were made for patients, to one in which the participants were active agents in the decision-
making process. In the following chapters, one of the main aims is to show how these 
new ways of being and relating generated by the research environment provided novel 
possibilities for engaging with issues of health, wellbeing and respectable living in 
adverse circumstances. 
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Chapter 4: 
A Disease beyond Reach: Clinic Staff Perspectives on 
the Past and Present of TB Control  
Dear Residents of Worcester,  
TB is a big problem. It’s a highly infectious disease and the main cause of 
deaths worldwide. Disobedient patients who refuse TB treatment are around 
in town and they infect the healthy, especially children and the elderly people. 
Currently TB is spreading like wildfire through Worcester. This means 
everyone can be infected with TB or die from TB. Our children and 
grandchildren might never have the opportunity to reach adulthood. Thus, all 
residents must immediately stand together to fight this evil and prevent 
Worcester becoming a ghost town.  
(Sister du Plessis, TB nurse) 
The above extract is from a flyer composed by a TB nurse at Worcester Community Day 
Centre, the largest of the three government clinics with which SATVI works most closely 
and in which I conducted fieldwork. Located just south of Durban Street – the long road 
spanning the length of Worcester that divided ‘whites’ from ‘non-whites’ under apartheid 
– (see Chapter 2, p. 48) – Worcester Community Day Centre (henceforth Worcester CDC) 
serves a population of around 70,000, primarily coloured, Afrikaans people living in the 
town’s low-income suburbs. Driving through the clinic gates for the first time, the first 
thing that drew my attention was the long queue outside, with people either undergoing 
triage by a uniformed nurse or waiting to be called inside (Figure 9). More striking, 
however, was the wrought iron gate at the entrance that slid open and shut behind patients 
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as they were summoned, and the metal detectors and security searches that ensued just 
beyond. The fortified nature of the building served as a stark reminder of the 
neighbourhood that the clinic was in and its proximity to gang territories (Muller 2004). 
After asking for directions, I was taken the TB department, which consisted of two rooms 
– a treatment room and administration room – around the back of the clinic, outside which 
sat another queue of people (Figure 10). A peek through the wide-open door of the 
treatment room revealed two nurses working with separate patients, as well as a third 
patient taking what appeared to be a handful of pills at a sink in the corner. One of the 
nurses looked up and, expecting me, introduced herself as Sister du Plessis – a world-
weary but highly experienced white Afrikaans nurse who, we will see, was driven to 
appealing to the residents of Worcester about a TB epidemic spiralling out of control.  
 
Figure 9: Worcester Community Day Centre 
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Worcester CDC is the largest and most central of the three clinics. The second, 
Empilisweni clinic, is located on the outskirts of Worcester, just inside the entrance to 
Zwelethemba, the primarily ‘black’, Xhosa-speaking township of around 32,000 which it 
serves. The third and furthest afield, De Doorns clinic, is nestled between around two-
dozen farms situated approximately 10 km outside of Worcester on the N1 highway, 
servicing a highly mobile population of around 22,000, many of which are only resident 
between October and March when their work is required by the farms. Residents both 
seasonal and permanent come from townships in Cape Town, the Eastern Cape, Lesotho 
and Zimbabwe among others. Between them, Worcester CDC, Empilisweni, and De 
Figure 10: The TB Department 
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Doorns clinics cover approximately 70% of the Breede Valley’s population of 167,000, 
with the rest divided among Rawsonville clinic and the smaller satellite clinics in the 
region. Across the three clinics, I observed and interviewed 20 clinic staff members, 
primarily nurses in the clinic TB departments, but also nurses in other departments (e.g. 
Child Welfare and HIV), facility managers, and the district managers working from 
Brewelskloof hospital. 
 This first of my ethnographic chapters hones in on the day-to-day work lives of 
clinic staff, particularly nurses, in order to describe the troubled post-apartheid healthcare 
landscape into which SATVI’s trials have been inserted. During the time of my fieldwork, 
the regional Department of Health had made TB its number one priority because, with an 
increasing patient load and ever more drug-resistant cases emerging, it had outstripped 
HIV and AIDS as the disease that was placing the most strain on the clinics. Although 
TB presents difficulties on several fronts, the overarching one was what the district 
manager referred to as “the gap between the clinic and the home”. This encapsulates, 
most pertinently, the dual challenges of (i) late diagnosis (contributing to the continued 
spread of TB) and (ii) ‘defaulting’ (patients starting but then prematurely stopping 
treatment). I will argue that this gap is historically determined by changes in the structure 
of the health system and a perceived dissonance between the theory and reality of how 
healthcare is supposed to function in post-apartheid South Africa. More specifically, the 
dissonance I identify is a between the ideal of free, rights-bearing citizens ‘taking 
responsibility’ for their health (by attending the clinics when sick), and a reality in which 
bad if not worse socioeconomic and epidemiological conditions often preclude this.   
 The pressure for managing this dissonance, however, was not evenly distributed but 
rather fell disproportionately on the shoulders of the nurses. The main ethnographic task 
of this chapter is to show how they experienced, attempted to make sense of and acted 
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upon the challenges of TB control and tries to suggest why practices of blaming, scolding 
and disciplining persist. Following a number of qualitative studies ‘writing back’ against 
the poor media reputation of nurses in post-apartheid South Africa (Walker & Gilson 
2004; Hull 2009; Joyner et al. 2014), this chapter argues that such practices were not 
evidence that nurses are uncaring or attempting to assert their superior status over 
impoverished patients. Rather, I will suggest that these practices were tried and tested, 
albeit often desperate, attempts to provide care for people in an environment that made 
this incredibly challenging. At the same time, it is through the work of these frontline 
agents of the state that TB control constitutes a key site in which the structures of 
dominance that have endured through the democratic transition are reproduced. For in 
responding to challenges, they reinforce governmental stereotypes of uncaring, 
irresponsible – and in Sister du Plessis’ words, “disobedient” – bodies while 
simultaneously deflecting attention away from structural determinants of the TB 
epidemic. Going forward into the rest of the thesis, the sentiment that I wish to convey 
on the part of the government clinic staff is of sheer frustration and waning hope, a 
disconnect between clinics and the residents that they serve and a powerlessness to get a 
firm grip upon a disease that has been curable since the 1950s.   
A Shifting Primary Healthcare Landscape 
During apartheid, healthcare in the Breede Valley was, as in the rest of the country, highly 
fragmented and inequitable. Aside from the minority who could afford private medical 
insurance (approximately 15%), the majority of the population were at least partially 
dependent upon the public healthcare system_. Disjointedly managed by the country’s 
fourteen separate health departments, the public health system was racially segregated, 
biased towards hospital-level care and the majority of services had to be paid 
for_(Coovadia et al. 2009). Of the clinics in which I conducted fieldwork – sizeable 
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buildings with large staff complements and offering a wide variety of services – only De 
Doorns clinic existed before the 1990s and even this clinic was considerably smaller 
during apartheid. With no nurses yet trained in primary healthcare (i.e. diagnosis and 
prescription), clinics during apartheid were oriented primarily towards preventative 
services (e.g. immunisations, antenatal care and health education) and dispensing 
treatment for certain diseases. The majority of curative services, meanwhile, including 
the diagnosis and management of TB cases, were run from the region’s secondary 
hospitals where most of the doctors were located (Worcester Hospital and Brewelskloof), 
with outreach to the rural clinics. For the residents of Worcester, receiving medical 
attention meant queuing up outside of Worcester hospital from 3-4 am to get seen that 
same day; in the case of people living on farms, it usually meant waiting for the doctor to 
visit the clinic once every few weeks. In short, for the Breede Valley’s poor, access to 
even the most basic of healthcare was severely compromised during apartheid.    
 Without deflecting attention away from the inequities of the public health system, 
for the purposes of this chapter it is important to note that experiences of being a clinic 
nurse during apartheid have been shown by a number of studies (including mine) to be 
often positive (Walker & Gilson 2004; Foster 2005; Hull 2009; Joyner et al. 2014). 
Firstly, with the bulk of curative services being rendered elsewhere, as well as the fact 
that many services had to be paid for, the patient load on the clinics was considerably 
less. There was also a feeling among many nurses that the profession was well-respected. 
Such respect was not only held by their (primarily coloured and black) patients, who as 
victims of the apartheid state were legally compelled to be subservient and obedient to 
healthcare professionals. Perhaps more surprisingly, they felt well respected and listened 
to by their superiors in the organisational hierarchy (Walker & Gilson 2004; Hull 2009; 
Joyner et al. 2014). Finally, and something which came out particularly strongly during 
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my research, was that nurses were an active presence in community settings, performing 
antenatal home visits, ‘defaulter’ tracing and health education. One thing that was 
especially valued by nurses was that, during home visits, one would not only see, for 
example, a baby, but also the other members of the household. Because of this, there was 
“very good communication with our patients”, as one nurse put the matter. Positive 
memories of nursing during apartheid are something that I shall go into more detail about 
later in this chapter, when we see how nurses used the past to highlight the troubles of the 
present. Suffice to note at this point that these are an important counterpoint to critiques 
of apartheid healthcare. 
 In 1992, with the end of apartheid imminent, the National Party ended the racial 
segregation of healthcare facilities, which was followed soon after by a radical 
restructuring of the health system in order to make healthcare more accessible to the 
country’s poor. The country’s fourteen health departments were consolidated into one 
national and nine provincial Departments of Health. With only 11% of the national 
healthcare budget being spent on clinic-based primary healthcare at the time of the 
transition, the Mandela government vowed to make primary healthcare, delivered through 
a district health system, “the cornerstone of health policy” (Coovadia et al. 2009, p. 828). 
Nationwide, 1345 clinics were built and a further 263 were upgraded (Coovadia et al. 
2009), and in the Breede Valley specifically, Empilisweni was built in the early 1990s, 
De Doorns was upgraded in the mid-1990s, and Worcester CDC was built slightly later 
in 2001 to take the place of some of Worcester’s smaller clinics_. Nurses were trained in 
primary healthcare, with the intention that many more curative services could be offered 
at the clinic level – including TB – which decreased the reliance upon (the very limited 
number of) doctors. User fees were scaled back and eventually eliminated (Foster 2005). 
Moreover, the Patient Rights Charter (1996) was introduced, which reflected the broader 
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post-apartheid constitutional emphasis on rectifying the wrongs of the past and ensuring 
that never again would people be subjected to the inequities and indignities of apartheid. 
The Charter spells out a wide range of rights including those to a full and comprehensive 
range of healthcare services, privacy and confidentiality, participation in health decision-
making and the right to refuse treatment. It also includes the right to a “positive 
disposition” on the part of health workers, one that “demonstrates courtesy, human 
dignity, patience, empathy and tolerance”. Finally, the Batho Pele programme marked a 
shift in how patients were viewed, from subjects of responsibility to ‘clients’ or 
‘customers’. The programme consists of eight principles which are designed to guide 
managers and healthcare professionals in correct practice, laying out an agenda for the 
reformulation of service delivery that is oriented towards customer choice and, 
importantly, enables patients to hold public servants accountable (Hull 2009).    
 The corollary of greater rights and more choice for patients, however, was a set of 
assumptions that patients would hold up their end of the bargain, as it were, which arrived 
in the form of patient ‘responsibilities’. Such responsibilities are spelt out underneath 
patient rights in the Patient Rights Charter (1996), and includes the responsibility to: take 
care of one’s own health; know their health services and what they offer; not abuse the 
health services; and comply with prescribed treatment regimens. However, it might be 
noted that this increasing emphasis on patient responsibility was happening at the same 
moment that the health sector faced a new wave of challenges through the 1990s and 
2000s. The clinics, despite being more in number and better resourced, were quickly over-
stretched, due to a number of factors including: the removal of user fees; increased 
migration into and within South Africa; the rapid onset of HIV and AIDS (which in turn 
amplified TB); as well as increasing alcoholism, substance abuse and violent crime 
(Walker & Gilson 2004; Compion 2008; Coovadia et al. 2009). Moreover, whilst taking 
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a welfarist stance in relation to healthcare and social services, the Mandela administration 
bowed to international pressure to implement neoliberal-inspired macroeconomic 
policies that greatly limited government expenditure on healthcare and social services 
through the 1990s (Compion 2008), including the Reconstruction and Development 
Programme (RDP) in 1994 and the Growth, Employment and Redistribution Strategy 
(GEAR) in 1996.  
 Against the backdrop of these neoliberal-inspired macroeconomic policies, the 
increasing emphasis on patient responsibilities in the clinics can be situated within a 
broader discursive shift in responsibility away from the state and towards individuals and 
communities, with the development of effective community-based care being premised 
on “creating ‘partnerships' with the private sector and civil society” (Compion 2008, p. 
96). One manifestation of this was the cadre of ‘home-based carers’ that emerged in the 
early 2000s, who were funded by NGOs to take over much of the community-based work 
previously performed by nurses. This includes health education, the direct observation of 
TB treatment consumption20, ‘defaulter’ tracing and palliative care for the surging 
numbers of people with HIV and AIDS. However, as commentators have observed 
throughout the African continent, the deferral of responsibility for health and 
development onto impoverished individuals and communities only serves to legitimise 
the withdrawal of the state from certain core functions (Compion 2008; Biehl & Petryna 
2013; Prince & Marsland 2014; Packard 2016). In South Africa, this deferral of 
responsibility could barely paper over the fact that the public health sector was simply ill-
equipped to handle the surging numbers of patients generated by the nation’s deteriorating 
                                                 
20 In the years since TB was labelled a ‘global emergency’ in 1993, the WHO’s primary 
response to the epidemic has been to advocate the worldwide implementation of directly 
observed therapy, short-course (DOTS) through country-level National Treatment Programmes. 
Motivated by poor patient ‘adherence’ and substandard public health interventions, DOTS 
remains a central component of public health efforts to control TB.  
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epidemiological profile. 
 Perhaps unsurprisingly, patient experiences of post-apartheid healthcare have been 
shown to be often far from positive (e.g. Sokhela et al. 2013) – something which, as we 
will see in Chapter 6, constitutes one push factor into SATVI’s clinical trials. More 
significantly for the purposes of this chapter, several studies have shown how the nursing 
profession has undergone drastic and detrimental changes. With insufficient staffing and 
training in healthcare facilities during the 1990s, nurses bore the brunt of the increased 
workload that came from the influx of patients, which was only exacerbated by many 
nurses heading to the private sector or overseas (Foster 2005; Joyner et al. 2014). Nursing 
became increasingly “facility-focused” (Daire & Gilson 2014, p. ii87), as there were too 
many patients attending clinic facilities and community settings had become too 
dangerous to sustain the active presence that nurses had during apartheid. Workloads in 
the clinics were increased further with a growing emphasis on patient data collection in 
order to hold staff accountable, something which “becomes a source of intense anxiety 
[for nurses] and serves to exacerbate [their] workload” (Hull 2012, p. 629; see also 
Strathern 1996). All of these factors came together at the same moment that patient rights 
were improving and resulted in many nurses feeling a profound sense of lost status and 
respect (Walker & Gilson 2004; Foster 2005; Hull 2009; Joyner et al. 2014).  
 The high-intensity, facility-focused nature of primary healthcare documented by the 
above scholars is very much the reality that I encountered when I started spending time 
in the clinics in December of 2014. In fact, if anything, it was amplified in the case of the 
TB rooms, for as highlighted in Chapter 1, the Breede Valley has one of the most severe 
epidemics in the world (with an incidence of 1,500/100,000), and as I quickly found, the 
‘TB rooms’ of these clinics are amongst the busiest of any South African healthcare 
setting. Without having even discussed TB control with the regional managers, it was 
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straight into these rooms that I began my excursion into TB control. In the following 
section, I thus begin ‘on the ground’, with a brief exploration of the daily rhythms of the 
TB rooms as I came to know them. Following this, I bring into view the particular 
challenges thrown up by TB in the Breede Valley and how these are connected to 
historical changes in the health system and epidemiological profile of the nation’s 
population since 1994. 
The TB Rooms  
Located towards the back end of the clinics, the TB rooms were large, well-ventilated 
spaces that each contained a couple of desks, a treatment table, a sink, shelves full of TB 
medication, filing cabinets and with room to walk around. The corridors outside were 
lined with chairs or benches for patients to sit in while they waited, whilst their back doors 
led to the clinics’ backyards, which is where patients were periodically sent to cough-up 
sputum samples. Far from sombre and clinical, the TB rooms all bore the signs of 
familiarity and domestication, scattered with stationery, post-it notes, bags of pills 
bearing patients’ names, and often the radio playing in a corner. Working from their 
desks, two or, in the case of Worcester CDC, three nurses and an admin clerk, were the 
permanent fixtures of the rooms, working side-by-side throughout working hours. 
Doctors from Brewelskloof visited on a bi-weekly basis to handle more complex cases; 
but as the regional manager said to me, like the majority of clinic services TB is a “nurse-
driven, doctor-supported service”. Most of the nurses were warm, friendly characters and 
allowed me to pull up a chair at the side of one of the desks from which I observed, asked 
questions and, when there was the chance, interviewed the nurses more formally. 
 From the second the clinics opened, the TB rooms were rife with activity, with 
people coming and going, manoeuvring around one another and trying to do many things 
at once. Most patients found their way to the TB rooms through attending the clinic after 
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experiencing signs and symptoms, and being sent to the right place following a process 
of triage at the front of the clinics. In the language of public health, this is referred to as 
passive case finding (PCF), which involves waiting for patients to come to the clinic 
rather than vice versa (active case finding [ACF]), and is premised upon patients 
recognising that they are symptomatic and promptly attending their clinic for treatment 
(Golub et al. 2005; Uplekar et al. 2013; WHO 2013). Other common paths to the TB 
rooms included: infants being sent from the antenatal department; HIV-positive patients 
being sent from the Infectious Disease room for TB screening; patients being sent from 
Brewelskloof Hospital (hospitalised TB patients who are well enough to return home); 
patients referred from other primary healthcare facilities; and referrals from SATVI (for 
the latter see Chapter 8). In the case of adults suspected of having TB, the first thing the 
nurses did was ask patients to produce two sputum samples outside in the backyard, which 
would be sent to the laboratory. The patients would be told to return 48 hours later for 
their test results. The process was a little more complex in the case of infants, because TB 
bacteria can only be detected in their sputum in 40% of cases (Moyo et al. 2012). As a 
result, they were tested for latent TB (via a Mantoux skin test) and then, if found positive 
48 hours later, they were sent to Brewelskloof hospital for a chest X-Ray, which would 
be examined by a doctor to determine whether or not they had active TB disease.  
 For patients who had positive results upon their next visit, the treatment process 
started immediately. To give a sense of the volume of patients (and the ratio of nurses to 
patients), at the end of 2014 there were 741 people being treated for TB at Worcester 
CDC, 393 at Empilisweni and 389 at De Doorns (which is only slightly below the Breede 
Valley’s incidence of 1,500/100,000). Upon diagnosis, the nurses started a ‘TB folder’ 
for each new case. Taking anything up to half an hour – “and every other one is a new 
case”, as Nurse Matthews at Worcester CDC said wryly – starting a TB folder involved 
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taking a clinical history, making basic observations and collecting demographic 
information. It also involved an HIV test. In fact, such was the co-infection rate that a 
diagnosis of TB was almost equivalent to a diagnosis of HIV (82% coinfection at 
Worcester CDC and, although I did not obtain statistics for the other two, the official 
figure for the region and country is 60%). Throughout their treatment, patients would 
have multiple appointments in the TB room. For the first two months of treatment, many 
people would come to the TB room every day to be observed taking their medication (i.e. 
DOTS). Aside from this, patients would have a sputum check at the two-month mark, 
four-month mark and at six-month mark. For many, this would conclude their relationship 
with the TB room and its nurses, and they could either stop attending the clinic or, in the 
of case patients needing ARVs, they would be referred to the Infectious Disease room for 
management of their illness.   
“It’s the Ones that are Out There” 
When I started spending time in the three clinics, I was quite taken aback by the sheer 
volume of patients moving through the TB rooms day after day, month after month. It 
was one thing hearing that the Breede Valley has one of the highest burdens of TB in the 
world; it was another to see what that actually looked like in the form of patients attending 
the clinics and the amount of work that this entailed for the nurses. However, when I 
related this sentiment to the head of Worcester CDC’s TB room, Sister du Plessis, she 
looked at me with an ‘oh please’ sort of expression and said, in a turn of phrase that would 
stay with me throughout my fieldwork, “the ones that come here aren’t the problem; it’s 
the ones that are out there” (her emphasis). This she said while pointing in a southerly 
direction out of the clinic and towards Worcester’s low-income suburbs.  
 By “the ones that are out there”, Sister du Plessis was referring to those people who 
were sick with TB and either not aware that they had a life-threatening disease or were 
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unwilling or unable to attend the clinic to receive medical attention. One kind of TB case 
this included was those people who had been infected with TB, had subsequently 
developed active TB disease, but were yet to be diagnosed and treated. This meant that 
they were highly infectious and, because of the overcrowded and impoverished living 
conditions in which much of Worcester’s population lives, likely to spread the disease to 
others (Compion 2008; Bynum 2012). I was speaking one morning with the district 
primary healthcare manager Dr Van Zyl, who expressed to me the futility of the situation: 
“You have this reservoir of infected people who just keep on getting the disease, which 
is compounded by the HIV problem. So they keep getting disease, and then infecting 
more and more people”. Moreover, the prevailing opinion among the TB room staff was 
that those who were sick consciously avoided coming to the clinic until they could 
function no longer without medical attention (we will see the reasons as to why this was 
the case later on in this chapter). As Sister Louw of Empilisweni’s TB room aptly put the 
matter: “the ones that come here are the ones that are really sick. They don’t come here 
until they are skin and bones”.  
 The thought of undiagnosed cases “out there” was certainly a source of concern for 
the clinic staff. However, a far more persistent source of frustration for them were patients 
who were diagnosed with TB, had commenced treatment but interrupted their treatment 
or stopped it altogether before the regimen was complete. This is widely referred to in 
high burden regions as ‘defaulting’, with people who default being referred to as 
‘defaulters’. The appropriateness of this terminology has been hotly contested (Farmer 
1998; Ditiu & Kumar 2012), a point to which we will return shortly. However, it is 
referred to, the premature discontinuation of treatment is highly dangerous both for the 
individual and from a public health perspective. Missing even a few weeks of treatment 
runs the risk of developing multi-drug resistant TB (MDR-TB), which includes those who 
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have become resistant to at least rifampicin and isoniazid, the two most powerful first-
line drugs (Bynum 2012; WHO 2016). The treatment regimen for those diagnosed with 
MDR-TB is much longer (up to two years), involves more toxic second-line antibiotics 
as well as a period of hospitalisation in many cases (at Brewelskloof, in the case of 
patients in the Breede Valley). Moreover, unless adherence is scrupulous for the entirety 
of the regimen, MDR-TB can easily become extensively drug-resistant TB (XDR-TB) 
(resistance to a number of second-line drugs). The protocol for XDR patients is that they 
are hospitalised at Brooklyn Chest Hospital in Cape Town for a minimum of three months 
– or at least until they are no longer infectious – but usually longer. The public health 
concern for both MDR-TB and XDR-TB is that these drug-resistant strains can be passed 
onto others, meaning that even without being non-adherent themselves, some people have 
to bear the consequences of those that have.21   
 With the consequences of non-adherence being so extreme, two other groups of 
health workers were crucial to TB control in the clinics. One of these was the clinic 
counsellors. Each clinic had two counsellors, whose job it was to, firstly, to help patients 
go through the difficult process of coming to terms with their illnesses and not only TB 
but also HIV and numerous other conditions. Secondly, and especially in relation to TB 
and HIV, their job was to instil in patients the importance of adhering to medication and 
to speak to those who stopped taking their medication. The other group of health workers 
were the home-based carers. Funded by the Boland Hospice (an NGO located on the 
premises of Brewelskloof hospital, near SATVI’s offices), each clinic had about ten 
home-based carers assigned to them to perform a variety of tasks including: taking TB 
medication to those who were unable to attend the clinic, ‘contact tracing’ (locating 
                                                 
21 The cure rate for XDR-TB is extremely low. O’Donnell et al. (2013) found in a study among 
XDR patients in KwaZulu-Natal that 22% of patients were cured or successfully completed 
treatment.  
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individuals in TB patients’ houses, especially infants, who should come to the clinic for 
screening) and ‘defaulter tracing’ (locating TB patients who had not been taking their 
medication). As Anna, one of SATVI’s nurses who had previously worked at the clinics, 
said: “they [the home-based carers] are the length of the nurse’s arm”, and performed the 
overwhelming majority of community-based healthcare tasks on behalf of the clinics. 
Each morning, the carers would come into the TB rooms to collect names, addresses and 
treatment, and sometimes assist with other tasks around the TB room, such as counting-
out pills. Empilisweni was by far the busiest, and on one occasion no fewer than ten 
people were in the TB room at once, including nurses, patients and home-based carers. 
 In spite of the work of the counsellors and home-based carers, the rates of non-
adherence were incredibly high and had only been getting worse in recent years. As Sister 
du Plessis said to me: “the defaulter rate, it keeps getting higher and higher”. The defaulter 
rate at all three clinics was about 20% and, at the time of my fieldwork, there were 6 
MDR patients at De Doorns, 14 MDR and 1 XDR patient at Empilisweni, and over 30 
MDR patients and 3 XDR patients being treated at Worcester CDC. The nurses pointed 
out that among these, a high proportion were gangsters or ex-gangsters, who they pointed 
out to me by drawing attention to the gang tattoos along their arms. It is against the 
backdrop of a frustration about the patients “out there”, whose presence was experienced 
primarily as an absence, that tensions often boiled over. It was a daily occurrence that 
scenes of the following sort took place in the TB rooms…  
 Sitting with Nurse Jacobs in Empilisweni’s TB room on a Wednesday morning in 
December 2014, a young woman slinked into the room holding a baby who was coughing 
profusely. Nurse Jacobs was aware of this particular baby and was immediately very cross 
with the woman, who was not the baby’s mother but rather someone sent in her stead. 
She was cross because the baby had been brought to the clinic the previous Friday and, 
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after a scan at Brewelskloof, had been found so sick by the hospital’s paediatrician Dr 
Gilbert that the baby needed to be promptly hospitalised. The mother was supposed to 
bring the baby to the clinic the following Monday morning to be admitted to the hospital, 
but had not showed up. Now, having sent the baby several days late with someone else 
(the mother’s presence was required), Nurse Jacobs lost her cool. She said to the woman 
– who was sitting very defensively and not saying a word – that if the mother does not 
bring the baby in personally tomorrow she is going to send her to the clinic social worker. 
In fact, at that moment the social worker happened to walk into the room for other reasons, 
and Nurse Jacobs pointed and exclaimed, “look here’s the social worker! The baby is 
sick, she’s coughing all the time and she [the mother] knows it”. Nurse Jacobs said “thank 
you” to the woman and then looked down at her desk as if to say, “you are dismissed”.  
 Similar events occurred in Worcester CDC almost every day I was there. I arrived 
at the clinic one day to find Sister du Plessis on the phone to a patient with XDR-TB (the 
most dangerous form of the disease) who had been released from Brooklyn Chest 
Hospital to attend the funeral of his wife, but was supposed to return to the hospital soon 
afterwards to continue his rehabilitation. However, he had now been out of the hospital 
for a month and had apparently decided to stay out. At the time that Sister du Plessis had 
managed to contact him by phone, he was busy setting up for his son’s birthday party. 
For obvious reasons, this deeply upset Sister du Plessis; the possibility of a large group 
of children being infected with XDR-TB did not bear thinking about. But this was a very 
real possibility and, as a result, Sister du Plessis threatened the man with all sorts, 
including calling the police. This episode was followed shortly after by an incident where 
the clinic had managed to summon an MDR patient to the clinic who had been off 
medication for a number of weeks. However, he had promptly changed his mind about 
being there upon arriving at the clinic, excused himself to go the toilet, and quickly 
Chapter 4 
 
116 
 
disappeared not to be seen again during my fieldwork. It was in one such moment of 
frustration that Sister du Plessis said to me:  
You can’t be nice to them. If you give them the pinky [little finger] then they 
will take the whole hand. Some of the sisters try to be nice to them but it is 
only me that will give them skel [to scold, or have strong words with]. Nobody 
likes me here. Only God loves me [she points upwards to the heavens]! But I 
don’t worry, I’m not here to be nice I’m here to do my work. 
Nurses and TB Discourse  
As highlighted above, the assumption written into the Patient Rights Charter (1996) was 
that, as patients were afforded greater rights in relation to healthcare, they would fulfil 
their end of the bargain and ‘take responsibility’ for their health, including complying 
with the protocols of the clinics. That individuals and communities would shoulder a 
greater burden of responsibility was, indeed, part of how primary healthcare was 
envisioned to function and what it was funded (and not funded) to do. But what these 
vignettes and Sister du Plessis’ subsequent comments show is that, from their 
perspectives, there is a clear dissonance between the way in which rights-bearing 
consumers of healthcare were supposed to behave in the ‘new’ South Africa and the 
reality which the nurses were confronted with day-in and day-out in the TB rooms. 
Indeed, as we can see from the above, it frequently reverted to quite heated confrontations 
between nurses and patients.  
 Social science literature has drawn attention to the ways in which the language of 
patient responsibility – and similar terms like ‘defaulting’ and ‘non-compliant’ – have 
functioned to legitimise the blaming of impoverished individuals for their own treatment 
‘failures’ (Farmer 2000; Compion 2008; Harper 2006; Harper 2010). In this, however, 
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healthcare professionals are often peripheral figures or cast as willing participants in 
harmful discourse. Indeed, in South Africa nurses have a terrible reputation in both 
academia and media for scolding and degrading patients – perhaps understandably, given 
how the above vignettes appear at face value. But rarely is a more critical gaze of the sort 
leveraged to vindicate patients passed through the health system and its workers to see 
what kinds of pressures and structural violence they are subject to. This is why the 
burgeoning body of literature responding to the condemning portrayal of nurses in South 
Africa is so important (Walker & Gilson 2005; Foster 2005; Hull 2009; Joyner et al. 
2013). While I ultimately concur with the above social scientists regarding the harmful 
nature of TB discourse, I believe it important to counter unproblematic blame placed upon 
frontline healthcare staff by drawing attention to the challenges they faced and how they 
experienced, made sense of and acted upon them. Staff struggles revolve around the 
primary challenge of TB control highlighted above, which district primary healthcare 
manager Dr Van Zyl broadly referred to as “the gap between the clinic and the home”. 
Several themes emerged during my time with the clinic nurses, which will be addressed 
in turn: isolation and accountability; patient responsibility and blame; and nostalgia for 
the past. 
(i) Isolation and Accountability  
One of the most frustrating facets of life as a TB nurse was not only that they were 
working on the frontline of one of the most challenging diseases to manage. It was that 
nobody seemed to appreciate the strife they were going through. As mentioned above, the 
TB rooms were around the back of the clinics at one remove from most of the other 
departments. The feeling among the TB room nurses was that none of the nurses from the 
other departments wanted to learn how to work in the TB rooms_. As a result, once 
assigned to the TB rooms they were largely stuck there and, moreover, denied the rotation 
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around the clinic that was standard practice throughout the rest of the clinics. Sister du 
Plessis, suggested that it was the infectious nature of TB and the poverty of TB patients 
that were the main reasons for this resistance among other nurses:         
It’s an infectious area…They are afraid that they’ll get TB…And I think it’s 
because there is not enough information.  Look, the staff say they can’t help 
us because they don’t want to know what’s going on here.  Then I told Sister 
Olivier, if they don’t come and see what’s going on here or come and work 
here, they will never know what is going on here, right? Look, for the people 
who come here it’s a social problem: they’re not so clean, they smell, you 
understand?  It’s not everyone who will work with that type of patient. 
Sister du Plessis here reveals an honest and uncomfortable truth about TB: that TB has 
heavy symbolic associations with notions of ‘dirt’. Kate Abney (2011), in an insightful 
thesis entitled Whoever Said a Little ‘Dirt’ Doesn’t Hurt? has written at length about this 
symbolism and how it contributes to the stigmatisation of TB patients. The association 
between TB and ‘dirt’ will be a recurring theme in this thesis and explored in most detail 
in Chapter 6 (where I will also discuss the association between SATVI and ‘clean blood’). 
Suffice to say at this point that, for Sister du Plessis, the ‘dirtiness’ of TB patients was 
one reason other nurses do not want to work with them. Moreover, it is precisely because 
of an ethical concern for patients and the danger of alienating them further that almost 
none of the nurses I encountered wore masks, thus adding to the risk of being infected.  
 The facility manager of Worcester CDC, Sister Pienaar, explained to me the logic 
behind the differential staffing of the TB rooms: 
Currently, there is a big, big issue with the staffing at TB. They are very 
frustrated there. At the end of the day we want every sister to do everything. 
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We want to rotate them. At first we rotate them on a quarterly basis, but we 
found out it’s better to put a person in the TB or chronic department for at 
least one year so that they can build a kind of relationship. But at the end of 
the day we said to each other, we mustn’t change the staff in the TB room. 
We must rather let them stay stable, the same people doing the job all the 
time. But what we are trying to do, we are trying to get sisters, one at a time, 
to learn also about TB. 
There was, in other words, a tension between wanting to rotate nurses to ensure that they 
had a comprehensive skill-set, on the one hand, and needing a higher degree of continuity 
in the staffing of the TB rooms, on the other. This understandably came across as a lack 
of fairness on those who were assigned to the TB room and unable to leave.  
 Worse than a feeling of being isolated in the TB rooms was the belief that that 
managers, both in the clinic and at district level, paid much attention to the statistics 
without actually coming and seeing what things were like in the TB rooms. This reflects 
the increasing incursion of ‘audit culture’ into the domain of healthcare provision in post-
apartheid South Africa (Hull 2012; see also Strathern 1992). The result was that the nurses 
felt they were being unjustly held accountable for the high ‘defaulter’ rates and poor 
treatment outcomes despite doing everything in their power to ensure that patients 
returned time and again to the clinics. Sister du Plessis related to me the troubling journey 
of self-doubt that she went through when the ‘defaulter’ rates began to skyrocket around 
the time that she began working in TB in 2009:    
Sister du Plessis (dP): I don’t know really, but it was very good.  And when I 
started here there were also statistics on the wall, and most of the time, a 
hundred percent, a hundred percent. When I came here it fell, and I think oh, 
me the problem, right? 
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Justin (JD):  I’m sure. 
dP:  But I do it right.  I also say that is the real thing.  And that’s what I told 
Dr [Van Zyl] when he phoned last year in November about a patient, and he 
was very angry.  So I said, doctor, TB is a bad problem in Worcester at this 
clinic.  The default rate, it’s going higher and higher. And I don’t think they 
realise what a big problem it is, because you talk and talk… 
JD:  The doctors. 
dP:  Ja, and also the operational manager, because they don’t come here so 
often, and now they realise when we talk.  I asked Dr [Van Zyl] that he must 
come and have a look here. Then he was here last week, but now I think they 
realise how many patients are here. 
As my fieldwork went on, there was a growing feeling among the TB nurses, as hinted in 
the above passage, that the clinic managerial staff were becoming increasingly aware of 
how out of control the TB situation was. This was, in large part, what prompted the 
Department of Health to place renewed emphasis on TB during the year of my fieldwork 
and efforts were being made to address this. However, the issue of staff rotation was never 
fully resolved during the time I was there and, as far as I am aware, remains a problem.  
(ii) Responsibility and Blame  
All of the nurses were well aware of the close relationship between TB and poverty. This 
was not only in relation to the mechanisms by which the disease is spread (e.g. 
overcrowded living conditions and poor sanitation) but also how it can be a barrier to 
attending the clinic for diagnosis and completing treatment (e.g. Farmer 2000; Compion 
2008; Harper 2006; Harper 2010; Das & Das 2007). To give one notable example of this, 
I was speaking to the facility manager of De Doorns clinic, Sister Kotze: 
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JD: What would you describe as the major challenge at the moment, 
especially with TB?        
R:  You know, as soon as we diagnose, number one, it’s poverty. Poverty 
plays a huge role in this community, and alcohol abuse as well. But as soon 
as the patients are diagnosed with TB, they start a few months or maybe a few 
weeks on TB treatment, but I think due to the poverty they need income [the 
implication being that they stop medication because of work]. 
However, with the daily frustrations of trying (often in vain) to steer several hundred 
patients through long and arduous treatment regimes, and the pressures placed on them 
from management, it is unsurprising that it was hard for them to always see the patients 
themselves as victims and to avoid placing blame upon their shoulders. Indeed, the 
discursive environment within which the nurses worked compelled it: the notion that 
patients must “take responsibility for their own health” was an almost omnipresent saying 
in the clinics, and invoked far more often by nurses than the corollary notion of patient 
rights. The fact that so many patients were not arriving at the clinics until they were at 
death’s door and stopping their medication prematurely was usually enough to arrive at 
the conclusion that they were not honouring the responsibility to safeguard their own 
health. 
 The clinic nurses expressed this to me in a variety of ways, drawing upon the 
inherited language of patient responsibility to shed light on patient behaviour. Nurse Kriel 
of Empilisweni TB room, for instance, said: “At the end of the day the responsibility of 
your health is your own. You can’t put the responsibility of being healed on someone 
else. You must stick to your appointments and the dates”. Sister Pienaar, facility manager 
of Worcester CDC, expressed to me with great regret that it simply seemed that people in 
the Breede Valley did not care about health:  
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R: We do whatever we can, but at the end of the day it’s your decision and 
your health, and you must come to the clinic. 
JD:  But that’s the problem, isn’t it, you’ve got on the one hand…one of the 
things that I’ve heard around, you want people to kind of take responsibility 
for their own health… 
R:  But they don’t want to…It’s very difficult for the staff because they are 
trying and they’re doing their best, but at the end of the day if you are my 
patient, I can’t just open your mouth and put tablets into your mouth. You 
know, it must come from yourself as well.  And you know, the kind of 
community that we are serving, they are very…it seems as if they don’t care. 
They really don’t care.  
What sticks out here is not only the way in which blame is placed on individuals, but 
perhaps more significant the way that generalisations were easily made. While it was the 
minority of patients that were visibly ‘not taking responsibility’, this was a stereotype 
which easily applied to everyone, resulting in an entire community being vilified as not 
caring: “they really don’t care”. Dr Van Zyl offered a slightly different reading of the 
situation. In his opinion, the reason that people are often not prepared to act in the best 
interests of their health is that “they do not have hope”. In such an impoverished and 
disempowered community as Worcester, people’s lives, in his opinion, often revolved 
around very immediate concerns, such making sure that they had food. A TB diagnosis, 
which entailed long-term commitment to taking unpleasant drugs – even when one is no 
longer feeling sick – was not, in his view, the primary concern for many.      
 Similarly struggling to make sense of the situation, Sister du Plessis’ explanation 
featured a large overlap between the language of patient responsibility and Christianity, 
an association with a long history in South Africa because of the missionary origins of 
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biomedicine (Vaughan 1991; Marks 1994; Hardiman 2006; Hull 2009). This she drew 
upon in a fascinating way to explain why it was that people in Worcester often did not 
comply with the clinics’ prescriptions:   
If you look, the end of the world is near, and there are so many people whose 
heart is not right…Most of the people here, if you don’t drink your pills, you 
haven’t got responsibility. Because the Bible says that your body is the body 
of god, so you must look after your body. And illness is part of this, right? 
TB can be cured, you must only drink your pills and then you can be cured…If 
the patient can change his whole attitude, it changes his heart. He starts taking 
responsibility for his illness. He will take his pills and complete it. He will 
see that all the people in the house who cough, he will try and try and talk that 
they must come to give sputum and to test for TB. And to try and support 
them, if there’s TB in the house, to drink his pills every day and to complete 
his treatment so that everybody at home can be cured from TB. All the 
children, younger than five, they will bring…give prophylaxis to prevent it. 
So, if the heart is right and it started at home, in each home, in each street… 
In this passage, we get a sense that, for Sister du Plessis, the TB epidemic is not only a 
highly moral condition but also one that has risen to Biblical proportions. The reason for 
the magnitude of the disease is a wide-scale failing of people’s “hearts” – “there are so 
many people whose heart is not right” – which worries her given that the end of the world 
and the Day of Judgement is near at hand. Vaughan (1991, p. 74) argues that “healing, 
for medical missionaries, was part of a programme of social and moral engineering 
though which Africa would be ‘saved’”. For Sister du Plessis, ridding Worcester of TB 
meant a combined emphasis on medical and moral healing, a sustained and community-
wide endeavour to change people’s hearts so that they attended the clinics. This, for her, 
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legitimised governmental intervention, the object of which was a particular imagining of 
immoral, irresponsible bodies that needed to be changed.   
 Yet reaching people with this message was precisely the problem. The clinics were 
disconnected from the communities that they serve, and those who most needed to attend 
the clinics seemed the least willing to go. Thus it was that Sister du Plessis composed the 
flyer with which this chapter opened, to be delivered to as many houses as possible via 
the home-based carers: “That is why the flyers must get out, right? The flyer must get to 
the home…The DOTS workers [home-based carers] who are in the field can go and give 
it out at the homes, you understand? Unfortunately for her, that flyer was never actually 
put to print. The managers deemed it too full of religious rhetoric and harmful language 
to be appropriate for mass distribution. One can certainly see why this was the case, given 
the kinds of words and phrases used: “disobedient patients who refuse treatment”, “evil” 
and “ghost town”. However, I would suggest that the reason that it was deemed 
inappropriate was the lack of sensitivity with which the message was composed rather 
than the message itself. Indeed, it was fostered by the discursive environment in which 
the TB nurses were working, compounded by their feeling of isolation. The flyer, I 
contend, ought to be read as an attempt – a desperate one, for sure – to get some kind of 
grip on what was happening “out there” and over which she and the other TB nurses 
seemed to have little or no control. On one level, Sister du Plessis’ efforts showed how 
much she cared.  
(iii) Nostalgia for the Past 
The nurses drew heavily on the language of patient responsibility in order to explain the 
TB epidemic and attribute blame. However, the “gap between the clinic and the home”, 
as Dr Van Zyl put it, was so wide that it seemed often to outstrip the capacity of 
‘responsibility-speak’ to offer tangible solutions to the problem. As a result, a number of 
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the nurses, especially those who had been practicing nursing during apartheid years, 
reflected back to a time when things seemed somewhat simpler. This is not to suggest 
that the nurses wished for a return to apartheid. It was just that certain forms of healthcare 
seemed to offer more effective means of controlling TB than the current prevailing 
paradigm revolving around the rights-bearing, responsible patient.  
 One aspect of healthcare during apartheid that was invoked repeatedly among the 
nurses was the active presence that nurses had in community settings. The assistant 
district manager Sister Kriel suggested the benefits of this community presence: “There 
was great interaction with your patients. It was nice because people who didn’t want to 
go to the clinic got seen”. Further to this, Sister Pienaar, facility manager of Worcester 
CDC, said that healthcare facilities had greater control over patients, who in turn listened 
to the nurses more: “we used to take the service to the community. We used to do home 
visits. There was more control over the patients, because the sister in the TB room can go 
out herself – that time the patients listened to us more”. Finally, Nurse Jacobs of 
Worcester CDC said to me: “Ja.  You can ask Terence (another nurse). They’ve got a 
scooter and then they go out to call on the patients to come in.  And they did come in, you 
understand, but now they don’t. They come once and never again...The problem is that 
they don’t care”. In the intervening time since the nurses stopped being such an active 
community presence, the home-based carers have, as we have seen, emerged to take on 
much of the work outside of the clinics. However, and despite being valued, there was a 
feeling that this was not the same as having trained nurses being able to go to people’s 
homes, not only because of the greater expertise of the nurses, but because people seemed 
to respect them more.  
 Part of the reason for this, however, was that patients had very few rights, and what 
seemed like respect was as much about subservience and obedience because of the fear 
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of the consequences. Sister du Plessis, however, felt that such was the scale of the TB 
epidemic that patients should not have the rights that they do now, especially in relation 
to TB control. In an angry moment, she said to me: 
In the beginning, it [TB] wasn’t such a big problem, but now it is, because of 
the defaulters. Now the patients have rights, but that time we didn’t have 
rights like after 1994. You know, I think that is a big problem. 
Few other nurses put the matter quite so matter-of-factly as Sister du Plessis. Nonetheless, 
patients being seen to ‘abuse’ their rights by failing to take responsibility was present in 
many nurses’ narratives. Moreover, nostalgia for apartheid healthcare among nurses has 
been similarly observed by Walker and Gilson (2004, p. 1257). Again, as Walker and 
Gilson do, I would stress that the nurses in no ways expressed a desire to simply return 
to apartheid. Rather, these backward-looking perspectives just show how much of a 
disconnect there is between the theory of TB control and its reality on the ground. 
Therefore, it is perhaps unsurprising also that tried and tested methods that were 
acceptable in the old regime – for instance scolding, disciplining, even threatening to call 
the police – were invoked in instances where the prevailing logic of patient responsibility 
reached its limits. Whether these techniques are justifiable and what their effects are is 
another matter. Sister du Plessis, certainly, could cite many instances where patients had 
kicked and screamed their way through treatment but had later thanked her for being 
tough.   
Conclusion 
In this chapter, I have attempted to highlight the challenges of TB control from the 
perspective of those working on the frontline of the epidemic. I have pointed towards a 
dissonance between the imaginings of how healthcare ought to function in post-apartheid 
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South Africa – rights-bearing individuals taking responsibility for their health – and the 
reality in which people were not attending the clinics once sick and ‘defaulting’ on 
treatment regimens. I have observed that the “gap between the clinic and the home”, as 
Dr van Zyl referred to it, is a product of a range of historical changes, including the 
restructuring of the health system, a lack of funding to support such changes and 
worsening socioeconomic and epidemiological conditions. And yet it was the nurses who 
shouldered the burden of negotiating this dissonance on the ground. By showing how 
they constructed TB as a moral condition which justified drastic measures, I have tried to 
show that the techniques deployed to get results were not deliberate attempts assert 
dominance over patients but rather ‘ugly’ acts of care in response to an ugly situation.  
 Yet, structures of dominance were exactly what was thereby reproduced through 
the interactions between the government clinic staff and their patients. Exasperated and 
overwhelmed, it was all-too-easy to lose sight of the structural determinants of TB that 
they knew to exist, to place blame upon individuals and, moreover, to generalise over the 
entirety of Worcester’s low-income, predominantly non-white population. Moreover, in 
Chapter 6, I will suggest that these discourses have been taken up and further moralised 
and reinforced by the community that is cast as such. TB control, I suggest, therefore 
constitutes a key site within part of a broader pattern of governmental discourse in 
healthcare and society more generally that, as Jensen (2008) observes, realises the very 
people, behaviour and groups that it seeks (explicitly at least) to transform. This is the 
context into which SATVI’s vaccine trials have been inserted, one experienced by the 
frontline clinic staff as hopeless and out of control. In the following chapter, through the 
eyes of SATVI’s team of fieldworkers, we begin our exploration of the institute’s vaccine 
trials by exploring what is happening in the very low-income settings that the clinics 
struggle so much to gain any control over. There we begin to see a series of social 
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processes moving in the opposite direction to the categorisations and interventions of the 
post-apartheid state.    
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Chapter 5: 
“We Treat them as Special”: The Social Dynamics of 
Recruitment in Post-Apartheid Worcester 
Larry, a fourteen-year-old Xhosa boy who wanted to take part in the Adolescent Trial, 
squinted at a dusty photo on the table of a girl his age whom he did not recognise. We 
were in his mother’s house; but Larry was no more familiar with it than I or the 
fieldworkers who I was accompanying. Larry had chased after the car while we were 
driving through Zwelethemba township, which was around five kilometres away from 
our current location, and when we stopped he had asked to take part in the vaccine trial. 
Fefe and Digby, the fieldworkers, had spoken to him before and knew that he had been 
living with his grandparents for the last ten years or so (although though they were not 
his biological grandparents but rather an old couple known to the family). Larry had been 
moved away from his parents’ house when he was very young because of an abusive, 
drunken father and had not been in contact with either of his parents since then.   
 To take part in the trial, he could not provide consent himself; it was his legal 
guardians from whom consent had to be elicited, with Larry providing his assent (a 
separate form). We went to his grandparents to initiate this process. However, it transpired 
that the grandparents were not his biological relatives and did not have any paperwork to 
prove they were his guardians. This presented a dilemma: either give up, or do something 
drastic, namely to try to find his long-absent mother. Larry was, to my disbelief at the 
time, willing to activate the latter option, as were his grandparents. The mother apparently 
lived in Avian Park, a suburb of Worcester known for its gang-related activities. Knowing 
how much R150 could mean to a boy in Larry’s position – the assumed, if unspoken 
reason for his interest – the fieldworkers decided to give it a shot. We drove over to Avian 
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Park and eventually found the house (after asking around), one of the most miserable 
shacks I had seen in Worcester to date, where we became part of a bizarre if warm 
reunion. Larry’s mother was thrilled to see him. Embracing him, she asked him about life 
and school and paraded him around to meet her neighbours. Yet, this very quickly blurred 
into setting up the furniture for a group discussion – some plastic chairs around a broken 
table – followed by animated explanations by the fieldworkers about the all-too familiar 
threat of TB, the need for a new TB vaccine, clinical trials and rights of participants. 
Consent was eventually given, documents were exchanged, forms were meticulously 
signed and, at the end, Larry and his mother decided to meet again properly during the 
school holidays. During the drive back to Zwelethemba, Larry did not say so much as a 
word, clearly lost in a world of thought. Arrangements were made for screening at the 
trial site. All that remained of that encounter were a series of consent/assent forms, where 
Larry and his mother’s names appeared side-by-side, mother and son, legitimising his 
participation in the trial.  
 SATVI prides itself on being able to fill its vaccine trials based almost solely on 
the basis of word or mouth or ‘snowball sampling’, at the heart of which lies its large 
team of field workers, a highly visible presence in Worcester who can be seen driving 
around in the institute’s white, branded vehicles. This above vignette, while by no means 
an everyday occurrence, gives a sense of the social substance of recruitment on the ground 
and what goes on behind the scenes in order to produce the appearance of a smooth 
insertion of ‘global’ ethical practices into impoverished settings (cf. Sariola & Simpson 
2011). Focusing upon SATVI’s fieldworkers, this chapter builds upon an expanding body 
of literature on fieldworkers in African research settings. These have drawn attention to 
the important ‘interface’ roles played by these intermediary actors balancing the abstract, 
distanced requisites of formal research ethics with the situated, relational ethics of face-
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to-face encounters (e.g. Geissler et al. 2008; Kingori 2013; Molyneux et al. 2013). The 
contribution of this chapter is, firstly, to shed light on the unique challenges thrown up 
by recruitment in a heterogeneous, stratified and often dangerous urban post-apartheid 
setting, and how the fieldworkers utilised their reputations, innovation and often bravery 
to complete their work. Secondly, it is to highlight a dimension of trial recruitment that 
is often overlooked given the emphasis placed upon material need: the value of 
participants to the research and the way that fieldworkers frame and vernacularise this 
message. I will demonstrate that the fieldworkers were acutely aware of the 
disempowerment and low self-esteem experienced by many of those with whom they 
interacted. They therefore believed that amongst the most important aspects of their work 
was conferring upon people a sense of being valuable, included and as capable of making 
moral decisions, something they were often not accustomed to elsewhere (as shown in 
Chapter 4). That this was considered so important by the fieldworkers problematises a 
tendency in existing literature on fieldworkers in African contexts to hold their relational 
work in opposition to the bioethical ideals of autonomy and altruism. The significance of 
this treatment for participants themselves will become clear in the following chapters, 
which introduces their perspectives into the frame.   
Fieldwork in a Post-Apartheid Setting  
Fieldworkers, which go by a number of titles in different research contexts22, are research 
staff who are typically hired from the study communities in which research is conducted 
and whose work involves face-to-face, community-based interaction with participants. 
Often holding high school certificates and with previous experience in the NGO sector 
                                                 
22 E.g. data collectors, research assistants, community interviewers (Molyneux et al. 2013), or in 
SATVI’s case, clinical research workers. I use the term ‘fieldworker’ because it is perhaps the 
most commonly used term in the literature.    
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(e.g. HIV counsellors), their roles include recruiting participants into trials (including 
conducting informed consent) and trial-related tasks for which medical training is not 
necessary, for instance collecting routine clinical data (Molyneux et al. 2010, 2013). 
Simon and Mosavel (2010, p. 4) observe that there are a number of pragmatic and ethical 
reasons for using fieldworkers to perform this kind of work: it contributes to local 
employment; the fieldworkers speak participants’ first language; they have knowledge of 
people’s norms and values and know local geography and community layouts; and they 
often have an “insider status” that fosters trust and communication between researchers 
and study communities (see also Molyneux et al. 2013).  
 Because of the income generated by formal employment, fieldworkers are often 
comparatively well off and with high social standing in the communities in which they 
work. At the same time, they tend to be amongst the lowest in the institutional hierarchies 
of research institutes because their role, unlike medical and scientific staff, requires few 
qualifications. While their work is easily construed as ‘simple’, ethnographic studies have 
shown that they play a vital and under-recognised role mediating between the abstract, 
distanced world of ‘global’ science and ethics and the material realities in which they land 
(e.g. Molyneux & Geissler 2008; Molyneux et al. 2013; Kingori 2013). In one of the most 
influential studies of clinical trial fieldwork, Geissler and colleagues (2008) show that the 
success of a malaria vaccine trial in The Gambia hinged at least partially on the ability of 
fieldworkers to counter the perception that the trials represented European interests by 
couching trial relationships within a familiar idiom of kinship. “He is now like a brother, 
now I can even give him some blood”, as one participant explained (see also Gikonyo et 
al. 2008; Leach & Fairhead 2011). Focusing more specifically on consent encounters, 
Kingori (2013) demonstrates that for data collectors in western Kenya, the principle of 
autonomy was peripheral to the data collectors’ ethical practice, who instead acted upon 
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their own interpretations of justice and beneficence. Also in Kenya, a recent collection of 
papers (Molyneux et al. 2013) comprehensively describes and analyses the variety of 
roles that intermediary actors play in clinical trials and the ethical challenges that the use 
of these actors pose. Taken together, the literature shows that “relational ethics” – that is, 
the ethics of face-to-face encounters – is crucial to the success of clinical science in 
contexts of extreme inequality (Geissler et al. 2008; Molyneux et al. 2013), a necessary 
corollary to the abstract tenets of formal research ethics.  
 SATVI’s fieldworkers are like those in other African research contexts in many 
respects. First-language Afrikaans or Xhosa speakers, the fieldworkers are hired from the 
Breede Valley and have an excellent knowledge of the geography of the area, values and 
norms and are well known and trusted. The following section gives a sense of their 
backgrounds, social standing and how this informs the trust and reputations they have in 
Worcester. Yet, as Simon and Mosawel (2010) argue, fieldwork and its associated 
challenges can vary greatly depending upon the nature of research and the degree of 
immersion of fieldworkers in trial communities (see also Molyneux et al. 2010). Several 
of the aforementioned ethnographic studies took place in rural settings where 
fieldworkers lived amongst participants throughout the duration of studies and often 
became deeply embedded in people’s social networks (if they weren’t already). The 
challenges that the fieldworkers faced and how they tried to overcome them were 
influenced by this high degree of immersion (Molyneux et al. 2010). While the 
fieldworkers often knew, or developed, relationships with participants, Worcester’s 
heterogeneous, stratified, destabilised and often highly dangerous urban environment 
threw up a unique array of challenges which departs from other accounts. In one day, I 
will demonstrate, they could encounter affluence, destitute poverty, people from different 
cultural backgrounds to themselves, and gang violence.   
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 Perhaps unsurprisingly, then, when spending time with the fieldworkers I began 
to appreciate a slightly different skill-set that they were drawing upon to complete their 
day-to-day work. This was, certainly, a form of relational knowledge. However, it was 
often not so much of an ability to maintain prolonged relationships, but rather adopting a 
state of continual adaptability, flexibility and responsiveness: a tactile knowledge of 
people, norms and values and also of geography, materials, domestic spaces and social 
networks. The necessity for adaptability was heightened by the fact that in different 
moments the fieldworkers were dealing with very different imperatives. When attempting 
to generate productive ‘snowballs’, they were often implicitly relying upon the poverty 
and abjection that made people available objects of experimentation. By contrast, in the 
consent encounters themselves, another series of concerns came to the fore. Trust had to 
be established, suitable consent environments constructed, documents assembled, 
narratives rehearsed and, perhaps most significantly, attempts made to ‘lower’ oneself to 
uphold the dignity of people in impoverished living circumstances. The main point that I 
want convey is that the fieldworkers were concerned with making the consent process 
meaningful to people: getting them interested in the science and what their role in it was; 
to put them in a position where they were making a genuine moral choice (cf. Kingori 
2015); but most pertinently to make them feel valued and worthy, not only as participants 
but more generally as people. This chapter thus begins to chart the transition that people 
undergo from being abjects to objects to subjects (Sariola & Simpson 2013), which I 
introduced in Chapter 1 to help draw out the meaning and significance of SATVI’s trials 
in people’s lives.   
Fieldworkers and Community Life 
Speaking to the fieldworkers, both on the road and during interviews, most described 
themselves as outgoing and extraverted but also trustworthy and discreet people who had 
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a passion for working with and for the community. In SATVI’s formative years, as we 
saw in Chapter 2, the fieldworkers were HIV counsellors who had been contracted from 
the Treatment Action Campaign (TAC), and had therefore developed skills and 
reputations through their work in this capacity. Since then, the fieldworkers have come 
from a variety of backgrounds, and even those from a counselling background staked 
their reputations on a wide variety of roles which combined and fed into their work for 
SATVI.   
Speaking to Edna, who had worked for SATVI since the BCG trial, she explained 
that she was not only known for her history as a counsellor, but as being active in the 
church, as regularly attending community events and funerals, and even brokering 
reduced taxi costs from R10 to R8 as price rose beyond what people could reasonably 
afford. Alex, an optometry technician by training, seemed to know every other person in 
Worcester, making sure to acknowledge everybody he knew as he drove through the 
town. He was also known and respected among the younger men because of his 
involvement in motorsports. Nomvula, another previous HIV counsellor, was very well 
known and respected in Zwelethemba because her mother ran a soup kitchen, which she 
had taken over. She had recently also taken to selling meats. Other backgrounds of the 
fieldworkers included KFC manager, hospital clerk, nurse and home-based carer.   
 It was noteworthy, however, that while they considered themselves to be 
respected individuals with good reputations and the trust of those they worked with, most 
were considerably less comfortable and self-assured in the more affluent and 
predominantly ‘white’ suburbs. This again testified to the stratified nature of post-
apartheid Worcester and the way the town remained divided by Durban Street. There 
were, however, one or two exceptions among the fieldworkers, for instance Demi, who 
was regarded as having an air of “high class” and “respectability” (ordentlikheid). 
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Coming from a middle-class background, she had found it difficult initially to adapt to 
conducting recruitment in “dirty” places and, while she was used to it and even enjoyed 
it on occasions, remained more comfortable recruiting in wealthier areas. This suited the 
other fieldworkers just fine, and they were happy, for instance, to let her conduct any 
work in the affluent suburbs. Nonetheless, as I will show below, working in these areas 
was likely to be far less productive than in the dense, accessible social networks in lower-
income suburbs.  
The Closures of Affluence  
Spending time with the fieldworkers, I began to get a sense of what was viewed as a 
‘successful’ day in the field. Three completed informed consent forms per day was par 
for the course. Four, five or more was be considered a productive day. Two, one or 
nothing – a far more common occurrence than the fieldworkers would have liked – was 
usually viewed as unsatisfactory. The recruitment cycle typically began by searching for 
people who had already given their details to SATVI, for instance by phoning the site or, 
in the case of the Adolescent Trial, putting their names and details in the box at school. 
From there, the hope was that further interest could be generated via people’s contacts 
and networks. However, this tended to be far easier in the lower-income parts of town. 
On one afternoon with Demi, we had a more ‘successful’ afternoon than expected 
precisely because it took an unexpected turn. We were out looking for a ‘white’ young 
man who had put his name in the box at Drosdy High, one of the middle-income schools 
of Worcester. However, we were having difficulty finding him because he had left two 
addresses, one his dad’s home in a block of flats in central Worcester, the other his 
boarding house at school. The problem was that, at his dad’s house, nobody was 
answering the buzzer, the phone went straight to voicemail and there was also nobody 
around, such as a neighbour, to ask whether they were in. We were eventually forced to 
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give up, and so we drove to a nearby shop and Demi got out to get something to drink. 
But in addition to a drink, Demi returned with two ‘coloured’ Afrikaans teenagers, who 
got in the back of the car. Demi exclaimed, “well these two are interested at least!” – they 
had recognised the car and approached Demi in the shop. We drove across Durban Street 
and down to Esselen Park, where the young men lived next door to one another. While I 
reserve a detailed discussion of how the consent process itself was conducted until later, 
both sets of parents fully supported the boys’ participation in the trial and, within about 
half an hour, Demi had two completed sets of consent and assent forms signed and an 
appointment made for them to come to the trial site for screening.  
Demi was already fairly satisfied, given how the afternoon had started. However, 
on the way back to the car another of the boys’ friends walked up and, recognising what 
had happened, asked to participate too. It turned out that he lived in a more dangerous 
area near Riverview. Demi, realising that this would take her out of her comfort zone, 
asked the teenagers (who had already been recruited) to join us for safety reasons. After 
the short drive, on the way into the boy’s house we walked past rows of men drinking, 
and Demi, despite her fear, smiled warmly at them as we walked past repeating 
“goeienaand [good evening]”. After finding the boy’s mother in the kitchen, Demi 
decided that this was not an appropriate environment for conducting the consent process, 
and so she took the boy and the mother back to the car, where she conducted the whole 
process in the dim overheated car light, leaning over into the back seat from the driver’s 
position, while the two teenagers stood outside guarding the car. After the final signatures 
were in place, we drove the teenagers back home and headed straight back to the office 
with a sigh of relief.           
 This series of events says much about the social substance of snowball sampling 
and where it does and does not work. The reasons why it was difficult to recruit 
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participants in wealthier suburbs were multiple. Firstly, the fieldworkers generally had 
fewer contacts in the affluent areas of Worcester, making it difficult to find a point of 
entry into their social networks. But even in the Adolescent Trial, where the fieldworkers 
had the details of interested parties in advance, in the frequent event that phones were not 
being answered, it was tricky to actually get face-to-face with prospective participants. 
Most simply, this was because there were usually high gates and walls around the houses, 
and as often as not the buzzers had been removed from the sockets. The removed buzzers 
in particular signalled a disdain for uninvited people – a measure which, while usually 
taken to deter ‘hawkers’ or job-seekers, was also off-putting for the fieldworkers. 
Secondly, even if initial interest had been expressed, the fieldworkers were pessimistic 
about their chances of successful recruitment. The feeling was that parents would often 
want nothing to do with TB and would refuse to let their children participate in the studies 
before the fieldworkers had even presented any information. Nomvula, for example, 
expressed how this had transpired in her experiences:     
I go to everyone, except the ones that I know are going to say no. But the 
people that are at my level. When I say people at my level, the lower 
level…it’s good for me because it’s easy to talk to them. Those ones with the 
big houses who are fancy, I really don’t go to those houses because the parents 
are going to ask, “why is she here? We don’t want those girls to stop at our 
houses”.                                                                                        
Nomvula was referring to wealthy people in general. However, I was speaking to 
Peter, a lively and confident Afrikaans fieldworker, who felt that it was ‘white’ 
people in particular who were less likely to let him into their homes. In fact, for 
Peter the pursuit of ‘white’ participants for him was doomed from the start:    
Chapter 5 
 
139 
 
I can’t think like white people, really I can’t. Because coloured and black 
people if you start talking to them they invite you into their houses, and say 
“no sit man sit”, and then they talk…But if I go to white people, neh! I never 
got the white people…Not that I’m afraid of going there, or don’t like them. 
I just know for sure that no, I won’t get that person to be a participant, so I’ll 
give it to them who are more comfortable [e.g. Demi]. 
Whether it was ‘white’ people or more affluent people more generally, what the concerns 
of these fieldworkers had in common was that the refusal to take part was not based upon 
a consideration of trial-related information (e.g. risks and benefits). Rather, the decision 
not to take part had been made before the fieldworkers could even begin.  
 Although rates of TB were much lower in affluent areas, it was interesting to find 
that, from the perspective of the fieldworkers, the primary reason for nonparticipation 
was not a lack of experience with the disease or even that the risks outweighed the 
benefits. Instead, for them it was because of the association of the disease with ‘poor’, 
‘dirty’ and ‘coloured’ bodies, which was discussed in the previous chapter (see Abney 
2011). That TB stigma was the driving force behind refusals was hinted at by Nomvula’s 
expression: “Why is she here? We don’t want those girls to stop at our homes”. But it 
was stated more explicitly by other fieldworkers: “you know when it’s a nice house they 
don’t want to participate, because of the stigma” (Judith); and: “They think it’s something 
dirty…If you have TB, everything is dirty….so they don’t want to be near you” (Demi). 
Now one might well ask, why was stigma an issue when it was healthy individuals that 
SATVI were interested in recruiting into its trials? It seems that many people just heard 
“TB” and, regardless of the finer details, immediately wanted nothing to do with the 
research and stereotyped those recruiting for it. Indeed, from the accounts of some of the 
fieldworkers, it seemed that people often reacted to them as though TB itself had come 
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knocking.  
Avalanche Sampling and Gang Territories 
By contrast, recruitment in the lower-income suburbs was, as suggested by my 
experiences with Demi, considerably more productive. Firstly, the task of approaching 
people and households in these areas was already facilitated by a high degree of 
familiarity with SATVI’s work. The white branded vehicles were such an active presence 
south of Durban Street that, every time I was out with one team of fieldworkers, it was 
rare not to bump into another team or two along the way. Moreover, calls of “the TB 
people” often followed the passing of the vehicles, and the fieldworkers waved or hooted 
at those (great many) people who they knew personally and/or as participants in the trials. 
This made the task of setting in motion productive ‘snowballs’ considerably easier.  
A snowball could commence with the name of a person who had responded to an 
advert or dropped their name in the box at school. In those instances, the index case could 
usually be relied upon to give the fieldworker at least one name. But this was often not 
even necessary. For example, recruitment activity for one trial could start where the last 
left off: by approaching a household which already had an established history of 
participation. In fact, often the fieldworkers did not have to go in search of participants; 
interested parties would come to them. Several fieldworkers expressed this to me. Ruby, 
an Afrikaans fieldworker from Riverview, said to me in the car one day that “all the 
people in Riverview know me and they will find out what study I am on and want to take 
part in that one”. Edna, moreover, said that: “when I come home from work and the car 
stops there, then there’s a couple at my house waiting for me: my child is this and this. 
Then I say, yes, it’s fine, I do have the stuff [consent forms] at my home”. Alex even said 
to me that there was one teenager in his street who, of his own volition, produced a list of 
interested people for him:   
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There’s one kid who I don’t even know personally who come up to me and 
says “uncle [Alex] I’ve got some names for you”. And he’ll have like eight to 
nine names and addresses! So, that’s the reputation I have built. This kid’s a 
participant, and he must have seen me spinning [a motor sport] or something. 
All of a sudden people know who you are and associate you with SATVI. 
With considerable pressure to enrol as many participants as they could, it is little wonder 
that the fieldworkers devoted more of their time and energy to recruiting in Worcester’s 
low-income suburbs. Indeed, what they were engaged in can probably be more accurately 
described as ‘avalanche sampling’ than ‘snowball sampling’.  
 While this gives the impression that recruitment is simple in these settings, it is 
important to recognise that most of Worcester’s poorest suburbs were coextensive with 
gang territories. The main gang territories were located in Roodewal, Riverview and 
Avian Park, and within the former two, the areas where the gangs were most active were 
the blocks of flats (Figures 11 and 12). The way in which these flats were constructed is 
consistent with the apartheid regime’s “racialized modernist vision” (Muller 2004, p. 56), 
low rise and uniform. While these flats were viewed by the predominantly ‘coloured’ as 
safe and friendly during the 1980s and 1990s, in recent years they have been colonised 
by gangs and the way the blocks are bounded and with large public spaces in the middle 
of them make them easily demarcated territories. When driving into Roodewal flats, one 
can see children sitting on the road, who are paid by the gangs to keep an eye on who is 
entering and phone them if police, rival gangs or anyone not welcome passed by.  
 At the time of my fieldwork, people were injured or killed on a daily basis – and 
the victims were not always gangsters. It is perhaps no surprise that, as we saw in the 
previous chapter, these were precisely the areas that the government clinics found so hard 
to access and gain any control over (even though Worcester Community Day Centre was 
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only a few kilometres from Roodewal flats). SATVI’s management were well aware that 
their staff were working in these areas and took measures to ensure that they were as safe 
as possible: the fieldworkers always travelled using cars; they were to go out in twos; and 
they were not to recruit after dark when things got ‘lively’. Yet as fieldworker Maggie 
said of recruitment in gang territories, “you never really know what’s going to happen”. 
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Figure 11: Roodewal Flats 
Figure 12: Two separate teams of fieldworkers coincidentally  
arrive at the same block of flats in Riverview  
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With the dangers of gang violence ever present, the fieldworkers relied heavily on their 
personal reputations as community workers and being known by the gangsters 
themselves. In fact, not only did the fieldworkers say to me that they have the licence to 
move around unchallenged but, moreover, would often be offered protection and 
warnings about gang fights so that they did not get caught in the crossfire. Christine, for 
instance, related an example where her colleague was challenged by some gangsters 
because she was not known to them personally but, upon finding that she was working 
with Christine, was offered protection while they worked: 
We were there, earlier this day, I parked the car and this guy came and asked 
[Imogen], “with whom are you working here?” And she said “with 
[Christine]”, and he said “ok ok ok we will stand here by the car and watch 
the car… So, people is knowing us. And especially when there’s gang fights, 
they know we are busy recruiting at the flats, then the ‘small’ gangsters will 
tell you, you must now get done because the gangsters – the ‘big’ ones – is 
coming. Or there will be a shooting, or a robbery, or this and that…so you 
must just go. You can come tomorrow again. Or you can come and just ask 
them, can I come? And they will say “no no not today, it’s not safe”. 
Here we can see how heavily reliant SATVI were on the reputations of the fieldworkers 
in order to access the people who were living within the scope the informal control of the 
gangs, particularly the way that they were seen to be looking out for the interests of people 
in these impoverished settings.  
 With that said, such was the pressure to generate sufficient numbers of participants 
that the fieldworkers sometimes pushed their luck. Mira recounted a recent experience 
where she was in one of the Riverview flats conducting the informed consent process 
with a prospective participant. The backdrop of the consent process, however, was Ruby 
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sitting downstairs in the car with the engine running whilst a gang fight moved nearer and 
nearer to the car. Mira said that she left it until the last minute to get the final signatures 
in place before hurrying to the car and both of them driving to safety. None of the 
fieldworkers were entirely comfortable with working in gang territories and, moreover, 
there have been much closer calls that it would be inappropriate to mention here. 
However, the way that this was generally expressed was that it was just ‘part of the job’.  
‘Reimbursements’ and the Unemployed 
Before moving on to an exploration of the consent process, it is important to state 
explicitly what, from the fieldworkers’ perspectives, was causing word of SATVI’s trials 
to spread faster than TB itself through Worcester’s low-income suburbs. Most suspected 
that, at least at the point of recruitment, it was the R150 ‘reimbursements’23 that were 
greasing the wheels of the recruitment bandwagon (I will show shortly that during the 
consent process they attempted to counter this imagining). One can certainly see why: 
mention of R150 seemed to follow the fieldworkers around wherever they went, although 
almost exclusively among young men, who often made ‘blood-for-money’ gestures at the 
cars. This involved rubbing one’s thumb and fingers together (indicating money) and 
pointing an index finger to the inside of the other arm (indicating blood draws). One 
young man, for example, came up to the car window while I was with Peter and said, “my 
blood is veeeeery expensive, you must give me R300”. Below and especially in the 
following chapter, we will see that this was precisely the image that threatened the 
respectability of trial participation and that people tried to consciously distance 
themselves from (Jensen 2008).    
 There has been extensive bioethical debate as to what amount of money – if any – 
                                                 
23 R150 was worth approximately £9 at the time of writing.  
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is ethically appropriate to give to clinical trial participants. Positions range from the 
conservative bioethical one that any situation in which participants can receive a net gain 
is ‘undue inducement’, to the view that participation should be reconfigured as ‘clinical 
labour’ in which determining a fair wage is the primary ethical priority (Geissler 2011; 
Sachs 2011; Cooper & Waldby 2014). In line with the former position, the R150 given at 
each scheduled study visit was conceived strictly as ‘reimbursement’ for losses, not an 
incentive and certainly not payment. However, the fieldworkers thought that the regular 
receipt of R150 was more than a ‘reimbursement’ and rather a significant contribution to 
household income. Several believed that SATVI’s trials would not generate interest 
without it. Harry, for example, said to me:    
But you know I think people do it more for the money. That is how I see it, 
because the kids will tell me “my mum’s waiting for this money I need to buy 
this and that”. If we didn’t have that incentive, we wouldn’t have any 
participants. 
Moreover, some suggested that one of the reasons that SATVI enjoyed privileged access 
to the gang territories, in addition to personal reputations, was that the institute was 
putting food on gangsters’ tables. Lincoln, one of the drivers, expressed this: 
The other thing is it’s also helpful for the community, in that the 150 is 
important, and in some areas, it helps us to get into that area, especially where 
the gangsters is. They know that maybe one of their family members is a 
participant so maybe in the morning there is no bread, but after we bring them 
home they know there’s money that can be used. That also covers us to go 
into areas.  
We might therefore suggest that when SATVI was known for community work, this was 
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not only for its research but also for the ways in which the institute had become part of 
and perhaps even helped to sustain the shadow economy of gang life.  
 On a more general level, several of the fieldworkers said that the whole recruitment 
business was implicitly reliant upon Worcester’s high unemployment rates. The simplest 
evidence for this was that most recruitment activity for the adult trials took place during 
what would usually be working hours, and therefore those who were available to them – 
and amongst whom productive ‘snowballs’ of participants were likely to occur – were 
disproportionately those not working. One fieldworker, Anette, even hinted that she 
included unemployment as part of the ‘inclusion criteria’: 
If I go out in the field, I’m looking for specific age groups, say 18-50, then I 
know this person was part of my previous study. Then I will ask them, “is 
there still some people in your family who are not working and is between the 
ages of 18 and 50?”. Then they will say, “no not in my family, but in that 
family and that family”. 
The reason for seeking the unemployed was not only in order to generate interest, it might 
be noted. It was also in the interests of retaining participants. I was informed that even 
though site visits can be arranged so that it does not interfere with people’s work, those 
who found employment often dropped out of the trials. This, in a sense, made unemployed 
people ‘better’ participants, ones who will see the trials through. I do not wish at this 
point to take any position on the matter, because below and in subsequent chapters we 
will see how resistant many people were to the suggestion that participation is or ought 
to be just about material gain. Nonetheless, from the fieldworkers’ viewpoints, the 
‘reimbursements’ were a significant lubricant for the spread of interest in the vaccine 
trials and that, ultimately, a high percentage of SATVI’s participants were unemployed.  
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Spaces and Relations of Consent  
So far, this chapter has focused upon how the fieldworkers handled the pressure to 
generate a sufficient quantity of participants to fill SATVI’s trials and how they navigated 
Worcester’s stratified urban environment. Yet, they also had to conduct high quality, 
GCP-consistent consent processes. The imperative underlying informed consent is the 
provision of clear, accurate information about the research and the voluntariness of 
participation such that informed, autonomous choices can be made (Geissler et al. 2008; 
Gikonyo et al. 2008; Geissler 2013). There is also, as will be discussed in the next section, 
a bureaucratic element, involving the meticulous filling of forms and gathering of proper 
documentation. The challenge was that, as recruitment activity was channelled into 
Worcester’s poorest areas, the social and material environments in which people lived 
did not easily translate into the world imagined by GCP, often living in destitute poverty, 
with high unemployment and few opportunities, and fragmented familial and social 
relationships.  
 Given the dissonance between bioethical ideal and material reality, a considerable 
amount of work was often needed before the process of eliciting informed consent could 
even begin. In the opening vignette, we saw Digby and Fefe having to contend with the 
fact that Worcester was not a setting in which one can safely assume that adolescents live 
with their legal guardians. But ultimately this did not deter them. Given Larry’s wishes, 
they devoted an afternoon (at the expense of recruiting larger numbers of participants, it 
might be added) to bringing him and his mother together so that their names could appear 
side-by-side on the consent/assent forms. One effect, it might be noted was that the 
consent process went some way towards creating the reality it purported to represent:  
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Larry and his mother re-established their relationship.24 During my time with the 
fieldworkers, I heard several stories where they travelled extensively, sometimes to far-
out farms, to track down the mothers of adolescents so they could take part.  
 Aside from assembling the necessary individuals, other conditions also had to be 
met before the consent process could proceed. Upon entering the house of Larry’s mother, 
a mattress had to be dragged out of the way into a corner, what limited furniture was 
carefully arranged, and Larry’s mother especially went out of her way to ensure a ‘proper’ 
environment for the interaction – cleaning, apologising for the mess, and fussing while 
the fieldworkers tried to assure her that she needn’t worry. In the scene with Demi, too, 
she realised that a house full of drinking men was not an appropriate environment for 
performing informed consent, and so she used the car instead. This was by no means a 
perfect setting, either, especially regarding the complex exercise in form-filling 
(discussed next section). However, it is perhaps worth reflecting how valuable the car 
was in this regard: not only was it a means of getting around in an often-dangerous setting, 
but it also provided a safe environment for the consent process. Ad hoc decisions like this 
were frequently made in the course of recruitment and often crucial for its success. 
 One of the things I was attentive to was the ways in which the fieldworkers 
conducted themselves when entering the homes of Worcester’s poorest – how they 
established trust, made people feel comfortable and created an environment within which 
the consent process could take place. Ethnographic studies of fieldworkers have 
highlighted a variety of ways in which social relations of consent are established, 
including being known as part of the community or otherwise as ‘good’ people (Kamuya, 
                                                 
24 When interviewing Larry at the site a few months later, I found that their commitment to see 
one another again had been followed up on and they were still in contact. Moreover, while I do 
not quote Larry directly in the following chapters, like many other participants his reason for 
wanting to take part was not for the money, which is what the fieldworkers assumed. Rather, it 
was because he wanted to find out more about TB and about whether he was healthy.      
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Theobald, et al. 2013; Kingori 2013), carefully balancing allegiances (Chantler et al. 
2013; Molyneux et al. 2013) and using familiar idioms to counter suspicions about the 
foreign interests of the research (Geissler et al. 2008). Speaking to SATVI’s fieldworkers, 
perhaps the most important aspect of the dynamic between themselves and prospective 
participants that they felt they had to address was their positioning as comparatively well-
off individuals representing a powerful organisation, which ran the risk of coming across 
as superior. Consequently, they unanimously thought that the most important attribute of 
being a fieldworker is the ability to ‘lower’ oneself and, moreover, to be mindful of the 
ways in which people arranged their domestic spaces, for example how they designated 
public from private (not easy within a few square feet). Alex expressed that this was hard-
learned but incredibly important:   
What I’ve learned in this whole SATVI thing as a CRW [fieldworker] is that 
you have to be level with the ground…You can’t go there sitting in people’s 
places with a type of attitude that you are a ‘highty tighty’ and that people are 
living in the squatter camps. The conditions are not so great. So you have to 
be really ‘to the floor’ [gesturing downwards]. I remember my starting years 
and I had to go into the camps, and it would be a one-room place. But you 
can’t go and sit on their bed because that’s their privacy, you have to adapt to 
certain kinds of things. So you say “I’m going to make myself comfortable”. 
And they’ll say sorry and make excuses but you say “no you don’t have to 
make excuses”.   
Nomvula, similarly, said that it was important to not to make it seem that they were a 
means to an end, which meant talking and presenting oneself to others in the “right way” 
and not in a way that made one seem “high class”:    
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The main thing is that you must talk to the people in the right way. Not like 
you just want to finish this work. So I’m always smiling and I always laugh. 
And then I don’t have styles. If I go to the small hokkie [small shack, literally 
chicken coop], the people say, “no, just sit here.” I say, “no, don’t mind, I’ll 
sit here on the crate”. So, you must make as if you become like those people. 
Don’t go to their houses and say “oh I’m smelling this, I’m high class”. 
It might be noted that this practice departs in certain respects from Kingori’s (2013) 
experiences with data collectors in western Kenya. Using illustrations composed by the 
data collectors, she shows that they saw the consent process as taking place across a large 
material divide between themselves (as representatives of power) and the people with 
whom they interacted. Material difference, rather than the bioethical ideals of autonomy 
and altruism presupposed by the notion of informed consent, was the dynamic 
characterising the encounter. By contrast the fieldworkers, perhaps with more in common 
with the fieldworkers observed by Geissler and colleagues (2008) in The Gambia, sought 
to mitigate against this gap and reconcile the respective interests of SATVI and the 
community they were concurrently a part of.  
 The way in which the fieldworkers lowered themselves was, in a sense, consistent 
with the bioethical imagining of the researcher-subject relationship. For in lowering 
themselves, their interlocutor was simultaneously in the ascendant, which inverted, 
however fragilely and temporarily, the power relationship between them. However, the 
motives of the fieldworkers and those of the ethical practice that they were charged with 
carrying out differed in at least one important respect. Whereas informed consent seeks 
to render visible the autonomous, rational, continuous person that can appear ‘on paper’ 
(Simpson forthcoming), the fieldworkers were far more concerned about the situated, 
relational individual in front of them and how they might make them feel valued, included 
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and moral, not only as participants but more generally as people. Fiona Ross, commenting 
on her informants’ attempts to build meaningful, respectable lives, writes: “Desperately 
afraid of being considered weggooi mense (throw-away people; it has connotations of 
being discardable, reject, surplus), they worked hard against the prevailing stereotype, to 
reframe themselves as valuable” (F. Ross 2010, p. 8). The ways in which the fieldworkers 
engaged with Worcester’s poorest reflected their awareness of what participation might 
mean in this context. Peter, for instance, described how he expressed to people their 
importance to SATVI:    
The name of SATVI as the institution must be known, I’m working for those 
people and they appreciate what you, as a participant, are bringing to them 
[his emphasis]. We are glad you have blood that is part of the study. Because 
not only SATVI, but the whole of your country needs you. Then you will see 
there’s a change. They really appreciate being valued…In healthcare, the 
patient needs the hospital. Here I exchange it and say SATVI needs you.  
Magda, while talking about home visits post-enrolment rather than trial recruitment, made 
more explicit reference to how downtrodden people often felt and how their work could 
make a difference to that:  
Those few minutes that you connect with people and before you said goodbye, 
you can do something great in that person’s life, with a few words, to make 
them feel worthy, to make them feel special. Because we work in areas that 
people have very low self-esteem…Without giving them a cold shoulder, you 
can use that minute or two to make them feel a little bit better, and to take on 
the day, and the next day. CRW [fieldworker] is a very important job. 
Mira, similarly, stressed that they treat people as “special” and, similar to Peter above, 
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observed also that this relationship differed from the way in which they were treated in 
the government clinics:  
Maybe it’s the way of approaching them. We treat them as special. As people 
equal to me. Not like you’re below me. That’s many times, even if the nurses 
don’t that way [in the clinics], that’s the impression that the patients got. But 
in the community, we as SATVI are like, “Hi tannie [auntie], how are you 
doing?” And you know you come to their level. 
This aspect of what trial participation means in impoverished settings is, I think, not 
highlighted enough in the literature. A common focus of anthropological critique has been 
how the abstract tenets of research ethics, especially autonomy and expectations of 
altruistic intent, miss the realities of research on the ground. Yet as I argued in Chapter 1, 
the way that this critique is advanced by drawing attention to the material benefits of 
participation arguably reinforces an image of ‘vulnerability’ that reduces the possible 
significance of medical research in people’s lives to its material dimensions (Chambers 
1989; Levine et al. 2004). Yet my findings with SATVI’s fieldworkers raise an alternative 
concern. Well aware of the treatment and stereotyping that people were subjected to in 
their interactions with the state and its employees (see Chapter 4), the fieldworkers saw 
their roles as important because of the ways in which they were able to move back against 
the inscriptions of the state on people’s lives. In this regard, the bioethical ideals of 
autonomy and altruism did not simply miss the reality of research on the ground. To the 
contrary, the fieldworkers saw the profound effects that treating people as valuable, 
worthy individuals capable of making moral decisions could have in an environment that 
threatened to erode the possibilities for positive self-imaginings. The following two 
chapters add to this emerging picture the perspectives of trial participants themselves.  
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Filling in the Forms 
The verbal component of consent was an important part of the work that the CRWs had 
to accomplish. However, a number of anthropologists have observed that, when push 
comes to shove, it is meticulous documentation that matters most in research governance 
(e.g. Petryna 2009; Douglas-Jones 2012; Simpson et al. 2015). Testimony to this was just 
how much paperwork needed to be filled in and documents to be assembled to legitimise 
participation. People’s birth certificates and clinic cards needed to be produced. Proof of 
parenthood or guardianship for the adolescent trials. Most importantly, three copies of 
the long and drawn-out consent forms had to be completed (one for SATVI and the 
regulators, the other for the participants), each of which required multiple initials and 
signatures. So intimidating were these forms that the fieldworkers often hid them from 
view until the last possible moment. In this final section, I will suggest that the 
bureaucratic component of consent had the potential to undermine the trust that the 
fieldworkers had developed with participants, requiring yet more compensatory work in 
turn.      
 The challenge, as with the verbal component of the consent, was that in an 
impoverished setting, it was not easy to make the world appear ‘on paper’ as the 
regulators demanded it. It was, in fact, an utter nightmare. One problem was that many 
of the adults in Worcester and some of the adolescents struggled with writing, and 
therefore the seemingly simple task of writing their names out in full multiple times in 
block capitals before signing them was very challenging. This was compounded by the 
fact that people’s names had to be written precisely as they appeared on the birth 
certificates, which was often different from the way that people spelled them in everyday 
usage. GCP dictated that any mistake, no matter how small, had to be crossed out with a 
single straight line (such that the mistake was legible), as well as dated and initialled by 
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the participant/parent, before the correction could be written. This could, naturally, result 
in a downward spiral: mistakes on mistakes on mistakes.  
 Kingori (2013, p. 365) observed of fieldworkers during a trial in Kenya that too 
much attention given to the consent forms “often increased suspicion and undermined 
trust in the verbal assurances given about the benefits and safety of their participation”. 
From my experiences with the fieldworkers, I would add that one sure way of 
undermining the fieldworkers’ efforts to make people feel valuable and worthy was to lay 
bare people’s compromised ability to write to the point of humiliation. For example, I 
was with Demi in one small house in Riverview while she conducted the consent process 
with a mother and her son. The mother had been completely happy until this point. 
However, making mistake after mistake, correction after correction, she was getting 
considerably distressed with the process and, in between each of the multiple forms, 
wondered around the kitchen muttering under her breath, “baie skryf (much writing)”. 
 The resourceful individuals that they were, the fieldworkers did however devise 
multiple techniques for minimising the negative effects of the form-filling. Demi, for 
instance, had realised that something so simple as offering people her pair of reading 
glasses could make a world of difference, something that people might not mention 
otherwise. More common techniques included, firstly, giving people a thorough pep talk 
about the need for accuracy but equally, that the process would take as long as needed – 
so ‘don’t worry’. Secondly, they placed the relevant birth certificate directly above the 
space on the forms where they would write, thus minimising the chances of mistakes. 
Thirdly, in cases where people were clearly uncomfortable with writing, the fieldworkers 
often stood close by, orchestrating almost every letter as it was composed. Of course, this 
ran the risk of coming across as patronising, even reinstating the power imbalance that 
they had tried so hard to counteract. Thus, anything like this was performed with great 
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caution and without looming over them. Finally, given that two copies of each form were 
needed, the final act was to fine-comb through the forms and decide which looked neater, 
with the scruffier of the two invariably given to the participants to keep. 
 It is with these considerations in mind that one can see why the fieldworkers tended 
to conceive of GCP not simply as a guideline for action but also the action itself; the verb 
‘to GCP it’ was used to capture the act of squeezing the consent encounter into the 
meticulous documented format required to legitimise participation. In short, the process 
of filling the forms was the final hurdle but one of the most difficult. It was, by a distance, 
the aspect of consent that the fieldworkers enjoyed the least, but it was one that had to be 
taken at least as seriously as the others. The last thing that was wanted was to have to 
return to the same house the following day, with a fresh stack of paper, to see the 
distraught look of a participant whose previous evening was already spent filling in forms.  
Conclusion 
This chapter focused upon the work SATVI’s fieldworkers, a highly-skilled group of 
individuals who mediate between the institute and the community on whom its TB 
vaccine trials are conducted. Their recruitment practices, I have shown, were concentrated 
upon precisely the low-income suburbs of Worcester – Roodewal, Riverview, Avian Park 
and Zwelethemba – that the government clinics struggle so much to assert influence upon 
(Chapter 4; see also map – Figure 2 – in Chapter 2, p. 50). This is partially because it is 
in impoverished setting that TB finds greatest traction (Farmer 2000; Benatar & Upshur 
2010). But it is also because, in contrast to the more affluent suburbs north of Durban 
Street, it is in these areas that the fieldworkers were known, respected and trusted and 
where social networks were more dense and accessible.  
 By exploring the social dynamics of recruitment practices in a heterogeneous, 
stratified and often dangerous urban setting, this chapter builds upon the expanding 
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literature on fieldworkers in African research contexts. While fieldworkers are generally 
hired to perform ‘simple’ tasks for which medical training is not required, ethnographic 
studies have shown that they play a vital, ethically-charged mediatory role balancing the 
objectifying logic of trial protocols and the needs and expectations of study populations 
(e.g. Molyneux & Geissler 2008; Molyneux et al. 2013). As I have shown, SATVI’s 
fieldworkers needed to draw upon a wide variety of skills as well as personal reputations 
in order to meet the dual and often competing demands of both their employers and 
residents. This included engaging the wealthy, generating productive ‘snowballs’, 
navigating gang territories and conducting a consent process that was in many ways blind 
to the challenges that they faced when entering the homes of Worcester’s poor.  
 I have also highlighted a dimension of clinical trial recruitment that has not received 
much attention in the literature: the ways in which the fieldworkers conveyed to people 
their value to the scientific endeavour and how they made it relevant to the setting in 
which they were working. The consent process is the point at which people living in 
conditions of abjection are entered into the ‘global’ scientific and ethical structures of 
clinical trials. On one level, the moment of enrolment is when trial protocols begin the 
process of rendering people into standardised, commensurable objects of 
experimentation. But at the same time, they also become visible as particular kinds of 
subject. While this is partially a product of the way in which international guidelines 
configure an inverted power relationship between researchers and subjects, I have shown 
that the fieldworkers’ line of sight was much broader than the restricted sense personhood 
contained within the category of the human subject. Keeping in view the whole person in 
front of them, what they considered to be most important about their roles was making 
people feel valued and included, not only as research subjects but as people more 
generally. This chapter thus begins to advance the aim of this thesis: to demonstrate how 
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SATVI’s trials have become entangled in people’s attempts to craft moral, respectable 
lives on the peripheries of social and economic life. The next chapter builds upon this 
picture by adding the perspectives of and interactions between participants and SATVI’s 
clinical teams at the trial site.     
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Chapter 6: 
Truth, Blood and Respectability: Trial Participation 
and the Embodiment of ‘Clean’ Blood  
One morning in September 2014, I was speaking to Susanna, one of SATVI’s nurses, in 
one of the side rooms of the ACS building. She was relating to me the story of a young 
man called Leighton, who had come to the site about a year previously (2013) to undergo 
screening for one of the vaccine trials being run at the time. The screening visit, as for all 
of SATVI’s vaccine trials, involved a number of tests and examinations that would 
determine whether he met the inclusion criteria to be enrolled into the trial (e.g. HIV test, 
tests for latent and active TB, liver and kidney function – see Appendix 2). However, 
Susanna noticed immediately that he was drunk, which precluded the possibility of her 
going further. Trying not to sound judgemental and not wanting to deter him from 
returning ever again, she said to him, “you must try if you come here again, not to do this, 
because otherwise our blood results and things, they will be whack”.  
 The reason Susanna was relating this to me was that one of the participants I 
interviewed during my fieldwork and who had been part of the Adult Safety Trial for 
several months at the time was none other than Leighton himself. Susanna informed me, 
with no small measure of pride, that he had indeed come back again and this time had 
passed screening with no difficulties. Although Susanna had not conducted the screening 
visit herself, she had been the attending nurse at the vaccination visit a week or two later. 
Seeing Leighton looking very different to the last time he had come to the site, she had 
remarked to him, “oh you look smart today!”. Susanna related to me how she had sat with 
him during the routine procedures of the visit and said to him:  
I said to him, he looks like my brother, actually. And he said “is it?”, and then 
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I said I loved him so much…but he died of TB. He was my best brother. But 
his lifestyle, his lifestyle [her emphasis]. Because it was so painful for our 
whole family, but I know he [Leighton] can do better. I always tell them they 
can do better. Do you know who you are? And you’re not supposed to do 
things like that. You can try, you can try. And the next time he come in, and 
he said “I will do my best”. 
Susanna, it must be mentioned, was the wife of a pastor, and when she was not working 
at SATVI helped to their run their well-attended church on Durban Street. This had a 
significant effect on how she engaged with participants. Nomsa, one of the fieldworkers, 
jokingly said to Leighton while she was checking his vital signs, “you know that’s Jesus 
over there?!” Whilst everybody was laughing at the time, something clearly left a mark 
on the man. When I interviewed him, he said that the reason he had initially wanted to 
take part was to check if he had TB. However, upon passing screening and being enrolled 
into the trial, something drastic happened:  
L:  For me, because I didn’t even know my status. 
JD:  You didn’t know your status. 
L:  Ja. I didn’t even know if I had been infected with TB. Because they didn’t 
have some people to tell us about those things. If I wasn’t not even in the 
study, I wouldn’t know about TB and the things that SATVI is doing. 
JD:  So you feel that now you’re a part of the study, you know your status 
and you know more about your health. 
L:  Ja, and also I can tell the people how does SATVI work. Even me, I was 
doing things that were affecting my health: smoking and drinking. But when 
I started to attend here, it’s when I quit those things to become a normal 
person because those things go into my blood. 
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JD:  So what was it about taking part that made you decide to stop smoking 
and drinking? 
L: I stopped everything and I became a reborn Christian. So it also helped me 
because I want to be in this study also to stop these things. Because if I keep 
on doing that, I’m with God. Because they told me from SATVI when they 
testing my blood and all those things. So I said, no, I cannot jeopardise my 
health and jeopardise god, so that means I need to lead my life better. 
The interactions between Susanna and Leighton reveal a complex entanglement of an 
array of phenomena that one might not think would converge in a clinical trial. This 
includes TB, blood, lifestyle, religion, morality and respectability to name but a few. 
Although unique in many respects, this case captured fragments of meaning that were 
present in many interactions and interviews with participants and staff. It will, therefore, 
serve as a point of reference, a guiding frame in this chapter as we encounter a variety of 
perspectives and interactions in SATVI’s trials.   
 In the previous chapter, I showed how people who were considered scientifically 
valuable to SATVI’s research were rendered visible as particular kinds of subject when 
being asked to take part in its vaccine trials. This was partially due to the ways in which 
international guidelines (notably GCP) shape research relationships gravitating around 
the autonomous, ‘universal’ human subject. More importantly, the category of the human 
subject was broadened through the relational work of the fieldworkers, who kept in view 
the whole person in front of them during consent encounters rather than the restricted, a-
relational part of them that appeared on paper. This chapter shifts the empirical focus to 
the relations between participants and SATVI’s clinical teams at the trial site, from 
screening through to the end-of-study visit often several years later (Appendix 2). The 
chapter extends the argument of the previous chapter by showing how, within the 
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inverted, dialogical relationship between healthcare professionals and research subjects 
brought about by the research environment, both participants and staff brought their own 
beliefs, values and ideas of proper personhood to bear on what it meant to be a human 
subject and how this subjectivity was connected to the science. Indeed, in the same 
moment trial protocols were rendering participants into standardised, commensurable 
objects of scientific knowledge, on the ground it was people’s deepest subjective states, 
moral agency – even the soul – that were the all-important objects of knowledge and 
intervention.        
 A key empirical thread running through this chapter, which reflects the ways in 
which many people (especially participants) made meaning of SATVI’s trials in relation 
to everyday conditions of structural violence and abjection, are two opposing symbolic 
associations. The first is the association between TB and ‘dirt’, one that Kate Abney 
(2011) has analysed in depth in an ethnography of TB-related stigma in Khayelitsha, Cape 
Town. This includes dirty places and people, but perhaps most importantly, as was hinted 
at by both Susanna and Leighton, dirty practices – notably, smoking, drinking, drugs and 
poor hygiene. In the first part of this chapter, I will build upon Abney’s work. I suggest 
that the connection between TB and dirt is intimately tied to the biomedical moralisation 
of the disease described in Chapter 3, perpetuating a cycle of blame in which the sick are 
held accountable for their disease and subjected to stigma. The moral character of TB 
was, moreover, not stripped away by the objectifying logic of trial protocols but, to the 
contrary, refracted through and even amplified by everyday scientific practices.   
 In contrast to the association between TB and ‘dirt’, SATVI has become known 
for being in the business of ‘clean’ blood – drawn, tested, researched and, according to 
some, circulated among the sick. What is significant about the idiom of clean blood, I 
will suggest, is firstly the tangible, contiguous and symbolically rich way in which it 
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positions the relationship between individual gifts and community benefit. Secondly and 
perhaps more importantly, it is the status and responsibility that it confers upon 
participants. In the introduction to a collection of papers entitled “Blood Will Out”, 
Carsten (2013) proposes a renewed anthropological emphasis on blood because of its 
uncanny ability to accrue layers of symbolic meaning. One theme that the contributors 
show to recur time and again is the notion that blood is “the stuff of truth…morally, 
personally, politically and medically” (Carsten 2013, p. S13). In her own article, Carsten 
(2013b, p. S130) examines a politically charged incident in Malaysia where a blood 
sample taken from a leader of the opposition “was claimed by some as having the capacity 
to 'reveal the truth' about his character”. Focusing on clinical pathology labs and blood 
banks, she shows just how difficult it is to separate the social from the scientific and that, 
when it comes to blood, there is the ever-present possibility of them collapsing into one 
another (2013b, p. S130).  
Using this intriguing notion of blood as the ‘stuff of truth’, I will show that to be 
someone of ‘clean blood’ is a state that is at once biological and moral, compelling 
participants to adopt or maintain a healthy, respectable lifestyle and avoid ‘dirty’ practices 
associated with TB. Participation for some participants, such as Leighton, could be a 
transformative, even evangelical journey, a process of responsibilisation that went far 
beyond the requirements of protocol – so far that it even conflicted with the 
epistemological purposes of the trials (cf. Brives 2013). Being with SATVI, I will 
ultimately argue, conferred upon participants a powerful form of symbolic capital, casting 
SATVI alongside other spaces, strategies and institutions in which people struggle back 
against the inscriptions of the state to emerge as moral, respectable individuals (Jensen 
2008; F. Ross 2010). At the same time, the figments of the ‘problem TB patient’ and the 
skollie lurked in the shadows, always threatening to rear their heads and had to be 
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continually worked against by participants and staff alike (Jensen 2008). The flip side to 
such morally charged understandings of trial participation was the dejection and shame 
that could come from exclusion, which is often overdetermined in a region rife with TB 
and its associated challenges.   
A Note on Quotations  
Direct quotes from my interviews with trial participants are followed by basic 
demographic information about them, as defined in Table 1.  
    
Shorthand 
order Demographic 
Abbreviation 
/units Explanation 
1 Age Years — 
2 Gender M Male 
  F Female 
3 First language A Afrikaans 
  X isiXhosa 
4 Vaccine trial ST Adult Safety Trial 
  ET Adult Efficacy Trial 
  HIV-EI HIV-Exposed Infant Trial 
    
Table 1: Shorthand used to describe participant demographics 
 
For example, (43, M, X, ST) is the shorthand for a 43-year-old male whose first language 
is Xhosa and who was participating in the Adult Safety Trial. All participants under the 
age of 18 were in the Adolescent Trial and therefore no trial designation will appear in 
the text for these younger participants. 
TB and ‘Dirt’ 
The vast majority of the participants that I interviewed were from either the Afrikaans-
speaking low-income suburbs of Worcester, including Roodewal, Riverview and Avian 
Chapter 6 
 
165 
 
Park, or the Xhosa-speaking township of Zwelethemba. Speaking to them over coffee or 
Coke, I was interested to hear a little about their lives. Of the 65 adults I interviewed, 
approximately 40% were unemployed25 and the remainder, with one or two exceptions, 
were typically employed in low-earning, often unstable jobs such as domestic workers, 
farm hands, factory workers, shop assistants and home-based carers (see Appendix 3 for 
socioeconomic indicators). While some were quite shy, especially those who had not been 
in the trials for long, most were very talkative and were quick to relate to me the 
challenges associated with living in post-apartheid Worcester. Gangsterism and drugs, in 
particular, were spoken about with great resent. The adolescents, it seemed, were 
especially affected by the gangsterism and violence, often having to stay inside after 
school hours because of the dangers of being outside when things got ‘lively’ in the 
evenings. Several of the young men I spoke with had faced considerable peer pressure to 
join gangs themselves, and even school was no reprieve because the gangs operated in 
the schools, with violence frequently breaking out.   
 In addition, almost every single participant had known someone with TB, be they 
family, friends, neighbours or colleagues. Some had witnessed seemingly miraculous 
recoveries after only a few weeks of treatment. Others, less fortunately, had watched as 
their friends and family slowly declined, were admitted to hospital (usually Brewelskloof) 
and sometimes even passed away.26_With such intimate experiences of the disease, at first 
I expected people to point towards structural factors like poverty, cramped housing and 
poor nutrition as drivers of the TB epidemic, which Farmer (2000) has highlighted using 
ethnographic illness narratives (see also Harper 2006, 2010). While this was partially the 
                                                 
25 It was not always contextually appropriate during interviews to ask about people’s 
employment status. I derived the figure 40% from those whom I was able to ask and from the 
average unemployment rate for the trial in which they were participating.  
26 It was not lost on these participants that we were speaking but a few metres from the main 
hospital wards where their loved ones had spent several months and possibly even died. 
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case, people’s understandings actually resonated strongly with the biomedical discourse 
around TB and arguably amplified its orientation towards individual responsibility and 
blame. To capture the richness of what participants expressed to me it is useful to turn to 
Abney’s (2011) thesis, Whoever Said a Little ‘Dirt’ Doesn’t Hurt?    
Based on her work in Khayelitsha, Cape Town, Abney (2011) shows that TB was 
thought of by residents primarily in terms of the organising metaphor of ‘dirt’ (see also 
Douglas 1966). Most people, for instance, thought that the reason there was so much TB 
in the township because it was ‘dirty’, in contrast to the ‘cleanliness’ of wealthier, mainly 
‘white’ areas such as Somerset West (Abney 2011, p. 33). Similarly, a number of the 
participants that I spoke to explained the prevalence of TB in Worcester in terms of dirt: 
“Riverview is very dirty. I suppose it’s because of that, and the insects” (21, F, X, ET). 
Puddles of dirty water, urine and other substances also featured in people’s explanations. 
The association was actually most apparent when I was walking around community 
settings in Worcester while I was helping with an anthropology student field trip.27 
Residents were understandably reserved about the subject of TB and, when they were 
happy to discuss the topic at all, were quick to distance themselves from the disease. This 
was either by proclaiming that they were ‘clean’ of TB or by pointing us towards ‘dirtier’ 
parts of the township to find out more. For example, one resident said, “No, you won’t 
find any TB mense [people] here but go to town on the other side there by the bridge…It’s 
riddled with TB mense, lots and lots” (Field Report, Sofia Ribeiro).  
‘Dirt’ was, to be sure, a metaphor for poverty. However, Abney found that ‘dirt’ 
was not only an attribute of living conditions and (coloured) bodies but also located in 
                                                 
27 This field trip took place between the 24th and 26th April 2015. The trip was part of a third-
year methods course at the University of Cape Town (UCT), and the specific task of the field 
trip was to find out what residents thought about TB and SATVI’s work. The main deliverable 
for the course was a field report. In this chapter, I use a number of quotes from the student 
reports, for which permissions have been obtained from UCT’s anthropology department and 
from students themselves. The name of the student is provided.      
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practices. She observes that “doing bad things to one’s body”, including “sharing 
cigarettes with someone who has TB” and “drinking too much” were perceived as key 
drivers of the epidemic (2011, p. 50). Not only were my findings consistent with this but, 
moreover, drinking, smoking, drugs and poor hygiene – which gave rise to some of the 
most evocative images of ‘dirt’ – were, by some distance, the most frequently cited 
reasons that TB was spiralling out of control in Worcester. Included below is a collage of 
quotes to give a snapshot of people’s reflections:      
A lot of people get TB.  I’ve never had TB.  And often it’s also people’s own 
doing, because hygiene plays an important role in one’s life, and often we 
don’t want to do these things.  So we leave things dirty or something like that, 
and that’s also part of…or I pick up a germ from people who spit in the road. 
(15, M, A) 
JD:  Why do you think TB is such a problem in this community? What would 
you say is the main cause? 
R:  The smoking and the drinking. They smoke with everybody and they drink 
with everybody. It’s there where the TB comes in. They don’t smoke alone. 
Maybe I’m sharing a pipe with you and so on, or I drink something and then 
maybe I pass the glass onto you and you drink out of the same glass. Or I 
have TB, but now I don’t tell you that I have TB, so it will spread. Maybe 
they are spitting here, then your child walks past and then she picks up that 
germ.  
                                                                                               (42, F, A, ST) 
There’s one guy in a flat in River View, he’s got TB and he’s not bothered.  
He doesn’t take his medication. He’s just hanging around on street corners 
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and using drugs. He couldn’t care. He’s just hanging around there. Now he is 
going to infect the next person. He is now going to spread that germ, but he 
could have prevented that by taking his medication. Now he's just carrying 
on.  
 (33, F, A, ST) 
In Chapter 2, I showed how TB has become highly moralised in biomedical discourse, 
with blame for the continued proliferation of the disease deflected away from structural 
conditions and onto afflicted individuals and communities (Farmer 2000; Compion 
2008). The notion that people “don’t care” was common among nurses, especially in their 
more frustrated moments, which sometimes took on a Christian inflection to the effect 
that a lack of responsibility was tied to an impurity of heart (Marks 1997; Hull 2009). 
What we can see emerging from people’s descriptions above is the stereotypical figure 
of the ‘problem TB patient’ (see Chapter 1, p. 21), one which draws upon but perhaps 
even intensifies the orientation towards individual blame by focusing attention on 
people’s ‘dirty’ practices. Jensen (2008, p. 11) observes that one of the most powerful 
ways in which “structures of dominance are reproduced”, in his case the stereotype of 
“problematic colouredness” (ibid, p. 183), is when the residents themselves start pointing 
fingers at one another to lay claims to respectability. I would suggest that TB, so prevalent 
and morally charged as it is, constitutes an important site of social reproduction of 
governmental stereotypes, both the ‘problem TB patient’ and the partially overlapping 
stereotype of the skollie. TB is neither an abstract, asocial biomedical category nor simply 
a function of structural violence Rather, it is intimately connected to the practices that 
people found most abhorrent.   
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“In my Life it is not Money that is Important, it is…”  
One of the questions that I built towards with participants was: why did you decide to 
take part in a vaccine trial? People’s motivations were diverse, overlapping, multiple and 
sometimes shifting. Overall, three main categories of motivation emerged – the same 
three, in fact, that were identified by Abrams et al. (2011) in a pilot study involving 
adolescents in one of SATVI’s earlier vaccine studies. These were altruism (40 
participants or 41%), health benefits (59 or 60%) and money (16 or 16%) (see Table 2 
for a detailed breakdown across the four trials). These figures, while not revealing much 
by themselves, are useful to orient the following exploration, and this chapter and the 
next will gradually unpack them and see what lies behind the numbers. The category of 
‘health benefits’, cited by the majority of participants, is explored both in this chapter and 
the next, the latter of which discusses comparisons and connections between SATVI and 
the government clinics (Chapter 6). This chapter, meanwhile, explores all three. 
    
Vaccine Trial Altruism Health Benefits Money 
Adult Safety Trial (n = 26) 10 (38) 22 (85) 4 (15) 
Adult Efficacy Trial (n = 27) 15 (56) 12 (44) 5 (19) 
HIV-Exposed Neonate Trial (n =12) 0 (0) 12 (100) 1 (8) 
Adolescent Trial (n = 33) 15 (45) 16 (48) 6 (18) 
Table 2: Breakdown of participant motivations n (%) across trials 
When I say that this chapter will explore all three, this does not mean keeping them 
analytically distinct in the a priori way that they are in the bioethical literature. Altruism, 
in particular, holds greatest moral legitimacy in research ethics and thus tends to be held 
at arm’s length from health benefits and money, both of which point towards the 
possibility of ‘undue inducement’ and are therefore regarded with caution (see Geissler 
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2011). One problem with this division is that it positions health benefits and money as 
indicators of ‘vulnerability’ in advance of hearing from participants themselves how they 
conceive of what constitutes morally legitimate and illegitimate reasons for taking part. 
In the emergent moral economy that I found surrounding SATVI’s trials, distinctions 
between legitimate and illegitimate motivations were certainly drawn and resolutely 
policed. But interestingly, both altruism and health benefits were deemed equally morally 
praiseworthy and in fact blurred together in the idiom of ‘clean blood’ that will be 
introduced shortly. Perhaps the most illuminating pathway into the moral economy to 
which I draw attention is by starting with what participants claimed not to be motivated 
by and which they would go to some lengths to disassociate themselves with: money.  
 During interviews, where it felt appropriate I asked participants whether they 
considered the R150 that they received at each study visit to be a significant amount of 
money and, moreover, whether it influenced their decision to take part. One reason for 
this was that, as we saw in the previous chapter, for the fieldworkers the money featured 
prominently in their day-to-day work, seemingly lubricating the wheels of the recruitment 
bandwagon. Contra the Medicine Control Council’s formal position that R150 was but a 
‘reimbursement’ for lost costs (Ballantyne 2008; Geissler 2011; Resnik 2015), almost 
everyone I asked directly about the matter (28 out of 31 or 90%) said that the regular 
receipt of R150 was a modest but nonetheless important contribution to household 
income: “Like the child must eat porridge in the morning before going to school, so 
maybe it can buy flour when there isn’t any flour. So, it does fill the little gaps, you 
understand?” (33, F, A, ET). However, despite this, very few participants saw money as 
a motivator, and in the instances that it was (16%), it tended to be a background 
consideration (the distinction between background and foreground is not reflected in 
Table 1). In fact, often without raising the topic of money myself, participants consciously 
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distanced themselves from the notion that money was responsible for their taking part, 
and it was uncanny how common this was expressed as follows: “For me it isn’t about 
the money. What is it to give to someone and you can save a life?” (18, M, A, ST); “In 
my life it is not money that is important, it is my health” (40, F, X, ET). Especially when 
health was invoked, people pointed towards their chests, emphasising the distinction 
between material gain and that which was important to them.   
 Interestingly, in the same moment that participants framed themselves as taking 
what they considered to be the moral high ground, they also stated that the money was 
the most pertinent factor motivating other people. Moreover, it was with morally 
questionable intentions with which other people sought money from SATVI, especially 
to fuel drinking or drug habits – the ‘dirty’ practices with which TB was associated. I was 
speaking with a woman from Riverview Flats: 
JD:  How did you hear about SATVI? 
R:  Friends of mine. 
JD:  And what did they say?  Were they positive? 
R:  Actually, most of them went for the money. Because I said to them, that’s 
not right, you have to help people. You just go for the money. Some of them 
are doing drugs, so that’s why they went for it. So I asked them, why don’t 
they take people like me who really want to do it? And so last time it 
was…what’s her name…[Susanna]…because I told her and she said, okay, 
fine, she’s going to put my name on the list.   
(44, F, A, ST) 
Finding a way of explaining this radical distinction between the morality of self and the 
questionable intentions of others – that nobody and everybody was taking part for the 
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money – caused me much grief in the writing of this thesis. But gradually, and especially 
upon realising that it was mostly coloured participants who endeavoured to build these 
walls, I came to the conclusion that perhaps the best lens through which to view the 
situation was in terms of Jenson’s (2008, p. 8) observations regarding the dual 
consciousness of colouredness (see Chapter 1, p. 35). Living in the shadow of their own 
governmental stereotype, people had to cast it aside to reveal their own morality, displace 
the shadow on to others and elsewhere. This was very similar the ways in which TB and 
its spread were located in (other people’s) ‘dirty’ practices.28  
 While illuminating, speaking about people’s motivations can only take us so far. 
What they are part of and hint towards, I believe, is a broader moral economy repudiating 
the ever-present threat of ‘dirty’ practices from spilling over into the ordentlike 
(respectable) space of SATVI’s trials. But before we explore this further, it is useful to 
speak briefly about how practices such as drug and alcohol abuse – some of the main 
indicators that someone was in it for the ‘wrong’ reasons – was handled in SATVI’s trial 
protocols.  
Excessive consumption of these substances was, on the whole, guarded against. 
Phase I studies such as The Adult Safety Trial, for instance, involved a drug test as part 
of screening. It was also standard practice to have questions regarding drug and alcohol 
consumption as part of the health questions at screening visits and throughout trials. 
However, it is not for immunological reasons that these substances are generally frowned 
upon. Rather, it makes for unreliable participants: they are less likely to attend all follow-
up visits (although the possibility that the R150 reimbursements might help subsidise a 
drug/alcohol habit questions this notion somewhat). When it comes to proving the 
                                                 
28 The phenomenon of ‘othering’ the negatives as a way of bolstering fragile and threatened 
identities is a widespread phenomenon. One recent example that springs to mind is Brexit, in 
which ‘foreigners’ are blamed for the societal ills of the United Kingdom.  
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efficacy of a new vaccine, participants’ scientific value resides in a disposition to develop 
TB, which is only heightened by substances that affect their immune system. In fact, 
SATVI’s trials are powered based on the region’s extraordinary TB incidence, 
inseparable from which are the region’s high rates of alcoholism and drug abuse (Health 
Systems Trust 2004; Compion 2008, p. 28). Therefore, so long as a potential participant 
appears reliable, trial protocols can quietly accommodate – and can do little about – such 
practices. By contrast, the moral economy inhabited by participants and staff danced to a 
different tune, one that defied the passive acceptance of the status quo embodied in trial 
protocols and even ran into tensions with the trials’ formal epistemological aims, as I will 
suggest later. Let us now return to where this chapter began, with Susanna’s interactions 
with Leighton.  
‘Looking’ Beyond What You ‘See’ 
Speaking with Susanna, she explained to me that, in her work with the church, she was 
accustomed to people coming through the doors looking for help and spiritual guidance, 
who were often deeply unhappy about their lives and circumstances, which sometimes 
led them to alcoholism, drugs and gang life. Counselling them, explaining to them that 
they were valuable in the eyes of God and, more generally, trying to instil in them a hope 
for better despite their often-destitute circumstances, was a large part of her life beyond 
SATVI. Through this church work, she was very well known in Worcester and knew the 
people in turn: “Because I grew up in Worcester, I know a lot of them, and they know 
me…When they go home, and I pass them and they say, isn’t that the pastor’s wife?” 
This meant that she was well acquainted with the social and economic challenges faced 
by Worcester’s constituents and often already knew participants and/or their families. 
 She went on to explain that she found it impossible to vacate her role as church 
leader when coming to SATVI:   
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For me it blends in. The church, and my work, it blends in…Everyone who 
comes in here – I don’t know if it’s because my husband is a preacher – but I 
see them as someone valuable. That’s how I see them. If they come in here, I 
will never see you as a participant, you’re valuable to me. So for me I’ll never 
ever see you as an object [sic]. I’ll see you as, you have a soul. You know I 
always said, the reason why you are here, and what does God say about why 
you are here, you were created. 
The close historical relationship between Christianity and biomedicine has been a 
recurring theme so far in this thesis, especially among some of the government clinic 
nurses who used it to make sense of and allocate blame for the seemingly biblical scale 
of the TB epidemic (Chapter 4). Here, Susanna’s remarks can be seen as a way of 
expressing through a Christian lens a well-documented tension that stems from moving 
from a healthcare-professional patient relationship to a researcher-subject relationship 
(described in Chapter 3). That is, between the abstract and distanced logic of trial 
protocols – where participants are treated as objects of experimentation and data 
collection – and the needs, expectations, and subjectivities of those with whom 
researchers actually interact (Easter et al. 2006; Fisher 2008; Timmermans 2010; 
Simpson & Sariola 2012). For Susanna, people had an inherent value as created beings, 
with a purpose that vastly transcended the category of ‘participant’. She felt it important 
that this was recognised, not only by herself but among her colleagues too: “For that, you 
know I normally watch that the other staff will also treat the participants the correct way, 
I’m very strict about that. They’re a participant, but please look at them beyond what you 
see”. Thus, while trial protocols were shaping participants into measurable, 
commensurable bodies, on the ground it was the moral agent (or the soul) that was the 
all-important object of knowledge and intervention. 
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 Susanna’s approach to participants is similar to the way that other research staff 
approached participants too. As we saw in the previous chapter, the fieldworkers went far 
beyond what they needed to do in order to convey to participants that they were valued 
and needed, not simply for science but as human beings. Some fieldworkers expressed 
this through a Christian lens like Susanna, and often prayed with people in their homes. 
The nurses, too, used their knowledge and experience to do what they could for 
participants within their capacities as researchers. With time to develop relationships with 
participants in a way that is often impossible in the chaos of a government clinic setting, 
almost all the nurses said that they got to know participants and often offered them advice 
(Easter et al. 2006). Dayna, for instance, said that the research environment was ideal for 
instilling a sense of responsibility and empowerment:   
It [research] taught me to still try with my participants to give a sense of 
responsibility and empowerment, whereas in the clinic nobody cares and 
people are starting to give up. I still have that drive. And this is a good place 
for encouraging good health, responsibility, and lifestyles. 
While Dayna suggests that the government clinic staff have started to “give up”, she and 
other nurses who had previously worked in the clinics also used SATVI as a platform 
from which to advocate the clinics and to counteract people’s overwhelmingly negative 
perceptions. This we will discuss in the next chapter.    
 The way that Susanna used her time with participants, similar to Dayna’s 
sentiments regarding responsibility and lifestyle, was to counsel participants at length 
where the opportunity presented itself: 
 I will sit, I will do what I must do, then if there’s time – I know it’s busy – I 
will counsel them, have long discussions with them. But I know who you are, 
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and I will treat you like that. So if you go, I’m sure that you will come back 
again. For that reason [her emphasis; read: not for the money] And you will 
tell the others outside…And the next time, when they come in here, you can 
see there’s a difference, there’s a change. Because they won’t come in here 
like, dirty again. They will try to be better. Really, you can observe that. 
Prior to her counselling them, there was certainly a chance that they would return time 
and again – but for what she considered to be the ‘wrong’ reason, that is, for the money. 
However, upon engaging with them, she believed that she often had a profound impact 
upon them such that they would return to SATVI again, but for a different reason, one 
that was not grounded in material gain. Most telling was her phrase, “they won’t come in 
here like, dirty again”, subtly indicating the kinds of ‘dirty’ practices for which money 
from participation was thought to be used. Leighton, in particular, reminded Susanna of 
her brother who had died from TB as a result of “his lifestyle, his lifestyle. Because it was 
so painful for our whole family, but I know he can do better”. Susanna, in short, used her 
research work to reach out to steer them towards ‘better’ lifestyles, away from the ‘dirty’ 
practices that might have led them through the door in the first place. 
 In this section, I hope to have shown that the movement from a nurse-patient 
relationship such as that found in a government clinic to a researcher-subject relationship 
does not amount to the stripping away of care. In fact, similar to the findings of other 
anthropologists and social scientists, it appears that the particularities of a research 
relationship actually engender novel possibilities for engaging with people (e.g. Easter et 
al. 2006; Fisher 2008; Timmermans 2010). Certainly, Sister du Plessis, as we saw in 
Chapter 4, was desperately trying to find such a way to reach out to people in Worcester, 
especially those who live in the houses and streets of ‘unruly’ TB patients. What I would 
like to take forward into what follows is the sharp sensitivity to drug abuse, alcoholism 
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and other ‘bad’ lifestyles that went beyond the narrow requisites of trial protocols. While 
participants were often thought to have come to SATVI in the first place for one reason, 
through interventions upon an object to which protocol was blind – the soul, the person 
etc. – the belief was these individuals might come to view participation in a new light. 
Donations of ‘Clean Blood’ 
Leighton, as we saw above, was clearly influenced quite profoundly by his interaction 
with Susanna and the trial of which he became a part. Not only did he decide to quit 
smoking and drinking; this also corresponded with a conversion to Christianity. But we 
might note that, while Susanna only made passing reference to me about the drawing and 
testing of blood samples – “…otherwise our blood results and things, they will be whack” 
– for Leighton this held considerable significance. For him, he quit smoking and drinking 
at least partially because, as he put it, “those things go into my blood”. While Leighton’s 
case was unique in many respects, his interpretations of the trial resonate strongly with 
how many other participants – and indeed some research staff – made sense of SATVI’s 
trials. Thus, before returning to Leighton’s conversion, here I explore the significance of 
blood as a site of meaning-making and draw attention to one prevalent set of meanings in 
particular, one that that stood out because of its symbolic richness and moral valence. 
This is the notion that SATVI is in the business of ‘clean blood’.  
 As the research institute’s name suggests, TB vaccines are SATVI’s raison d’être. 
All research activities are, in one way or another, oriented towards the ‘greater good’ of 
a new vaccine. Yet for those on whom research was conducted, vaccines made a fairly 
limited appearance: they were administered once (sometimes twice) at the beginning of 
the trials and then never again – although research staff observed closely for adverse 
events. Many people would not even pass screening and therefore receive a vaccine. 
Blood draws, by contrast, were arguably a far more ‘visible’ presence during trials. Every 
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person who visited the field site to enrol in a trial had their blood drawn at least once. 
Moreover, should they pass screening and be enrolled, their blood was drawn at intervals 
throughout the trial, through to the end-of-study visit often several years later. With this 
in mind, when I asked the 40 participants who had expressed altruistic motivations how 
they understood their role in SATVI’s research, 18 (45%) explained their participation in 
terms of ‘donating blood’ (the majority of other responses involved either vaccines, 
notions of ‘protection’ or gave less away with phrases such as “helping others”). 
Moreover, many other participants with alternative motivations, especially health 
benefits, mentioned either explicitly or implicitly an importance of their blood to 
SATVI’s research efforts.  
Conceptions of what blood donation entailed varied considerably from participant 
to participant. It was difficult, at times, to discern whether participants thought that 
research was being done on their blood, or whether they believed that it was being 
transfused directly into the bodies of the sick. But given SATVI’s association with TB, 
donations were often expressed in relation to TB patients:      
JD:  What was your personal reason [for taking part]? 
R: Oh, my personal reason. When I look around me and see the people in my 
community getting sick with TB, that was my reason, there are many people 
who are suffering and who have TB, so what is it to me, who is one of the 
healthy ones, just to help by donating [blood]. 
                                                                                               (33, M, A, ET) 
In my thinking…this blood of mine is going to the people with TB, because 
they need blood. 
                                                                                                (24, X, F, ET) 
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Others were less specific about TB in their explanations. For instance, one adolescent I 
conversed with said: “I like to give blood to people who need it” (14, M, X). In addition, 
some participants used the notion that they were giving blood as a starting point from 
which to position their own role in the community as moral and respectable individuals 
in relation to the moral failings of others. For example, one lady expressed that her 
participation was connected to her being a role model and caregiver for children who 
were not looked after well by their parents:  
JD:  So how do you see yourself helping others? 
R:  Okay, it’s actually about giving my blood to other people, and that can 
help and save them…And I love my children…not actually just mine…any 
children, I love them. All the children there in the A-block and B-block where 
I live [Riverview Flat Blocks], they call me mummy. You see, it’s because I 
have a heart, and I don’t talk like their parents or other people talk to them. 
Because most of them don’t talk nicely to their children. And as a person and 
a mother, you must be a role model for a child. And that’s what I am in the 
community there by our side. 
JD:  And so do you think that being part of the SATVI study here is a part of 
that role for you? 
R:  Yes.  
(44, F, A, ST) 
From an abstract bioethical standpoint, that blood donation was such a prevalent 
understanding of SATVI’s trials might raise alarm bells because it easily falls into the 
category of ‘misconception’. However, I contend that it should not be delegitimised and 
dismissed as a mere ‘misconception’ but rather be viewed as a conceptual solution to the 
abstract bioscientific notion of how individual participation can translate into positive 
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community health outcomes. Whereas the scientific conception of a vaccine trial was 
vague at best to most participants (not a single participant explained SATVI’s research 
as such), blood was something that people knew. It was something that they found 
relatable and had experience with, for instance in healthcare settings, in the work of the 
blood transfusion service29 and in religion (explored below). Blood provided a 
hermeneutic ‘point of entry’ into the science; it allowed people to pull things in and make 
sense of the trials in a way that was arguably not available to them through other means. 
It was telling that those who expressed their role in the trials in terms of vaccines tended 
to do so hesitantly. Those who spoke the language of blood donation, by contrast, usually 
did so confidently and with considerable clarity. 
What is significant about the blood donation, however, is not only its destination 
but also what it says about the people from whom blood is drawn. It was observed above 
that, insofar as efficacy trials are concerned, participants’ scientific value resides in a 
disposition to sickness, that is, a certain probability of developing active TB (approx. 
1.5/100 per participant per year). However, conceived in terms of blood donation, 
participants’ value to SATVI, to the contrary, resided in being and staying healthy. During 
interviews with participants, several expressed to me that, it was only once blood had 
been screening for disease that it could be circulated: “Me, blood that is taken…for sure 
is checked that it is right, and then it will support those people who need” (20, F, X, ET). 
There was, in fact, overlap between health-related and altruistic motivations for taking 
part: “I have also joined because you know more what’s happening to you and your 
health. You learn more. And it is good to donate blood for someone else and so on” (33, 
F, A, ET). But perhaps most interestingly, I began to notice in both community settings 
                                                 
29 The South African National Blood Service (SANBS) is a familiar presence in Worcester, and 
a few participants stated that they had donated blood to SANBS themselves. During my 
fieldwork, I often saw the mobile clinics of the Blood Service at Brewelskloof hospital. 
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and interviews that the blood needed to be ‘clean’. Perhaps the most aptly expressed 
example emerged during the aforementioned field trip, when one group of students were 
talking to a mother with three children, all four of whom were currently enrolled: 
I asked her if she has heard of SATVI and then she said yes, she and all three 
her children were involved in the programme. I asked her to explain what 
SATVI did, she explained that they “take your blood”, it’s a kind of 
“donation” of blood. She didn’t know what exactly they do with the blood, 
but she knew the blood had to be clean blood. So if you are involved with 
SATVI you know you are healthy. She also went on to explain that they were 
particularly interested in getting school children’s blood because it was 
“clean”.   
                                                                   (Field Report, Terena Koster) 
The remark about children’s blood being clean was particularly revealing. For it conjures 
images of purity, innocence and perhaps being untainted by the ‘dirty’ practices usually 
associated with adulthood, for instance drinking, smoking, drugs or sex. This was, 
potentially, reinforced by some of the associations drawn by SATVI’s staff between these 
practices and the drawing of blood. We saw above, for example, that Susanna told 
Leighton that he should not come to the site whilst drunk lest it be reflected in the blood 
work. One of the fieldworkers, Peter, even told participants and their parents they should 
not to take drugs because it affected their blood:    
And when I speak to the participants and parents and all this, I’m actually 
also telling them that, don’t use drugs. Don’t do that, because we as SATVI 
and the research we don’t want you to do that because we need your blood, 
well you as a person, so don’t do that. 
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The picture that is therefore beginning to emerge is that the blood draws that lay at the 
heart of participation for many did not only reveal diseases. They also, importantly, acted 
as a window into lifestyle and a signifier of morality. In other words, there was a tight 
connection between doing good to for the community and being good oneself. It is in this 
regard that, following Carsten (2013a), it becomes useful to view blood as “the stuff of 
truth”. Like the example of the Malay politician explored by Carsten (2013b), so too 
SATVI was believed to have the capacity to see the truth about people’s moral agency, 
with only the ‘clean’ being edible to enter and continue donating blood in the trials. We 
might even see SATVI’s trials as enacting a kind of simultaneous medical and moral 
triage, wherein not only biological but also moral states become known through the 
process of drawing and testing of blood. This notion will be explored in the following 
section, where we revisit Leighton’s interpretations of his interaction with Susanna and 
the trial.  
Trials as Moral Triage 
Leighton, like many participants, said that he decided to take part in the first instance 
“because I didn’t even know my status”, by which he meant whether he had TB. However, 
upon finding himself to be TB-free, he underwent a profound transformation. Having 
explored both Susanna’s way of engaging with participants and the associations between 
SATVI and ‘clean blood’, we are now in a position to revisit his journey. What I will 
suggest in this final section is that Leighton’s interpretation of Susanna’s Christian 
message was refracted though and even amplified by the idiom of ‘clean blood’, 
connecting Christianity and medical science in interesting and unexpected ways. At the 
same time, Leighton’s narrative draws attention to the fragility of positive lifestyle 
changes in a destabilised and impoverished setting such as Worcester.    
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 The conversion of Leighton resonates very strongly with Jenson’s (2008, p. 181) 
ethnography in the ‘coloured’ township of Heideveld, where he showed that religion was 
used by young men seeking to leave gang life as an “embodied strategy of self-
improvement”. Leaving a gang was terribly difficult, and claiming to have departed from 
gang life was not enough: one had to demonstrate, repeatedly, to both gangsters and polite 
society alike, that one had truly left. Jensen spoke to one young man called Shaun who, 
in addition to apologising to those he had wronged, pointed towards the embodied 
practices that had had to adopt to instil trust: 
If you are a Christian and carry a bible, then you can get out, but not by 
yourself. You must be a Christian in their eyes. You mustn’t smoke. You 
mustn’t drink. Walk with a suit and your bible, and they will see that you are 
a Christian. That is why they won’t touch you. 
(Jenson 2008, p. 182) 
All the while, people were “watching his every move for traces of what was presumably 
was always already there…the paradox that faced all coloured men from the townships 
as they staked their claims to respectability” (ibid, p. 183). I would like to view Leighton’s 
conversion in the same light as Shaun’s, but argue that it is, if anything, even more 
powerful as a ‘strategy of self-improvement’ because of the very close intertwining of 
religion, participation, blood draws and lifestyle.   
On first glance, it seems odd that the supposedly mundane, bioscientific practice 
of drawing and testing blood might find affinity with Christianity. However, Carsten 
(2013a), in fact, supports her depiction of blood as the “stuff of truth” by drawing 
attention to a long history of this conceptualisation of blood in Christian thought. In the 
same volume as Carsten, Bildhauer (2013) finds in Medieval texts the reoccurring notion 
that blood that is rendered visible has the ability to reveal people’s innermost states, 
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including truths about both their health and their moral propriety. Carsten (2013a, p. 8) 
adds that these ideas are themselves partially derived from biblical writings, for instance 
Leviticus (17:1-15) which depicts blood as “both the animating life force and the bearer 
of the soul”. SATVI’s blood draws – which for many constitute the “beating heart of the 
trial” (Brives 2013, p. 398) – might, therefore, be read as an act of making blood visible, 
revealing both biological and moral states.  This is not to suggest that Leighton had been 
reading Leviticus - although he may well have been exposed to these ideas in the 
symbolisms and rituals of church. Rather, it is to say that there is a considerable amount 
of conceptual room for a turn to Christianity to happen in conversation with ‘mundane’ 
bioscientific practices.  
Susanna might have been committed to ‘looking’ beyond what she ‘saw’. But 
from where Leighton was sitting, this was aided by the drawing and testing of blood, 
offering a particularly powerful means of looking and knowing. SATVI would, in effect, 
know exactly what he had been doing in and between his visits to the site, whether or not 
he told them. This was suggested in the following excerpt from our conversation, after he 
expressed how he felt about finding that he did not have TB:     
I never knew how healthy I was. Even now when I’m out there in the 
community, I know my status.  I know I’m a hundred percent cure.  Nothing 
is wrong with me…I don’t have fear when I’m walking there because I know 
I’m healthy a hundred percent. Because now I’m over the weekend. A lot of 
things are happening on a weekend. People are drinking beer, partying and 
all those things. Because I know I’m a part of SATVI, I don’t belong in those 
things. I must keep my body healthy, and I must come Monday and they 
would…Today the results when they have come. 
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Being a part of SATVI, he suggests, he could no longer take part in some of the things 
that he did before, particularly “drinking beer, partying and all those things”. In fact, for 
Leighton, following protocol – conceived of as not partaking in ‘dirty’ practices – was 
akin to following the word of God. Hence in the opening vignette, he says: “I want to be 
in this study also to stop these things. Because if I keep on doing that, I’m with God”. 
Perhaps I am not going too far as to suggest that it is almost as though a church preacher 
had the remit to draw and test blood as an act of religious confession. That is, in effect, 
exactly what was happening when Leighton came for follow-up visits – an extension and 
indeed amplification of religious authority through a bioscientific experiment.    
Here we can begin to appreciate the power of trial participation as an embodied 
technique of self-improvement. One had to really be someone of ‘clean blood’ to stay in 
the trial – at least, according to this interpretation of SATVI’s work. In the same moment, 
this also conferred upon Leighton and others like him a powerful form of symbolic 
capital, a robust marker of respectability that could be worn on one’s sleeve. It might be 
noted that clinical trials are often lamented in the social scientific literature for being so 
short, a critique which certainly carries weight in terms of life-saving medications (e.g. 
Geissler et al. 2008; Petryna 2009; Kelly 2011; Nguyen 2011). But in a context where, as 
Fiona Ross (2010, p. 5) observes, any kind of stability is hard to come by, two-to-three 
years of trial participation is a comparatively long period, one in which one can receive 
attention, support and even small amounts of money along the way. It is no wonder that 
SATVI has become an important part of the landscape of hope and moral aspiration in 
which people in Worcester strive to overcome this seemingly unsurmountable stereotype.  
Leighton, as he suggested, no longer belonged around people who engaged in 
certain kinds of lifestyle. Yet at the same time, he said that he – and other participants 
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who I unfortunately was unable to speak with – tried to convince other people to join 
SATVI and undergo the same kind of transformation they went through: 
JD:  So you stay away from those people. 
L:  And when we are around them we try to tell them about SATVI. They are 
scared because they are not fine with…because the blood tells you more about 
yourself. 
JD:  Okay, so they are afraid that they are going to hear about… 
L:  The things that they are doing. 
The problem he experienced in this was that people were often less willing to hear about 
‘themselves’ than he. Studying HIV surveillance in KwaZulu-Natal, Reynolds et al. 
(2013) suggest that the ‘gift’ of blood in medical research is in many respects a poisoned 
one. They show that, while the research might be construed in terms of community 
benefits, blood samples contained “dangerous knowledge”, eliciting fears of its 
circulation (2013, p. 122). Similarly, in the SATVI context, the truth-bearing capacities 
of blood were such that they could reveal not only positive and health-affirming truths 
but also negative and potentially stigmatising ones. Indeed, the truths revealed by blood 
can be read to go beyond the biological to the very essence of personhood.  
 With this cooler theme in mind, it is important finally to consider that, whilst trial 
participation might constitute a particularly powerful strategy of self-improvement, 
success was far from guaranteed, even for the ‘initiated’. Although I was largely unable 
to talk to people who left the trials, I received hints that some people felt unable to return 
to SATVI in the wake of ‘deviations’ from the lifestyle they felt was required of 
participation. Leighton said that he knew people who had not ‘made it’ through the trial: 
“they are not making it because every time you are here, you are being tested, so it tells 
you about what we are doing in past days since the last time that you were meeting”. In 
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addition, some of the students during the anthropology field trip encountered an 
Afrikaans-speaking man who said that, while his blood was ‘clean’ upon entering 
SATVIs trials, ‘dirty’ practices subsequently ended his participation:    
“SATVI het my blood gebruik. Maar nou is my bloed vuil, ek doen ander goed 
wat maak dat my bloed nie meer skoon is nie.” (SATVI used my blood. But 
now, my blood is dirty; I partake in other things that cause my blood to not 
be clean anymore). Tylor asked him if he could tell us what these ‘things’ 
were that caused his blood to not be clean anymore, and he just smiled and 
simply stated: “Sommer net dinge” (Simply just things). We both could see 
that he did not want to elaborate on the situation.  
                                                              (Field Report, Kylie Opperman) 
In many ways, this (ex-)participant’s remarks to the students captures everything this 
chapter has suggested about the idiom of clean blood: that SATVI was “using” his blood, 
that this blood had to be “clean”, but that he had engaged in “dirty” practices which had 
subsequently ended his participation. What is noteworthy is that, insofar as trial protocol 
was concerned, he would certainly not have been excluded because the quality of his 
blood had been compromised by drinking, drugs or whatever else. It is, in fact, possible 
that he was not formally excluded at all but simply felt too ashamed to return again, which 
was perhaps suggested by his responses to the students. But even if he was excluded – 
perhaps because he developed TB or another medical condition – the way he understood 
what exclusion meant was evidently not in the amoral, matter-of-fact way of a trial 
protocol. Rather, it was perceived as a personal moral failing. This only goes to emphasise 
the great weight that could be placed upon people’s shoulders when people entered 
SATVI’s trials and the dejection and shame that could come when they were found 
wanting.  
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Conclusion  
By following the interactions between Susanna and Leighton, this chapter has drawn 
attention to the ways in which both research staff and participants made meaning of 
SATVI’s trials and made them relevant to their lives and circumstances. Although 
people’s motivations and interpretations were diverse, multiple and shifting, what 
crystallised through these everyday scientific encounters is a moral economy that 
operated according to a different logic to vaccine trial protocols. The trial protocols were 
partially resigned to alcoholism and drug abuse among study cohorts. By contrast, this 
moral economy involved a sharp resistance to practices considered to be ‘dirty’ as people 
brought their own beliefs, values and ideas of proper personhood to bear on what it meant 
to be a human subject. For research staff like Susanna, this entailed not simply viewing 
participants as objects but rather as people of inherent worth, and in which the all-
important object of knowledge and intervention was not the body but rather the person, 
the moral agent and even the soul. But this was taken further by participants themselves, 
because the logic of ‘clean blood’ collapses the subject-object distinction altogether, 
intimately connecting internal states and bioscientific value. At stake was the everyday 
sense of self: of being able to lead an ordinary, healthy and respectable life in conditions 
that have been rendered extremely precarious by centuries of domination, exclusion and 
racial stereotyping (Jensen 2008; F. Ross 2010).   
 In the introduction to this chapter, I suggested that the idiom of ‘clean blood’ not 
only danced to a different tune to vaccine trials but also potentially ran into tension with 
it. After the trial of MVA85A, there was a lot of talk about the susceptibilities of efficacy 
trials to ‘failure’ even when a vaccine shows promise in early-phase testing. One 
possibility, as suggested in Chapter 3 (p. 95), was that the intensity of case finding during 
the trial might have ‘washed away’ the effects of the vaccine before it had the chance to 
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work. This chapter suggests another possible interference in the trial design. Adult trials 
are powered by a 1.5/100 probability that a participant will develop TB each year. But 
what happens if people like Leighton are not passively accepting this disposition to 
sickness and, in the effort to set themselves apart as responsible, health-conscious 
individuals, start radically transforming their lifestyles? Could it reduce the number of 
TB cases below the number required to produce a statistically significant result? I am not 
advancing this suggestion as anything other than speculative conjecture of a social 
scientist and, moreover, do not wish to overstate the capacity of people’s abilities to 
escape the structural determinants of TB. I only wish to underline that the so-called 
‘vulnerable’ are not simply sitting down and awaiting their fate but rather using SATVI’s 
trials in creative and unpredictable ways that have tangible effects both on their own lives 
and the trials themselves. Could it possibly be that the situated moral projects being 
pursued through the trials have weighed down and overtaken the biomedical future that 
the trials seek to bring about?   
 Most of these fascinating social dynamics, it might be noted, unfold beyond the 
visibilities of the state, among precisely the people and in the suburbs that the government 
clinics struggle to gain any control over (Chapter 4). While writing this chapter I could 
not help but wonder what Sister du Plessis will make of its findings, whether it will be 
met with interest, bemusement, scepticism or otherwise. In the next two chapters, I bring 
the government clinics back into the frame, and draw attention to the relationships, 
comparisons and connections between SATVI and these clinics. This is especially 
relevant given that many participants would be referred from SATVI to the clinics in the 
event they were found to have a medical condition. These chapters, too, highlight the 
tensions between the moral, respectable people that participants experienced themselves 
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as and the governmental stereotypes that resolutely lurked in the background (Jensen 
2008).    
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Chapter 7: 
“We are not Dominating Them”: Comparisons and 
Connections Between SATVI and the Government 
Clinics  
Moving back and forth between SATVI’s trial site and the government clinics during my 
fieldwork, one thing which never failed to strike me was the tangible difference in the 
mood and atmosphere between the two kinds of institution. Waiting for study visits, 
participants chatted, drank coffee, ate breakfast, watched TV, played music and 
manoeuvred chairs to sit in larger groups. They were also often social with the research 
staff, and it was not uncommon to see warm embraces between participants and staff, 
especially in the Adolescent Trial. By contrast, the government clinics were crowded, 
sombre and often tense environments. This was partially because more of those attending 
the government facilities were sick. But over this was layered the clear markers of state 
authority: metal detectors and security guards at the entrance (in the case of Worcester 
Community Day Centre [CDC]), people sitting quietly with their heads down and their 
body language closed, and people funnelled this way and that by uniformed nurses.  
 These differences were noticeable for me, but they also featured prominently in 
participants’ appraisals of SATVI’s research environment too. The previous chapter 
focused upon how people viewed their role in the trials and examined the complex 
interplay between personal and community health contained within the idiom of ‘clean 
blood’. Yet many participants – 59 (60%), in fact – said that among their reasons for 
taking part in the trial in the first place was a concern that they might have developed a 
medical condition they did not know about. This concern was usually most pronounced 
at the screening visit, where a variety of tests and examinations were conducted to 
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determine whether they were eligible to enrol (see Appendix 2); but as people were all-
too aware, sickness and disease are ever-present threats in post-apartheid Worcester and 
could therefore occur at any point during the trial. SATVI’s work consequently 
overlapped with that of the government clinics, and participation would directly lead to a 
visit to a clinic in the event that a disease was diagnosed and they had to be referred for 
treatment.30 Building upon the previous chapter, this chapter explores how people 
concerned about their health perceived SATVI’s role in the local healthcare landscape, 
especially how they drew comparisons and appropriated connections between SATVI and 
the government clinics.  
 I will argue that, while SATVI does not consider healthcare to be part of its remit, 
a combination of push factors from the government clinics and pull factors towards 
SATVI have led the institute to take on an important, albeit largely unacknowledged, role 
in the Breede Valley as a ‘first point of care’. Part of the reason for this, I will suggest, is 
the superior medical resources and expertise that SATVI’s trials have brought into the 
frame: shorter waiting times, high-end diagnostics, the presence of doctors and a referral 
process that might help to access healthcare through the government facilities (Barsdorf 
et al. 2010). However, perhaps the most important aspects of what made SATVI attractive 
to people as a healthcare setting had to do with the relational aspects of care.   
 Chapter 4 described how the Mandela administration radically restructured the 
health system to improve access to healthcare among those who had historically been 
most deprived. The Patient Rights Charter (1996) spelled out a range of rights, including 
those to a comprehensive range of healthcare services, privacy and confidentiality, 
participation in health decision-making and also to a disposition on the part of healthcare 
                                                 
30 As was discussed in Chapter 1 (p. 51), SATVI does not provide any treatment for any 
conditions diagnosed during vaccine trials but rather refers participants to their normal 
healthcare provider, usually a government clinic.    
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professionals that demonstrates “courtesy, human dignity, patience, empathy and 
tolerance”. Yet as the chapter went on to demonstrate, from the perspective of clinic staff 
there was a fundamental dissonance between the theory and reality of post-apartheid 
healthcare provision and it was difficult for them to always remain patient when, from 
their perspective, people often seemed unwilling to ‘take responsibility’ for their health. 
Participants, as this chapter suggests, viewed the situation very differently. They felt that 
in the government clinics they were unjustly subjected to scolding, feared that their 
medical information would become public and in general felt that they were on the bottom 
of a hierarchy that carries residues of the country’s past (Jewkes et al. 1998; Sokhela et 
al. 2013). Against this backdrop, the ‘flatter’, more dialogical health relationship 
introduced by SATVI’s trial environment was valued highly and, as I will argue, 
manifested in a powerful form of care. The respectful, dignified treatment people felt 
themselves to receive at SATVI represented the way that they felt entitled to be treated 
in the government clinics. And with few able to afford private medical aid or willing to 
shoulder out-of-pocket doctor expenses, participants made sure to use SATVI as far as 
they possibly could.  
 In making this argument, I draw upon the perspectives of both participants and 
research staff, especially nurses. However, by way of a clarification, this chapter 
privileges participants’ perspectives, both in order to highlight health-seeking practices, 
and also because their views diverged in certain respects from staff. Participants viewed 
themselves as responsible, health-seeking individuals using SATVI as a particular kind 
of health space. The research staff agreed with this to an extent and, as I introduced 
findings from participant interviews into my conversations with the clinical teams, they 
began to shed additional light on why participants saw the institute in this way. At the 
same time, many of the nurses experienced some internal conflict, wanting to see 
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participants in the light that participants saw themselves but also having to bear the 
consequences of when they demonstrated an apparent lack of concern for their health, 
much like the government nurses in Chapter 4. I leave these issues until Chapter 8, which 
explores the interactions between SATVI and government clinic nurse when it came to 
referring sick (and often ‘uncooperative’) patients to the clinics for TB treatment. This 
chapter, meanwhile, takes its lead from participant perspectives, gradually adding the 
perspectives of staff to shed additional light on why they perceived certain kinds of care 
in the research setting.  
Perceptions of Care in Research Settings 
Social scientific studies have demonstrated in a wide variety of contexts that research 
relationships do not amount to the stripping away of care and that the organisation of 
clinical trials can engender unique therapeutic relationships. Easter et al. (2006), for 
instance, suggest from a study of early phase gene transfer trials in the US that 
participants, while aware that research was not being performed for their benefit, valued 
the relationship between the researchers and themselves more than their usual healthcare 
provider, especially because of the intimacy and trust that developed over time. Other 
studies focusing on research involving people with limited access to healthcare (e.g. 
uninsured citizens in the US, Russia and Poland) have further shown that participants 
receive not only treatment but also ongoing monitoring, psychosocial support and help in 
the case of emergencies (Fisher 2009; Petryna 2009; Timmermans & Mckay 2009; 
Zvonareva et al. 2014). Stigmatised populations, as Timmermans and Mckay (2009) 
suggest from their study on a trial involving methamphetamine addicts in the US, might 
derive particular benefit from trial environments, with non-judgemental staff, greater 
confidentiality than in the public sector, and also a supportive environment in which to 
attempt to break addiction.  
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 Ethnographic and other qualitative studies in Africa have drawn attention to the 
stark difference between government healthcare and that which becomes available 
through participation in clinical trials (e.g. Geissler et al. 2008; Nguyen et al. 2007; 
Barsdorf et al. 2010; Nguyen 2011; Kamuya et al. 2014). However, perhaps because of 
this stark difference and the emphasis on the preservation of minimal survival, with 
notable exceptions (e.g. Barsdorf et al. 2010; Brives 2013; Zvonareva et al. 2014), 
emphasis has tended to be on biomedical interventions, considered outside of the 
healthcare relationships in which they are delivered (though fieldworkers have received 
considerable ethnographic attention [e.g. Geissler et al. 2008; Molyneux et al. 2013; 
Chapter 5]). In South Africa, there is evidence to suggest that this ought to be an area of 
focus, with several studies highlighting negative patient experiences in government 
facilities, for instance “rude” and “uncaring” staff, the public sharing of patient 
information and generally hostile and degrading environments (Jewkes et al. 1998; 
Muller 2004; Gilson et al. 2005; Sokhela et al. 2013). There is thus a gap in the literature 
focusing upon how participants in clinical trials perceive research relationships in relation 
to those in government facilities.  
 Barsdorf et al. (2010) note that in most preventative trials in South Africa, 
participants are referred to government facilities for treatment (as with SATVI). They 
argue that it is important to discern how people view the responsibilities of researchers in 
such arrangements given the under-resourcing of public programmes. Speaking to 
stakeholders in HIV prevention trials in KwaZulu-Natal, they show that the research 
relationships were perceived as “caring and supportive” (2010, p. 84) and that, because 
researchers were viewed as being in a relationship with participants and in position to do 
so, that they should help facilitate treatment through the public programs. Yet they offer 
little sense of the historical context of the clinical trials in the region, the social substance 
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of these ‘caring and supportive’ relationships and the extent to which perceptions of care 
were informed by experiences in government facilities.  
  In this chapter, I will suggest that participants’ perceptions of care in the research 
environment were intimately connected with experiences in government clinics and, in 
fact, SATVI was viewed as almost the diametric opposite of the clinics. Once again, the 
empirical schema running through this thesis – that is, the transition from abject to object 
to subject (Sariola & Simpson 2013) – is useful for shedding light on why participants 
viewed the research environment so positively. Accustomed to scolding, disciplining and 
other indignities in the government clinics, people felt highly vulnerable and exposed 
when seeking healthcare through the public sector. Yet their disposition to develop TB 
made them valuable as scientific objects, placing them in the line of sight of SATVI’s TB 
vaccine trials. In the process of becoming objects, they were “reconfigured as universal 
‘human subjects’” (2013, p. 52), that is, autonomous, rights-bearing individuals “to whom 
certain standards, protocols and guidelines apply” (ibid, p. 52). Much of what it means to 
be treated as a universal human subject, for instance as autonomous and with dignity and 
respect, might barely register in a Western research setting. However, when viewed 
against the backdrop of the post-apartheid health system, the novelty of SATVI’s research 
environment to participants becomes more apparent, as does its positive uptake.  
Health Checks and Blood Screenings 
When discussing the health-related benefits of trial participation in the previous chapter, 
the main focus was on blood tests and the close interconnections between personal and 
community health. But as I found during interviews, SATVI’s reputation as a health 
setting went beyond blood tests, and people were well-aware, often before a fieldworker 
had explained the trial procedures, of the broader ‘package’ of tests and examinations that 
were performed at screening and throughout the follow-up process (Appendix 2). 
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Knowledge of SATVI’s diagnostic capabilities often came from having friends, children, 
relatives or others who had taken part and who have had positive experiences. One 
participant in the Adult Safety Trial explained to me that her child had been in the trial of 
MVA85A and her experiences led to her to take part herself: 
JD:  Can I ask, why did you choose to have your baby as part of the study? 
R:  Soos julle mos nou weet, TB is ‘n groot ding in die gemeenskap.  En 
hoekom ek vir hom daar neergesit het, dis omdat ek stel belang in my kind se 
gesondheid.  (As you know, TB is a big thing in the community. And the 
reason for putting his name down, it’s because I want to know about my 
child’s health). 
……………… (a few minutes after) 
JD:  So did having your baby in the study make it more…did it affect your 
decision to take part in this study yourself? 
R:  Ja, ek het goed gevoel. Dis hoekom ek nou maar self hiernatoe gekom het.  
(Yes, I felt good. That’s why I came here myself). 
(23, F, A, ST)31 
Memories of SATVI’s work and what the trials entailed for participants went back as far 
as the BCG trial, it might be added (Chapter 3). But it was not only TB that people were 
worried they might have and that would be revealed through the trials procedures. In fact, 
HIV was mentioned just as often as TB. Worries about HIV were most pronounced in the 
HIV-Exposed Infant Trial, in which all of the mothers took part for the health of their 
babies (see Chapter 6, Table 2, p. 169) and were concerned in particular with ensuring 
that they did not pass on the disease to their babies. But in the other trials, too, participants 
                                                 
31 See Chapter 6, Table 1 (p. 164), for the guide to shorthand used to describe participant 
demographics.  
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mentioned HIV tests among their reasons for taking part:  
JD:  So can you just tell me a little bit about how you got involved with the 
study? 
R:  My friends were part of the study. I asked them how does one get involved. 
They told me, but I never really got a chance. But I kept on asking them when 
will the people be coming back to you again; when will they ask the people 
again. Because I’m very interested in becoming part of the study…  
JD: What did you see your friends doing that made you want to take part?  
What made you interested? 
R: They told me about the tests for TB that you get tested for, and AIDS. 
(20, M, A, ST) 
Aside from infectious diseases such as TB and HIV, people also mentioned chronic 
diseases such as hypertension, diabetes and high cholesterol. Many did not have any 
particular worry in mind when consenting to take part but simply wanted to receive a 
thorough medical examination. With people seemingly using SATVI in a similar way to 
how one might use any other healthcare provider, I then asked participants why they 
wanted to hear about their health at SATVI rather than elsewhere. This question, I found, 
hit a nerve. For it prompted many to speak passionately about the differences between 
SATVI and the government clinics as well as the connections between them. The rest of 
the chapter is divided into four sections, reflecting the main themes that emerged from 
participants’ reflections: access and clinic environments; hierarchy and communication; 
diagnostics and follow-up; and referral into the health system.  
Access and Clinic Environments 
Most of the participants I talked to live in Worcester, either south of Durban Street or in 
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the township of Zwelethemba. With Worcester CDC sitting just north of Roodewal, and 
Empilisweni clinic lying at the edge of the township, most residents lived near to a 
government clinic. There were notable exceptions, however. Residents living in Avian 
Park were located around eight kilometres from Worcester CDC and thus this often meant 
paying for a taxi to the clinic if necessary.32 Moreover, those living on the farms outside 
of Worcester – which included several of the adolescents – either had to wait for a mobile 
clinic or get a lift with the farmer to town. Another, less visible barrier to accessing 
healthcare were the gang territories. When I was in Riverview with Jenna, one of the 
nurses, we encountered one incredibly thin young woman who had TB disease but who 
had stopped attending the clinic for medication. Looking like she was near death, Jenna 
asked her why she did not seek treatment when the Worcester CDC was only ten minutes 
away on foot. Her boyfriend was a gangster, she explained, and going to the clinic meant 
going through Roodewal, a rival territory, where she feared she would be recognised and 
shot. Sadly, it appeared that allowing her physical health to deteriorate was the more 
promising alternative.   
 Most participants could make it to a government clinic without too much difficulty. 
In fact, there is such thing as being too close to a clinic, as will be discussed shortly. One 
of the first, although by no means the least appealing, aspects of the government clinics 
that people related to me was just how long the queues could be (Bogart et al. 2013; 
Sokhela et al. 2013). Queuing occupied the vast majority of the time spent in a public 
clinic, especially if one had not yet been diagnosed. This meant starting a clinic file (if 
necessary), going through observations and seeing the primary healthcare sisters before 
being moved onto a more specific department (if necessary) – each of which had its own 
                                                 
32 Given the lack of access to a clinic in Avian Park, which had among the highest rates of 
infectious disease, the district manager Dr Van Zyl informed me there were plans to build a 
clinic there in the coming years.   
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queue. One young lady, speaking of Empilisweni clinic, said that: “Their service is not 
good at all, because if you go there at eight o’clock in the morning, maybe you are going 
home at…The whole day you were there” (21, F, X, ET). By contrast, SATVI’s trials 
allowed one to avoid this queueing process to an extent:     
JD: Would you rather hear about your health here than anywhere else? 
R:  Yes. 
JD:  And why is that exactly? 
R:  Because when you go to the day hospital or something, then you have to 
sit a long time.  You don’t get the results easily, like they get it here.  Then 
you have to wait a long time.  But here it’s very quick. You get the results 
quickly. 
(44, F, A, ST)  
People related a similar situation in relation to the recently established appointment 
system at Worcester CDC and De Doorns clinic. This system was designed to manage 
the flow of patient traffic more efficiently, and involved people making an appointment, 
either in person or over the phone, to be seen during a specific hour window on a given 
day. While the impression that I got from the clinics was that this would mean waiting a 
few days at most, a number of participants expressed that it could take several weeks to 
get an appointment, especially if it was deemed not to be urgent. Their impression, 
therefore, was that the new system functioned to further limit access to state resources, 
keeping the problems beyond their walls (Muller 2004). SATVI, again, was perceived to 
offer faster test results: “I just wanted to find out if I was HIV-positive, and that lady 
[SATVI nurse] told me she’s going to do it right now because at the clinic you can wait 
two or three weeks…And I got my results” (26, M, A, ET). 
 It was not just the length of waiting times, however, that set SATVI apart from the 
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public clinics; it was also the kind of waiting environment. Muller (2004), in an 
ethnographic study of a community health centre in the Cape Flats, noted that the building 
became “increasingly fortified” in response to gang related activity in which clinic staff 
had been threatened and injured. Worcester CDC had a similarly fortified appearance and 
security presence, given its proximity to gang territories, and a number of participants 
expressed how cold the building felt. SATVI, by contrast, had a much warmer and 
friendlier feel to it, and participants were often quite taken aback the first time they came.  
They took our names and came to explain what the study was about. I read 
the pamphlet that they gave me. Then they contacted me to say when they 
were going to fetch me. But I find it quite…how can I say…the people who 
are working here are very friendly, even the cleaners and the girl at security, 
they are also very friendly. 
   (40, F, A, ET) 
People also commented on the food and coffee that they were offered while waiting: “It 
is nice, because they are offering us coffees with biscuit” (21, F, X, ET); “So at least apha 
uyakwazi ukufika utye. Kumnandi wethu (So at least here you can arrive and eat. It’s just 
nice” (20, F, X, ET). This perceived kindness and conviviality also characterised 
appointments, which will be discussed below.    
 Arguably the more pertinent aspect of the waiting environment at SATVI for those 
who were concerned about their health, however, was the inscrutability of people’s health 
statuses. At the government clinics, the queues were not only long; people would also end 
up waiting outside of the department – for instance prenatal, infectious disease (primarily 
HIV), TB, and chronic disease – that they would be visiting. People were absolutely 
terrified that other people would see them waiting and make assumptions about what 
diseases they had. This was especially pertinent among Xhosa-speaking participants, 
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given the proximity of Empilisweni clinic to the community that it serves and the modest 
size of Zwelethemba. One young woman said: “At the clinic there are a lot of 
people…And they’ll know your status, and they will go around and talk about it” (23, F, 
X, ST). Another said: “Like now, they said, if you’re sick with this sit here; if you’re sick 
with that sit there. So people know, if you’re there, oh you have a problem” (21, F, X, 
ET). I even heard that often people in Zwelethemba would use Worcester CDC rather 
than Empilisweni clinic, especially regarding HIV, in order to receive medical attention. 
These findings are by no means unique in South African contexts (Horwood et al. 2010; 
Gilbert & Walker 2010) and, moreover, Abney (2011) found that TB patients sometimes 
commute to avoid being seen at their local clinic – such was the fear of stigma 
 At SATVI, by contrast, it was far more difficult for people to know who was there 
for what reason, or whether they were healthy or whether they were not. The one thing 
that might be suspected of a participant, as discussed in the Chapter 5, was that they were 
there for the R150 ‘reimbursements’. This was an image people were concerned with 
avoiding, but certainly less so than a having stigmatised disease (i.e. TB or HIV).     
Hierarchy and Communication  
After waiting for a short while, participants were almost invariably greeted by a warm, 
smiling nurse as they went in for their appointments. In the last chapter, I described the 
social dynamics of nurse-participant interactions, but without a comparative focus with 
government clinic nursing. That there might be a discernible difference between SATVI 
and the government nurses was recognised right from the BCG trial. SATVI’s first site 
manager Dennis – who we heard much from in Chapter 2 – attributed this to the very 
different settings within which the nurses were engaging with people:  
The BCG [SATVI] nurses are so kind, and the public service nurses are so 
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rude. They say “wait there” while the BCG nurses say hello, call you Mr or 
Mrs, and ask you nicely...Those sorts of thing [attitudes of clinic nurses] are 
real, this patient for the public service nurses is one of a thousand, and for the 
BCG nurses this is one piece of gold, one that you must have. 
Dennis was referring to the overcrowded, rushed and irritable environment of the 
government clinics, in which each patient is but one many who need to be manoeuvred 
through the crowded clinic spaces, often through the use of commands. By contrast, the 
power dynamic is inverted in the research environment, with each individual carrying a 
far greater “value”, which necessitates individualised, friendly treatment: asking them not 
commanding. Based on the previous chapter, I would contest Dennis’ characterisation of 
participants’ value to the nurses in terms of a “piece of gold”, a term which brings to mind 
the notion of “biocapital” (Sunder Rajan 2006). Nonetheless, there was certainly a 
retention motive at play during research interactions, to a greater extent than clinic ones.33  
 Lydia, a professional nurse during the BCG trial and now and head of human 
resources, suggested that the way that participants were treated by research staff in 
comparison with the government facilities was often a “convincing factor” for 
participants:  
They saw that as a convincing factor to participate in the research, because 
they get a good medical examination, and people are actually nice to them, 
and have time for them. Because the health services can be pretty offhand and 
you have to wait forever, and then you get to an irritated nurse. Whereas now 
                                                 
33 This is not to say no retention motive exists in the government clinics. Persuading patients to 
keep on their medication is certainly made easier when nurses strive to be friendly and 
respectful to patients. The difference is that in research encounters, even if a participant does not 
follow protocol, one can never rebuke them.    
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everyone is happy to see you...so you can hardly blame them for participating. 
Lydia also, interestingly, mentioned that they don’t judge the adolescents about having 
sex: “They [SATVI nurses] don’t look down on the teens and say ‘what the hell are you 
doing here’, rather they say ‘please, you need to have safe sex”. The implication that 
attitudes to the effect of “what the hell are you doing?” are prevalent among government 
nurses is supported by a number of studies (e.g. Wood & Jewkes 2006; Harries et al. 
2009). 
 One professional nurse, Lorna, perhaps went the furthest in connecting the ways in 
which participants are treated at SATVI to the legacy of domination and control in the 
health sector from apartheid. For her, the fact that SATVI nurses did not wear uniforms 
went some way to relinquishing control and domination over them and emphasising that 
it was their choice whether to take part:    
The fact that we don’t wear uniforms, we wear private clothes, so we are not 
dominating them. We respecting their rights as a person. So, if I had my 
epaulettes on, they know if I speak they must just do. But here, you give them 
an open platform to say yes or no. You’re not enforcing. You’re not forcing 
them to take part.   
Lorna’s statement adds to the findings presented in previous chapters. Chapter 5 explored 
the recruitment practices of the fieldworkers and showed how they attempted to ‘lower’ 
themselves to mitigate the difference in socioeconomic status between themselves and 
participants, from which they attempted to make people feel valued. Chapter 6 
demonstrated how the study nurses strove to look beyond the distanced, objectifying logic 
of trial protocols to acknowledge the people sitting in front of them. Lorna’s assertions 
suggest that we add the visible identity of research nurses as “private” citizens rather than 
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as state actors as another key way in which the research relationship relinquishes of power 
and control over participants in favour of more equal engagements.       
  Participants had very much the same opinion, and their explanations are consistent 
with findings from studies offering patient perceptions of government clinics (Jewkes et 
al. 1998; Gilson et al. 2005; Goudge & Gilson 2005; Sokhela et al. 2013). To give a sense 
of just how pertinent the stark difference between SATVI and the government clinics was 
to participants, in one of my first interviews I was in the middle of asking my first question 
when the woman in front of me cut in: 
R:  Kan ek gou net iets sê?  (Can I just say something)? 
JD:  Hmm. 
R:  SATVI is vir my beter as die klinieke, want as ons kliniek toe gaan met ‘n 
probleem, ek voel nie lekker nie of as ek nou gaan vir ‘n toets, hulle 
verwys…hulle sê vir jou maak ‘n datum, maar hulle help jou nie baie lekker 
nie.  (SATVI for me is better than the clinics because if you go to the clinic 
with a problem, maybe I’m not feeling well or I’m just going for a test, they 
refer…they tell you to set a date, but they don’t help you very nicely).  Hulle 
gesles nie lekker met jou nie.  (They don’t talk very nicely to you).  So die 
klinieke hier rond, dis maar nou net hoe ek voel daaroor, hulle diens is baie 
swak.  (So the clinics around here, that’s just how I feel about it, their service 
is very poor). 
(24, F, A, ST) 
Many other participants related the way in which they were treated in the government 
clinics, although I will relate just two more examples here:  
They’re going to shout you; you don’t come, you don’t come eat your 
Chapter 7 
 
206 
 
medication! All that stuff, blah, blah, blah.   
(21 F, X, ET)  
Daai Dr [actually referring to a nurse at Rawsonville clinic]…ek weet ook nie 
wat is haar naam nie…sy is baie onbeskof.  (That Dr [nurse], I don’t know 
what’s her name…she’s very rude).   
(14, F, A)  
What was troubling to me upon hearing these accounts from participants was that it was 
not only patients who had given the government nurses a reason to reprimand them, such 
as being ‘non-compliant’, who were treated as such (which is problematic enough in 
itself). It seemed also that there was a presumption in advance that all patients were like 
those who had been before them. This might partially be due to the busy and irritable 
atmosphere of the clinics, with the nurse already in a bad mood. But it seemed to be more 
than this; people felt that a stereotypical frame was placed over them, which at Worcester 
CDC might be called “problematic colouredness” (Jensen 2008, p. 183). This was 
partially suggested in Chapter 4 by Sister du Plessis’ frustrated statement, “You can’t be 
nice to them. If you give them the pinkie [little finger] then they will take the whole hand”. 
The result was that people felt that they were already on the defensive when they stepped 
foot in a clinic, ready to be placed in the role of the unruly patient. It might be supposed 
that this presumption, in turn, could feed into a self-fulfilling prophesy in some cases.       
 An important and closely-related aspect of trial interactions to the above discussion 
of hierarchy and power is that of communication. Clear communication between 
researchers and participants, as well as giving participants the opportunity to ask 
questions, lie very close to the heart of research ethics, because it is integral to people 
making rational, informed choices to take part in clinical trials (Andanda 2005; Geissler 
et al. 2008). Trial protocols dictated that at every visit, participants were informed of what 
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was happening, asked whether they were happy to continue taking part (i.e. not just during 
the initial consent process) and given the opportunity to ask questions. Of course, one of 
the most important messages to be communicated was that the trial was being conducted 
for the purposes of knowledge production and not for the benefit of participating 
individuals. Yet, the open channels of communication between SATVI’s staff and 
participants – the freedom to ask, question, be critical and hold staff to account – was part 
of what made SATVI attractive as a health setting. This was related by both staff and 
participants, often closely interrelated with the theme of hierarchy. Study co-ordinator 
Dayna, for example, said:  
People are more open about discussing their health here, and their problems, 
and their treatment, or their participation in the study. People aren’t scared to 
ask what their results are, for any test SATVI do. In the clinic, they’re scared 
that the sister is going to shout at them, or be very short with them. Here, on 
the other hand, we are very open with participants. We make it clear that they 
can complain if there’s something wrong, and that they make staff feel 
accountable. This makes them open up to you. 
Examples from participants were again numerous. Many spoke passionately about how 
they valued how they had everything clearly explained to them at SATVI, contrasting this 
with the way ‘care’ works in the government clinics: 
JD:  Why would that be?  What do you consider to be nicer about hearing it 
here? 
R:  At the clinic the people aren’t really friendly. They would just talk to you 
like that.  But here they are very friendly and they will explain to you nicely, 
step-by-step, how everything works and how you can get it and so on. 
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R2:  What is the difference between the service at the clinic and the service 
at SATVI?  What can you say is the difference? 
R:  Like I’ve said, they are friendly.  We won’t still say, no, we’re not coming 
back tomorrow when they’re calling us.  But at the clinic they will maybe say, 
no, we’re not going to come again because there isn’t a good service. 
(32, F, A, ET) 
JD:  What do you expect them to do if they find out there’s a problem with 
you? 
R:  In the time that I’m here and they maybe find out that there’s a problem 
with me, then I would prefer that SATVI’s doctor refers me and then I will 
go to a private doctor on my own.  But I don’t have a desire to go to GGS 
[Worcester CDC], you understand. Okay, sometimes there are doctors who 
you feel safe to talk to, but at other times there are sisters who just…how can 
I say…look, here at SATVI, you feel free to talk and to ask questions, but 
there you don’t feel…because you don’t know…I can ask the sister a question 
and she will explain it to me, and then the other sister comes in and this one 
just starts to unpack…and some of them are very impatient and rude.  They 
don’t appear to be willing to help you.  Then they will just tell you, go over 
to **, or they will refer you to somewhere else.  Very often they are impatient 
with you. 
(33, F, A, ET) 
Conducting research on patient experiences of public clinics in the eThekwini district of 
South Africa, Sokhela and colleagues (2013) found that patients could accept the 
inevitability of long queues in the clinics on the condition that they were treated 
respectfully and kept informed and ‘in the loop’. Paraphrasing Leebov (2009), they argue 
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that “communication by nurses has the greatest impact on how patients evaluate their 
experiences” (Sokhela et al. 2013, p. 7; see also Walker & Gilson 2004; Gilson et al. 
2005). This says much about the kind of care that people would like to receive in the 
government clinics. The way in which people are asked to make decisions for themselves 
in research settings has been shown to result in tensions in some contexts, for instance in 
Sri Lanka (Sariola & Simpson 2011). However, in a context where people did not feel 
that they were deemed worthy of participating in their own health, the novelty of having 
everything explained to them and being asked to take part in decision-making was 
received warmly.       
 There was, however, also value placed on knowing when not to communicate. 
Above I suggested that one of the reasons that people feared the government clinics, 
especially Empilisweni, was the publicity of medical information. It was also felt that in 
the government clinics, the appointments themselves were not confidential. One woman 
explained to me how she felt that appointments occurred in Worcester CDC, comparing 
this with the confidentiality at SATVI:   
You talk to the sister…there are two sisters…you talk to the one about what 
your problem is and why you are there.  Now, at that moment I’m a patient. 
Then she talks to you about what the other sister said, and then she talks to 
according what’s in my file, I can call it, and then she shares this with you.  
But here are other patients as well, do you understand, and they are just 
talking amongst each other about this patient. And I’ve heard about this many 
times, they talk amongst each other about the patient, yes, she’s got this and 
that wrong with her.  But here, I can talk to the doctor and he keeps it to 
himself.  Do you understand, it’s private.  I’m sitting with him on my own.   
(33, F, A, ET) 
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Understandably, this was also an important concern for the mothers in the HIV-Exposed 
Infant Trial, all of whom were HIV-positive: “By die kliniek voel dit nie vir my dis veilig 
nie. Hier voel dit vir my dis veilig want wat ek sê of wat uitkom sal net hier bly. (At the 
clinic, I don’t feel safe. I feel safe here because whatever I say or whatever comes out 
will just remain here) (F, A, HIV-EI). This participant’s use of ‘safety’, a term often used 
in relation to physical threats, is a powerful way of expressing how profoundly vulnerable 
and exposed people felt in the government clinics. SATVI’s trials, rather than something 
which people are vulnerable to as bioethical literature suggests (e.g. Kipnis 2001; Lott 
2005; Horn 2007), might actually be one of the only places people felt truly safe, allowing 
them to avoid, if only partially, some of the perceived indignities of receiving ‘care’ from 
the state. Between the inscrutability of the waiting environment (see above) and the closed 
doors of study consultations, the privacy and confidentiality afforded by SATVI’s trials 
were amongst the most important reasons that residents highly valued the institute as a 
health setting.   
Diagnostics and Follow-Up 
So far, this chapter has explored why it was that SATVI was viewed as a preferable space 
to check one’s health without taking into consideration the kinds of diagnostics that are 
conducted during SATVI’s trials. One reason for not addressing this earlier is that, as I 
will suggest, matters of medical resources and expertise were very difficult to disentangle 
from the issues of the relational aspects of care that have been discussed above. This came 
out very quickly during interviews with participants. There was a feeling among many 
that, if they went to a government clinic for medical attention, then they were likely to 
just be sent away with paracetamol or aspirin. The implication was that they were not 
cared about enough to warrant the kinds of thorough medical tests and examinations that 
were needed to determine that they were sick and needed treatment:  
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JD: Why don’t you like going to the clinic? What are the good and the bad 
things that you have experienced there?  
R: Uya e-clinic, ukuba uyile, ufumana iPanado, ukuba uyile ufumana i-
Disprin, so hayi suka! (You go to the clinic, if you go, you get Panado 
[paracetamol], and if you go you get Disprin [aspirin], so no go away!). 
(27, M, X, ET) 
Another vividly expressed that you would see people who needed to be sent straight to 
hospital but, rather than calling an ambulance, were just given “pills”:   
JD: So what do you think, you mentioned some of their kind of whatever, 
what do you think are one of the main problems with Empilisweni or the good 
things or the bad things about the clinic there?  
R: There’s a people that are so very, very, very ill, sickly, they come to 
Empilisweni, give you pills, another people they are falling down when they 
comes out in the gate.  
JD: Hmm. 
R: They must know to call an Ambulance. There is no Ambulance there. 
(40, M, X, ET) 
There was, therefore, a feeling of being brushed aside. SATVI, by contrast, was perceived 
as a space in which comprehensive diagnostics were performed, not only at screening – 
although this was the point at which people were generally most concerned about diseases 
that might be picked up – but also regularly throughout trials. This involved everything 
from simple observations (weight and blood pressure) to high-end diagnostics (e.g. blood 
tests for liver and kidney function) that would not routinely be performed in the 
government clinics, as well as guaranteed examinations by a medical doctor. Professional 
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nurse Lorna gave a sense of the array of tests and examinations:      
They love to join SATVI, because they know that for the first day they’re 
being paid, but for the second they’re also doing all the tests and stuff – liver 
functions, full blood count, HIV...And a doctor’s examination, they have to 
sit with them before they start on treatment. They do a full history as a part 
of this. Here we don’t have a problem with people saying no. To get a blood 
test through the clinic, you need to have a very specific problem before they’ll 
do that. In the adolescent study, for instance, they are not just doing the 
vaccine, but also a load of tests to see whether they are generally well. The 
difference between the SATVI participant and the non-SATVI person is that 
they know what’s going on with their health. The other is not up to date – 
even the urine samples...they pick stuff up at an early stage and can be 
referred for treatment. 
Participants mentioned many of the diagnostic services described by Lorna and more 
when they expressed the medical benefits of the trials. One participant, for example, said 
that if she were to visit a government clinic, she might only get to see a nurse, whereas at 
SATVI she would see a doctor. Thus, whereas at the clinic she might be quickly sent 
home again – as others suggested above – SATVI would be more thorough:      
JD:  Would you rather hear about your health here at SATVI than, say, at the 
clinic or the GGS40 or wherever you go?  Would you rather hear about your 
health here? 
R:  Yes, for me, I feel more comfortable here…Here, it’s a lot better for me 
and a lot safer.  Because sometimes, the clinics out there, they don’t do what 
they are doing here with you.  Sometimes, there they only take **[possibly: 
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‘tests’] that’s done already.  Here, at least you see a doctor and you explain 
to him.  He asks you questions.  Sometimes, there you don’t see a doctor.  
You can only just see the sister.  Then she says, okay, your blood pressure is 
fine, you can go home.  But here you can see the doctor and you can talk to 
him and tell him how you’re feeling and so on.  I feel more safe here, here at 
SATVI.34 
(33, F, A, ET) 
In addition to the medical expertise of doctors, participants also had much faith in the 
blood tests to identify any diseases: “They check your blood every time”, one man noted. 
Indeed, in the previous chapter, following Carsten (2013a), I characterised blood as the 
“stuff of truth”, the tests sensitive enough to offer a window into their lifestyles beyond 
the confines of the trials. Between the availability of doctors and the sensitivity of the 
blood tests, there was therefore a far greater confidence in the diagnostic competency of 
SATVI, in contrast to the feeling that the government clinics might just send them away.  
 Some people would have a medical condition diagnosed at screening and were 
therefore referred to their local clinic for treatment (see next section). But for those who 
were enrolled into the trials, people also drew attention to the fact that they would be 
continuously monitored throughout the trials for signs of TB and other diseases 
(Zvonareva et al. 2014). As we saw in the previous chapter, this was not a passive exercise 
in waiting for the inevitable (cf. F. Ross 2010 Chapter 7), and in fact, as we saw, the 
monitoring process was used in creative and unexpected ways. Nonetheless, participants 
derived great comfort knowing that, if they developed TB or another disease during the 
study, then SATVI would soon tell them about it. Through the government facilities, by 
                                                 
34 Again, this notion of feeling “safe” at SATVI appears in people’s narratives, contrasting the 
institute with how they felt in the government facilities.  
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contrast, they were worried that disease would not be picked up nearly as quickly: 
What I’ve realised is that if you are in this study and you get TB during this 
time, then it can be picked up easily and you can be helped.  So your TB can 
be cured and you will receive any medical care for it.  So for me this is a 
wonderful opportunity, and even for the community of Worcester and the 
towns surrounding Worcester, we are given a great opportunity from SATVI. 
So this is what SATVI put in. I’m also a community person and I would like 
to give.  I’ve also studied home-based care. That is my field actually, but 
now… 
(40, F, A, ET) 
JD:  So do you feel safer from TB, now that you are a part of the study? 
R:  I feel much safer. 
JD:  Why is that exactly? Now that you are part of the study, what do you 
think SATVI will help with? 
R:  You see, if I get TB now, I know that SATVI will tell me.  But if I go to 
the hospital or to a doctor, they will just tell me there’s nothing wrong, you’ve 
only got bronchitis or something like that. Then by the time they find out I’ve 
got TB, then the TB would have gone to the next level. You see, that’s why. 
(34, F, A, ST) 
There really was some truth to this, as I will suggest in the next chapter. Of course, the 
follow-up process was directed towards proving the efficacy of a new TB vaccine as much 
as it was for the health of participants. In fact, as was noted in the description of the trial 
protocol above, there was a sense in which TB cases were actually desired (in the control 
group), for without these diagnoses a vaccine’s efficacy cannot be proven. Nonetheless, 
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the fact that participants were regularly monitored for signs of disease was taken by many 
participants as a demonstration of just how much they cared. One participant, suggesting 
that there was “no care” in the clinics, said of SATVI: 
JD: Did you decide it was better for your child to hear about his/her health 
here at SATVI than at the clinic?  
RF: Ewe. (Yes). 
JD: Okay, why is that? 
RF: Ingxaki iclinic yethu ayina hoyo kakhulu mandivele ndithethe nje nyani. 
So ndabona apha ukuba umntu uhoyo likhona. Nalanto ixesha elinizi 
uyafowunelwa ubuzwe ukuba umntwana unjani. (The problem our clinic has 
no care, let me just tell the truth. So, I noticed that here for a person there is 
care. Even that thing for a long time you receive a call and you are asked how 
is the child). 
(F, X, HIV-EI) 
Referral into the Health System 
In the event that a medical condition was diagnosed during a vaccine trial, participants 
were referred to their local clinic for further diagnostics and potential treatment. 
Depending on the nature of the vaccine trial and its requirements, this might or might not 
have entailed exclusion (certainly a diagnosis of active TB would entail exclusion).  
Participants were, with one or two exceptions, well aware that SATVI’s capacity to help 
them was limited to diagnostics and referral. Some suggested that they had no 
expectations of SATVI after the moment of referral: “Hulle sal vir my sê ek moet kliniek 
toe gaan. En ek sal mos nou dadelik gaan want ek het mos nou by hulle uitgevind (They 
will tell me when to go to the clinic. And I will go immediately because I found out from 
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them) (24, F, A, ST). Others, as Barsdorf et al. (2010) found in KwaZulu-Natal, said that 
they thought that SATVI should help them to secure treatment at their clinic: 
JD:  If SATVI were to find out that there’s something wrong with your health, 
what would you expect them to do? 
R:  They must help me.  They must say to me, right, we see that this is wrong, 
and we are going to help you and phone these people.  So if that person comes 
with a problem, then they must be keen to help.  So they will make it easier 
for me because SATVI will phone those people and those people will know 
about me, I can get an appointment and go to them.  I can go on such and such 
a day and they will help me. 
(44, M, A, ET) 
People therefore did not see SATVI as a replacement for the government clinics, with 
SATVI taking responsibility for their health from the moment they entered a vaccine trial. 
‘Therapeutic misconception’ would therefore be a very misguided characterisation of the 
way in which SATVI featured as a health space (Geissler et al. 2008; Kelly 2011; Leach 
& Fairhead 2011). Rather, SATVI was being appropriated as a ‘first point of care’ of sorts 
to potentially avoid some of the more deplorable factors that people associated with 
accessing care in the government clinics.  
 The referral letters take on particular significance when we take into consideration 
the fact that people felt that they would likely be turned away from the clinics with only 
paracetamol or aspirin after only trivial examinations had been conducted. Whyte (2011), 
based on her work in Uganda, draws attention to the materiality of paper in medical 
research and the ways in which it acts as a “material token” for access to healthcare. 
Referral letters from SATVI, bearing definitive test results alongside the institute’s 
insignia and the signature of a researcher, were unsurprisingly viewed by participants as 
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legitimating claims to healthcare that might otherwise be denied to them. I reserve a more 
detailed exploration of the mechanisms of referral until the next chapter, where we will 
see that participants’ expectations that SATVI could help them enter the health system 
were not unfounded. However, at the same time we will see perspectives from both 
SATVI and government clinic nurses that depart from the self-imaginings of participants 
as responsible, health-seeking individuals. Suffice it is to say at this point that SATVI has 
rerouted pathways to care into a health system experienced as inhospitable and degrading.   
Conclusion 
The expanding body of social science literature on clinical trials demonstrates 
convincingly that the orientation of medical research towards the production of 
knowledge does not amount to the stripping away of care and that, to the contrary, 
research can engender novel possibilities for care that are preferential in certain respects 
to accessing healthcare in ‘normal’ healthcare settings (Fisher 2009; Petryna 2009; 
Timmermans & Mckay 2009; Zvonareva et al. 2014). The appeal of research participation 
is, understandably, heightened in contexts where government healthcare provision is 
severely compromised, as it is in the majority of African nations (Geissler et al. 2008; 
Nguyen et al. 2007; Barsdorf et al. 2010; Nguyen 2011; Kamuya et al. 2014).  
 In this chapter, I have contributed to this literature by drawing attention to the 
comparisons and connections that participants drew between SATVI and the government 
clinics. Various factors made SATVI attractive as a health setting, including shorter 
waiting times, high-end diagnostics, the presence of doctors and facilitated healthcare. 
But as I hope to have shown, the most important reasons that participants preferred 
SATVI as a health setting had to do with the relational dimensions of care – that 
participants felt valued, respected, included in medical decision-making and generally 
treated as equals. It must be noted that dignity, respect and inclusion are clearly 
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underscored into the Patient Rights Charter (1996), a document which is meant to 
engender a clean break from the exclusions and inequities of the apartheid health system 
(see Chapter 4). Yet, the reality today for the majority who are reliant upon the state for 
healthcare is a health service that is experienced as inhospitable, authoritarian and often 
degrading. In the fervent critique of neoliberalism in healthcare, it is rare to hear notions 
such as ‘choice’ and ‘autonomy’ being associated with care (Fisher 2007; Mol 2008). 
However, when SATVI’s trials are viewed against the backdrop of the post-apartheid 
health system – and the way in which people are reconfigured from abjects into 
‘universal’ human subjects (Sariola & Simpson 2013) – it is perhaps unsurprising that 
such notions might carry some appeal. Indeed, whilst SATVI considers itself to be outside 
of the health system, the practices and protocols that are designed to maintain this distance 
are part of the reason the institute is so deeply embedded within it, offering participants 
an approximation of the kind of treatment that they feel entitled to as citizens of post-
apartheid South Africa.   
 The findings presented during this chapter, especially the reflections of participants, 
easily apportion blame to government nurses, casting them as rude, uncaring and 
authoritarian. One of the implied solutions to such attitudes is to retrain them in the ‘softer 
skills’ of patient management – which, it might be added, was beginning to happen during 
the year of my fieldwork. But an important reason why Chapter 4 focused upon the 
perspectives of nurses was to ward against easy solutions such as this. There, I argued 
that the nurses’ patient-blaming and practices of scolding were due to their having to 
manage a fundamental dissonance between the theory and reality of TB control, itself a 
function of a chronic lack of public spending on healthcare (Compion 2008). The fact that 
residents are clearly not as ‘irresponsible’ and ‘uncaring’ as their stereotype suggests does 
little to change the grievances of the government clinic staff. Rather, that government 
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clinic staff and the people they serve harbour such animosities towards one another 
testifies to the power of the neoliberal language of ‘patient responsibility’ to deflect 
attention away from structural determinants of both disease and under-resourced 
healthcare facilities. This chapter has shown how SATVI features in this unstable and 
divided healthcare landscape as a partial alternative to the government clinics. The next 
chapter, meanwhile, examines how the institute can appear from another angle as part of 
state governmentality.  
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Chapter 8: 
“We Don’t Treat We Refer”: Sovereign Responsibility 
and the Transition from Participant to Patient 
“Next!” Upon hearing Nurse Jacob’s call, a skinny, bedraggled-looking man in his early 
thirties walked into the TB department of Empilisweni clinic. The man sat down, leant 
across the desk and handed Nurse Jacobs a letter. She took it, looked down and read it in 
a manner that suggested she had seen many like it before. It was a letter of referral from 
SATVI. Worded in polite language, the letter said that the man had been screened to 
participate in a vaccine trial but that the tests and examinations had revealed an abdominal 
abnormality which could be disseminated TB. The letter therefore advised that the clinic, 
as his healthcare provider, run further diagnostics.  
 Nurse Jacobs, looking up, was immediately cross with the man. This was because 
he had already been in the TB room with the same letter the previous week. Upon the 
recommendation of SATVI, they had booked him an abdominal scan at the hospital for 
yesterday – but he had not attended. Nurse Jacobs was cross not only because he had not 
turned up, but because it would be several days before he could have another done. She 
gave him a long, hard stare from across the table before saying to him sternly: “You were 
not here yesterday. I’m going to book you another appointment for Monday. Don’t 
forget”. He nodded and looked down. She picked up the phone and dialled.  
 While nurse Jacobs was on the phone, I had a brief conversation with the man 
from my position seated at the edge of the desk. His responses revealed experiences of 
trial participation that are similar to many of the other residents who appeared in the 
previous chapters. He told me that SATVI’s fieldworkers had visited his home, where he 
lived with his sister and her two children. Both he and his sister were interested in taking 
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part in the vaccine trial for which they were recruiting. After the fieldworkers had 
explained to them the inclusion and exclusion criteria, his sister was immediately deemed 
ineligible because she had high blood pressure. He, however, had not been diagnosed 
with anything – although, he expressed to me, he was not feeling well – and was booked 
in for a screening visit at SATVI’s site at the hospital a few days later. I asked him why 
he had decided to take part, and he cited a number of factors. He said that he was first and 
foremost worried about a pain in his chest and had gone to SATVI with the expectation 
that, as he put it simply, “they will help me”. Moreover, he said that “I want to donate 
blood”, quickly adding, “I like to donate blood for the people who need”.  
Having found out at SATVI that he might not be healthy, he said that he was very 
concerned to get the problem resolved as soon as possible. However, he was not currently 
working. The reason that he did not attend the scan the previous day was that a potential 
job opportunity had arisen and he simply could not afford to pass it up. Therefore, he had 
attended the clinic first thing today instead. At the same time, he was in a bit of a hurry 
to get away again, as SATVI’s fieldworkers were due to return to his house today to give 
him the results of the additional blood tests they had run as part of screening. He was, it 
seemed, still hopeful that he could participate in the study. Yet of course, he would also 
need to show them the results of the scan. Knowing that I was working with SATVI, the 
man asked me in a worried tone, “what must I tell them [SATVI]?” At this point, Nurse 
Jacobs had gotten off the phone and heard the last part of our exchange. She was suddenly 
even more cross with him. After having words with the man, she turned to me and 
exclaimed, “you see, now he’s in a hurry because SATVI are going to pay him! 
This final ethnographic chapter completes our exploration of SATVI’s vaccine 
trials by focusing upon what occurred in the frequent event that a participant was 
diagnosed with TB or another medical condition, which could happen almost anytime 
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between screening and end of study visit years later. SATVI, as observed earlier, does 
not provide any treatment for diagnosed conditions during vaccine trials (cf. Geissler et 
al. 2008; Leach & Fairhead 2011). Rather, as is common in South African research 
contexts, where government healthcare provision is comparatively strong in relation to 
other parts of Africa, SATVI refers participants onwards for treatment, usually to their 
local government clinic (Barsdorf et al. 2010). The act of referral can be read as a status 
transition from ‘participant’ to ‘patient’, visibly enacting the differential responsibilities 
of research institutes and government healthcare providers. This not only upholds the 
sovereignty of the government in providing care for its citizens but moreover partially 
sidesteps the possibility of ‘therapeutic misconception’ that emerges when healthcare 
delivery more explicitly spills over into production of bioscientific knowledge.  
 The picture that I began to paint in the previous two chapters, however, was that 
despite the image of distance and objectivity, SATVI has become intricately entwined in 
the local context of health seeking and delivery. Chapter 6, especially, highlighted that 
participants perceived the institute as a safe, respectful and caring environment in which 
to undergo routine diagnostics and, moreover, a preferable point of entry into what was 
perceived to be a hostile and often degrading healthcare system. SATVI was, in fact, 
viewed as almost the diametric opposite of the government clinics, with its identity as 
separate from the state integral to its emergent healthcare role. This chapter examines 
SATVI’s effects on the landscape of primary healthcare from another angle and emerges 
with a different ‘version’ of its contributions. Focusing upon the institutional 
relationships between SATVI and the government clinics, the chapter asks: in what ways 
have SATVI’s trials stepped into the work of TB control? How did the government clinic 
staff perceive the flows of patients from SATVI to their doorsteps? How was 
responsibility for participant patients allocated and enacted? I draw upon the notion of 
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“sovereign responsibility” developed by Hannah Brown (2015) as a way of thinking 
through the complementarities, ambiguities and tensions that exist at the border between 
research and care.  
 I will show that SATVI’s research staff, especially nurses, were highly conscious 
of the institute’s superior resources and, as a result, in their communications with 
government clinics (both via referral letters and speaking directly), were conscious to 
display humility and deference to them as participants’ rightful healthcare providers. 
However, the institute’s incursions into everyday healthcare provision were difficult to 
ignore, in some cases challenging the sovereignty of the clinics, particularly by seemingly 
offering competing services and being seen to ‘pay’ their participants (as seen in the 
above vignette). Nonetheless, SATVI’s trials were, on the whole, valued by government 
clinic staff because they functioned to extend the state’s reach into hard-to-reach 
community settings via their mobility in low-income suburbs (see Chapter 5). Moreover, 
SATVI’s researchers were seen to actively survey participants during trials and place TB 
cases on the clinics’ radars when positive diagnoses were made. Responsibility for TB 
cases diagnosed by SATVI was ambiguous, however, especially in the event that 
participants did not promptly seek treatment and threatened to disappear from view. By 
showing how these responsibilities were worked out in practice, I suggest that the 
transition from participant to patient in the act of referral is a ‘bumpy’ one, leaving many 
grey areas for those who had to balance a sense of responsibility towards trial participants 
with the delicate relationship with the government clinics.  
 It might be noted that the ‘version’ of SATVI’s emergent role in healthcare 
presented in this chapter differs somewhat from that which emerged primarily from 
participants’ perspectives in Chapter 7. Whereas participants tended to view themselves 
as responsible, health-seeking citizens, this version involves a greater scepticism among 
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both research and clinic staff that participants always acted in the best interests of their 
health, especially when it came to a diagnosis of active TB. In fact, the governmental 
stereotype of the ‘irresponsible’, ‘uncaring’ TB patient which we have encountered time 
and again was frequently activated and placed over sick individuals. This chapter 
therefore ends the ethnographic chapters on a sobering note, reminding us of the limits of 
people’s abilities to cast off the structural violence that shapes them and underscores the 
magnitude of the challenges facing the health system in post-apartheid South Africa. I 
will not try to suggest that either the account presented here or in Chapter 7 is ‘correct’ 
or closer to the ‘truth’. Rather, I contend that these diverging accounts show just how 
messy and divisive the TB epidemic is and how complex research institutes’ 
entanglements in healthcare can be, lending themselves to multiple and conflicting 
interpretations.  
Partnerships with Healthcare Facilities    
When clinical trials are conducted in resource-poor settings, substantial investments are 
often needed to support not only research centres but also government facilities involved 
in research. The superior resources that arrive on the back of trials are thus often highly 
visible and rendered side-by-side with normal healthcare provision. Despite the 
significant differentials in power and resources between research institutes/sponsors and 
host-country healthcare facilities, the relationships between them are, as Geissler (2013, 
p. 17) observes, framed within the language of collaborative partnership: “The language 
of collaborative partnership, compounded by the fictions of official government policy 
and those of the global development partners, insists that these different medical 
institutions and the clinical practitioners inhabiting them engage as equals”. The 
resources that are channelled into government healthcare facilities are thus theoretically 
regarded neutrally—or, if anything, as a “mere complement” to existing services (ibid, p. 
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22). The ethical framing of the relationships between medical research institutes and 
government facilities is thus very similar in kind to that between researchers and 
participants, that is, premised upon the ideals of autonomy and material independence 
(ibid, p. 18).  
 Based on ethnographic research with a team of district health managers in Kenya, 
Hannah Brown (2015) challenges the notion of equal partnership in global health. The 
multiple international NCGs that funded treatment programmes in the region were, 
theoretically, at the service of the state – they “‘supported’ programmes that the Kenyan 
government ‘implemented’” (2015, p. 342). Such relationships were often talked-up by 
the NGO representatives themselves as they sought to solidify their positions. However, 
in practice these relationships were more complex, because the NGOs had a vested 
interest in demonstrating the success of programmes. While the diverging imperatives 
and jurisdictions “were at times complementary”, these distributed and ambiguous 
jurisdictions often the resulted in “struggles over sovereignty” as NGOs and the managers 
asserted their managerial rights over health programs (ibid, p. 341). Brown calls the space 
in which the transfer of resources from sovereign to citizen are organised one of 
“sovereign responsibility” (ibid, p. 340). Under-researched in anthropology, this 
conceptual space is useful for shedding light on the pluralistic forms of governance that 
characterise neoliberal Africa and the workings of global health partnerships.   
 Complementarities and contestations in sovereign responsibility are implicit in a 
number of studies that have focused upon how clinical trials impact upon routine 
healthcare provision when they are conducted within government facilities. One of the 
main ways in which trials have been shown to be experienced positively by facility staff 
is through various ‘secondary benefits’ that accrue from trial-related activity. That is, 
benefits not due to the experimental interventions themselves but rather the operational 
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conduct of the trials. This includes things like improved service delivery, training for 
healthcare staff, additional transport services, and healthcare infrastructure (Sariola & 
Simpson forthcoming; Petty & Heimer 2011; Crane 2013; Geissler 2013; Liheluka et al. 
2013; Tinto et al. 2014; Angwenyi et al. 2015). At the same time, however, clinical trials 
have also been seen to overstep their remit, with detrimental effects on healthcare. For 
instance, they can result in differential access to services for patients, siphon off staff, 
interrupt healthcare delivery and bring about uncertainty as to what will happen when the 
trials end (Angweni et al. 2015). Given the severe underfunding of government healthcare 
in many trial locations, the resources that arrive on the back of clinical trials are usually 
appreciated more than they are resented. Nonetheless, positive perceptions no less than 
negative ones question the ideals of ‘collaborative partnership’ and should arguably be 
viewed with a critical eye to obligations and expectations generated in unequal 
encounters. 
 Understandably, studies of government staff perceptions of clinical trials have 
tended to focus upon research conducted within healthcare facilities – on “how research 
reshapes clinics”, as Petty and Heimer (2011) put it. As observed above, however, in 
South Africa it is common during preventative trials for research institutes to refer all 
diagnosed cases to government facilities for treatment. Barsdorf et al. (2010), in one of 
the only studies to date with a focus upon such systems, show that participants and facility 
staff thought that researchers have some form of obligation to participants beyond the 
moment of diagnosis and should, for instance, “help participants to access” treatment. 
Yet, this says little about the relationships between research institutes and government 
facilities that are attendant upon the process of referral, especially in the context of a 
disease as challenging and divisive as TB. In the following exploration, I will further 
Brown’s (2015) notion of sovereign responsibility by shedding light on how 
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responsibility is allocated, managed and transferred between SATVI and government 
clinics. Importantly, we will see that while SATVI and the clinics were in almost absolute 
agreement as to who was responsible for what, the key dynamic throwing up questions 
of responsibility was the seeming unwillingness of people to act in the best interests of 
their own health and that of others (see Chapter 3). I thereby further Brown’s analysis by 
showing that questions of sovereign responsibility can emerge not only because of 
competing interests between state and non-state institutions but because the subjects of 
research and care do not always follow the ‘script’. 
Refer not Treat, Advise not Prescribe  
In Chapter 5, we saw how SATVI’s nurses, within a different kind of relationship with 
participants than in ‘normal’ healthcare settings, treated them as autonomous, 
responsible, health-conscious and community-minded individuals. This way of being 
treated, which was a novelty to many participants, was one of the most important reasons 
why they saw SATVI as a safe, caring environment in which to have their health checked 
and a preferable point of entry into the health system were anything diagnosed. However, 
several research nurses did harbour the worry that, with them being so ‘nice’ to 
participants, in conjunction with the other ‘luxuries’ of the research environment (e.g. 
transport, food, money), some participants would be more reluctant to trade this for their 
local government clinic when a diagnosis of TB or another medical condition was made. 
In this regard, the common expression, “we can’t treat we must refer”, was not only 
uttered with resentment of their limited capacity to help; it was also a reminder to 
participants and indeed themselves that, if a medical condition was diagnosed, 
participants had to be able to seek out treatment by themselves. Study co-ordinator 
Monique, for instance, said: “you need to refer them or make them responsible for taking 
this further, that’s all you can do…we’re very careful about not carrying the participant 
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– don’t give them too much”. 
 Referrals took the form of a letter bearing SATVI’s insignia and address at the top. 
For ease of use, a template was usually typed up in advance of any given study, and all 
the author had to do was fill in the gaps with necessary details (Figure 13). The 
responsibility for referring a participant ultimately fell to the principal investigator. 
However, exactly who composed the letter depended upon the nature of the trial and the 
specifics of the diagnosed condition. In infant trials, for instance, it might be the principal 
investigator who examined information from the field and decided if they should be 
brought in for diagnostics, but from the moment they arrived, Brewelskloof Hospital’s 
paediatrician Dr Gilbert took charge. Upon examination, he would either discharge 
infants or refer them using a SATVI-branded referral letter. In particularly severe cases, 
they might be admitted straight to Brewelskloof Hospital. In SATVI’s adolescent and 
adult trials, where the hospital’s doctors were not involved, it still did not have to be the 
principal investigator who composed the letter. Instead, it could be delegated to the study 
co-ordinator or a professional nurse (but never enrolled nurses or fieldworkers). 
Generally, one copy of the referral letter was handed to the participant to take to their 
local clinic and another was faxed through to their local clinic. But because of the 
infectious nature of TB, when participants were diagnosed, a case notification was also 
faxed through to the Department of Health.     
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Despite the international medical resources and expertise at SATVI’s disposal, the 
referral arrangement was such that the moment participants were referred to the clinics, 
the state’s protocols had complete authority – and referral letters were designed to reflect 
this deference. A primary marker of respect, I was informed, was that upon diagnosing a 
medical condition, the referral letter should advise not prescribe what should be done. As 
seen in Figure 13, the referral is generally phrased in the following way: “At 
screening/follow-up was found: …[insert test results]… Please could you assess the 
participant, and refer him for further treatment, if necessary”. Humility was especially 
important when participants were sent having undergone tests that the clinics do not have 
the resources to conduct and that threatened to reveal a resource ‘gap’. Dayna explained 
Figure 13: Typical SATVI Referral Letter 
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this to me using the example of the quantiFERON blood test for latent TB: 
We can’t force ourselves on the health service…Let’s say a participant is 
quantiFERON positive…So we would write a referral letter to the clinic 
saying, “this participant is taking part in this study, one of the criteria was that 
we did the quantiFERON test, which came back positive. That is a marker for 
IPT [isoniazid preventative therapy]. Could we please advise you to work 
according to your programme?” So, we’re not going to say, “you have to do 
the IPT [isoniazid prophylactic therapy]”, rather “we advise you to work 
according to your IPT programme”.35 
Although deference to the authority of the state was written into trial protocols, I quickly 
found that SATVI’s nurses, particularly those who had previously worked in government 
clinics, fully supported this stance towards the clinics. This was because they knew the 
hierarchical nature of the healthcare system and the respect that one was expected to show 
towards their superiors. Thus, they were aware how badly referrals could be received if 
they were perceived to challenge the authority of existing power structures. If anything, 
the notion of ‘collaborative partnership’ that tends to frame the relationships between 
research institutes and public facilities in the transnational research enterprise (Geissler 
2013) conveys too much power to SATVI when it came to everyday interactions with the 
clinics. Monique, for example, expressed to me that whenever engaging the clinic staff, 
especially when visiting the clinics personally, one had to place oneself at the very bottom 
of the pecking order to receive their attention. As she put this, “you have to make yourself 
so small, smaller than the patient”. It might be noted that this act of ‘lowering’ oneself 
                                                 
35 Isoniazid is one of the first-line drugs for the treatment of TB. However, it is also used as a 
preventative drug for young children who have been in contact with a TB patient. Isoniazid 
preventative therapy (IPT) is a six-month regimen, as with TB treatment.   
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was observed in Chapter 4, where the fieldworkers attempted to construct a meaningful 
environment for the consent process in the houses of Worcester’s poorest.  
  What SATVI’s staff had somewhat less control over was how their participants 
acted when they were referred to the government clinics. This also had the potential to 
challenge the sovereignty of the clinics in a similar way to how research staff acted. I was 
speaking to Anna, a research nurse who had worked at Worcester CDC during the BCG 
trial and recalled when participants first showed up on their radar:  
Right in the beginning, the relationship wasn’t so good. Some of them didn’t 
introduce research so clearly to our people. Now they just hear there’s blood 
that they draw, money and that. And now they come to the clinics and they 
tell us “we can’t take this because we belong to SATVI” or “we can’t have 
this injection because we’re already at SATVI”. Then you must tell them 
SATVI isn’t a clinic, its only research. You must still come to our clinic…So 
it was our work, then, to go and sit and tell them you must still come to the 
clinic for your injections, your chronic medications. You are only taking part 
in a study of SATVI. They think they can leave us because they are with 
SATVI now. 
Feelings on the part of participants of ‘being with’ research institutes have been observed 
in research contexts elsewhere in Africa, especially where routine healthcare is offered as 
part of trial participation (e.g. Geissler et al. 2008; Leach & Fairhead 2011). But this, as 
we can see, was considered an affront to the authority of the clinics given that SATVI 
were supposed to stay clear of this domain. The findings presented in Chapter 7 suggest 
that few participants today would consider SATVI to be a direct ‘replacement’ for the 
clinics. This is no doubt a result of considerable efforts on the part of SATVI’s staff to 
convey to participants that they can only refer them and to defer to the sovereignty of the 
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clinics in this regard. Nonetheless, as we also saw in Chapter 7, and will see in this chapter 
from a different angle, SATVI’s resources continue to exert considerable influence upon 
the local context of health seeking and delivery, particularly in relation to case finding 
and management, that no amount of deference, humility or distancing could entirely 
obscure.  
Clinic Staff Perceptions of SATVI 
When spending time with the clinic nurses in Worcester Community Day Centre 
(Worcester CDC), Empilisweni and De Doorns (especially their TB rooms), I was 
interested in how they perceived SATVI’s studies and how they affected their day-to-day 
work. I witnessed a few concrete examples – such as the vignette with which this chapter 
opened involving Nurse Jacobs – where participants came into the TB rooms bearing 
referral letters. But in fact, the nurses felt that the best way to give me a sense of SATVI’s 
effects upon day-to-day healthcare, especially TB control, was to find examples of the 
patient folders of participants. These stood out because, for ease of identification, 
‘SATVI’ was usually written in the top left hand corner. Moreover, often the first 
document inside – of which there could be many, including DOTS support documents, 
details of complications and non-adherence, and referrals to and from Brewelskloof 
Hospital – was the referral letter from SATVI that had brought them to the clinic the first 
place. Sister du Plessis estimated that, since she started her work with TB in 2009, 
approximately 10% of their caseload had come from SATVI, which reached a peak of 
around 20% during the latter stages of the large infant trial of the vaccine MVA85A 
between 2009 and 2012 (see Chapter 2). Given the nature of SATVI’s trials since 2001, 
the majority of the participants referred to them were infants and, of these, a large 
proportion were not actually sick but required isoniazid preventative therapy because they 
had been in contact with a TB patient. Nonetheless, with an increasing number of 
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adolescent and adult trials being run, referrals from these age groups were common too. 
 Although my ties with SATVI might have influenced them somewhat, the nurses 
generally had positive views of research staff, suggesting that the value placed upon 
deference and humility – making themselves “so small”, as Monique put it – had its 
intended effect. Nurse Jacobs, for example, said:  
They really try to be humble when they come in. And they wait for their 
chance to knock. Nobody behaved rudely that I know of, or don’t want to 
wait.  Because when they are coming in here they wait. They ask for 
something, and then we can’t help them that morning. And they’re not only 
bang in here.  
They also did not see the referrals sent from SATVI as a burden upon them. For instance, 
I asked the facility manager of De Doorns clinic whether she considered SATVI’s trials 
to give them “extra work”, to which she replied: “No, not really. In fact, I see that as our 
patient, and we need to render a service on a daily basis to that patient”. There was even 
a feeling that SATVI were more respectful when referring participants to the clinics than 
other referring institutions were (e.g. secondary hospitals), which were sometimes 
perceived as ‘dumping’ patients upon them: “They just say, go to the clinic, go to your 
nearest clinic, that’s all they tell them”, as the TB clerk at Worcester CDC put it. In short, 
from what I could ascertain, there were no feelings among the nurses that I spent time 
with that SATVI’s staff were ever rude or disrespectful when interacting with the clinic. 
Whether it was because their ‘insider’ knowledge of the clinic power structures or 
otherwise, they were generally well regarded and were not considered a burden upon 
routine healthcare.    
 But at the same time, SATVI was not regarded as a neutral, distanced actor, a mere 
‘collaborator’ operating in the separate realm of research (Geissler 2013). Despite 
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conscious displays of deference by SATVI’s staff, the clinic nurses were under no 
disillusion that SATVI had command over greater resources than they and which 
impacted upon the local context of health seeking and delivery. From their perspective, it 
was SATVI’s high-resource environment that convinced people to join the trials, often as 
a partial alternative to the government clinics. Their reflections in this regard overlapped 
considerably with the findings presented in Chapter 7 (see also Barsdorf et al. 2011; 
Zvonareva et al. 2014). They mentioned the queueing: “They don’t want to sit in line. 
People get very impatient to sit in the lines” (Nurse Jacobs, Empilisweni). They 
mentioned perceptions of rude and uncaring nurses: “The people, when you ask them, 
they will tell you that they have this picture of nurses, if they miss only one date, then the 
nurse won’t help them” (Sister Harmse, De Doorns). They were also aware that people 
were terrified of the stigma associated with HIV and which SATVI somewhat allowed 
their participants to avoid. Nurse Jacobs said to me:  
SATVI is more private. The people that are going into their houses, they don’t 
need…as I say, there’s a stigma if you go to room six. Then they know, oh, 
if you’re sitting by room six, then you are HIV-positive. But if they’re going 
into the houses they know, okay, they are busy doing a study on TB. There’s 
a difference. If they’re coming to the clinics, if you’re going in by that room, 
you’ve got HIV. 
Overall, however, they thought that monetary ‘reimbursements’ were the primary driver 
of participation in SATVI’s vaccine trials: “they give money for them and it helps with 
their needs” (Nurse Jacobs, Empilisweni); “they get R150, and then they do tests” (Sister 
du Plessis, Worcester CDC); and “money, usually money, because my friend is doing that 
now” (Paediatric Nurse, Worcester CDC).  
 While the significance of the money appears on first glance to be socioeconomic, 
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interestingly I found that it could contest the sovereignty of the clinics no less than 
‘alternative’ healthcare services. Firstly, the idea that SATVI were ‘paying’ their 
participants ran up against the way of thinking that the clinics strove to instil in 
Worcester’s constituents, that premised on ‘taking responsibility’ rather than incentive. 
This, as we saw in Chapter 4, had political inflections, with some nurses resenting that in 
post-apartheid South Africa people expected everything to be ‘handed’ to them, one of 
the reasons that the current model of healthcare relations does not function well. SATVI, 
therefore, sent the ‘wrong’ kind of message to the community they were trying to 
influence. Secondly, in terms of routine healthcare relations, when a participant entered 
a TB room bearing a referral letter, it could place a measure of doubt in nurses’ minds, as 
shown in the vignette with which this chapter opened involving Nurse Jacobs and her 
patient. Were they there out of genuine concern for their health or simply that they were 
afraid that, if they did not, they would lose out on their R150? “You see, now he is in a 
hurry because SATVI are going to pay him!”, was the nurse’s frustrated exclamation. In 
short, the shadow of SATVI always followed participants into the clinics. And any 
association with the institute had the potential to raise eyebrows as to what was motivating 
their appearances at the clinic and whether they would continue attending once the 
incentive was off the table.  
 Despite a degree of resentment and perhaps envy that SATVI had a greater ‘hold’ 
over the Breede Valley’s constituents than they, the clinic staff nonetheless thought that 
the trials made an important contribution to TB control. As I have begun to show already, 
this ‘version’ of SATVI’s healthcare role diverges from that which emerged in Chapter 6 
and involves a heightened scepticism among both research and government clinic staff 
that all of their participants were concerned first and foremost about their health. The 
following exploration is split into two partially overlapping sections: (1) community 
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presence and active case finding; (2) post-diagnosis management of participant patients.  
Community Presence and Active Case Finding 
In Chapter 4, I suggested that one of the main frustrations of the clinic nurses regarding 
TB control was that, despite the contributions of NGO-funded home-based carers, they 
felt unable to access and exert influence on Worcester’s low-income suburbs, especially 
Riverview, Roodewal, Avian Park and Zwelethemba – the TB ‘hotspots’. The feeling of 
confinement behind the walls of the clinics was felt particularly strongly by those nurses 
who had practiced during apartheid and where, although healthcare was highly 
inequitable (Packard 1989; Coovadia et al. 2009), for them it was a time of greater 
community presence and control. By contrast, SATVI was perceived to be an active 
presence in precisely these hard-to-reach areas. The facility manager of Empilisweni, for 
example, said to me that “they [SATVI] are not so much in the clinics. The place they are 
is mainly in the community”. Sister Kruger of Worcester Community Day Centre 
similarly said: “I see a lot of cars driving around in the community, visiting houses”. 
Nurse Jacobs, reflecting upon the poverty in which most TB patients live, commented 
that “they [SATVI] see the situation at the house and so on”. SATVI’s trials, in other 
words, led them to be an active presence in the areas that the clinic nurses wished they 
were able to exert greater influence.   
 But SATVI were not only active in these areas; the government clinic staff were 
also well aware that, once people had agreed to take part in a vaccine trial, they were 
screened for TB by the institute’s nurses and doctors and then regularly followed up 
throughout to determine whether they developed the disease. “They follow up that patient 
very well”, as Sister du Plessis explained. Although few of the clinic staff referred to it 
as such, what SATVI were effectively engaged in by screening and following up 
participants for TB was a form of active case finding. Active case finding is deemed the 
Chapter 8 
 
237 
 
appropriate standard of care for contemporary TB vaccine trials (Moyo et al. 2012), and 
involves actively searching for TB so that cases are picked up and picked up earlier, which 
gives participants a better prognosis. In fact, active case finding has recently been 
advocated by the WHO as a necessary component of TB control because, although 
passive case finding in conjunction with improved treatment has “led to substantial global 
progress” (Uplekar et al. 2013, p. 1248), passive case finding is thought to be incapable 
of detecting cases early enough to sufficiently reduce TB incidence (WHO 2013; see also 
Golub et al. 2005; Golub & Dowdy 2013; Uplekar et al. 2013). The problem for health 
planners is that wide-scale use of active case finding remains beyond the resources of 
most developing countries – South Africa included – and so passive case finding will 
continue to be the primary method of case detection for the foreseeable future. “Those 
are the resources that we don’t have, and will probably never have”, district manager Dr 
Van Zyl remarked.  
 While the government clinics did not possess these resources themselves, however, 
all TB cases that were identified during the trials were immediately referred to them, 
including their names, addresses and contact details. In my conversations with the clinic 
staff, they often compared and critiqued their own passive case finding strategies with 
SATVI’s capacity to conduct active case finding amongst their participants. The 
impression I got from the nurses and support staff was that the kind of individuals SATVI 
were referring over to them were those that they might not otherwise have seen – or at 
least, until a much later stage. For example, I was talking to the TB room clerk at 
Worcester CDC about the kinds of day-to-day knowledge sharing that SATVI and the 
government clinics engaged in:     
JD: So would you call it an exchange of data then? 
R: You could say that because they actually found the people. Sometimes 
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they did find the people and people that we ordinarily would not have found. 
Some patients we wouldn’t have found back in the areas where we don’t have 
a far-reaching…we can only reach the people closest to us. 
JD: People that come into the shores. 
R:  Ja. It’s difficult for us to go actually outside and actively search for 
patients.  So in a way they do give us data. Not the data that they do research 
on, but the basic data: the patient has got TB, this is his name and his surname, 
and then that is the address and you should follow up on him. 
For this TB clerk, SATVI had a greater ‘reach’ than the government clinics into 
community settings, and as a result they would often have TB cases on their radar that 
the clinics might not have otherwise, along with the “basic data” that would enable to 
follow up on the patients. A similar response came from Nurse Botha of De Doorns 
clinic’s TB room when I asked him whether he thought that SATVI and the clinics had a 
“complementary relationship” with one another:       
JD:  Would you say that it’s a complementary relationship with SATVI?  
R:  I think it’s a good thing because sometimes we don’t reach all of the 
patients.  And they will come and they will send a little baby, or they will 
come and say that they tested this child and he must go and do the screening 
there. 
Sister May of Empilisweni’s TB room, meanwhile, observed that SATVI’s staff did visits 
to Worcester’s schools to conduct a variety of screenings and follow-ups, something 
which she stated was beyond the scope of the resources of the government clinics:      
JD: Do you ever find it’s almost more work for you? 
R: Like they go to the schools. We don’t go to the schools. So they check the 
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children, and they find children of people that are supposed to be starting on 
TB treatment or ARVs or follow-ups.  So they’re doing a good job. 
When the clinic staff were reflecting upon the benefits of SATVI’s active case finding 
techniques, they were certainly concerned with the health of the patients themselves. 
However, from an epidemiological perspective there was also the infection factor: the 
longer patients remained undiagnosed, the more likely they were to spread the disease. 
Some of the clinic staff took this more distanced perspective and noted the advantage of 
SATVI’s active community presence upon infection rates. Sister Harmse of 
Empilisweni’s TB room, for instance, said to me that: “They pick up cases of TB and 
send them to us – we’ve had about three or four since October. They’re a very committed 
team. They pick up cases that are out there in the community, which is good because then 
they don’t infect everyone”.  
 Paediatric TB is less threatening from a public health perspective than TB in other 
age groups “because it is usually smear-negative and is thus considered to make a 
relatively minor contribution to the spread of TB” (WHO 2007, p. iv). However, TB is 
even more of a threat to infants than others: children under two years of age tend to be 
the least symptomatic and yet are at the highest risk of developing severe TB, including 
TB meningitis (WHO 2007; Hatherill et al. 2010; Bynum 2012). Dr Gilbert, 
Brewelskloof’s paediatrician, was therefore highly appreciative that streams of infants 
were brought within his reach by during SATVI’s infant trials:    
For their outcomes, it was good. We picked up some children that were so 
sick and weren’t at the clinic, but were sent here [the CV ward] first time, 
with active TB, so sick that I couldn’t send them home for their TB treatment. 
They must be admitted here [Brewelskloof]. Fresh from the street. 
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Whilst severe cases of TB were far from uncommon, as Dr Gilbert suggests, the aggregate 
effect of active case finding across study cohorts was that the kind of TB picked up tended 
to be mild and early stage. This might be contrasted with what was happening outside of 
the trial environment, where, because of the subtlety of symptoms and limited access to 
healthcare, cases tended to be picked up at a more advanced stage. In other words, the 
chances of survival were higher through being part of a trial. District manager Dr Van 
Zyl went so far as to say that SATVI, by identifying TB during vaccine trials, was making 
a “significant public health contribution”. 
 Speaking to both research and clinic staff, I also began to get a sense of the difficult 
social situations that could be encountered as infants and their mothers came to the trial 
site after TB was suspected and how tricky these were to handle. Nurse Botha of De 
Doorns clinic recounted one incident where they had a child who they wanted to send for 
X-rays with suspected TB. This child was also a trial participant, and in fact SATVI 
wanted to expedite the process to ensure the child was diagnosed as soon as possible. 
What struck me was the emphasis that Nurse Botha placed upon the mother’s motivations 
for taking the child to SATVI, given that she had missed several clinic appointments:   
I did have a patient, a mom with her child, and the child was supposed to go 
for X-Rays.  But that child was in the study.  So, they asked if they could 
come and get the patient and take the patient to X-Rays – but earlier. There is 
like a…we help each other…That mother, when she goes to SATVI they give 
her money.  So maybe she was like that, because she didn’t come on our dates. 
She thought we wouldn’t give her money, so she’s not going to go. 
Study coordinator Dayna further explained what happened when this mother brought the 
child to SATVI’s site:  
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She demanded the money while doing the procedure [gastric lavage]. I said, 
no, it doesn’t work like that, I must first complete the procedure and then I 
can give you the money.  Can you just go on a little bit?  And she was very 
abusive to us…And one of the CRWs got agitated with her: “ja, you must go 
and buy milk for the child, and you must go and do this with the money for 
the child”. And I intervened and I said, you know what, we have no right at 
all to tell her what she must do with the money. If she feels she wants to do 
whatever with the money, that is up to her.  We have no right.  It is her child, 
remember, we can’t take responsibility for her child. This is her child.  Please, 
do not tell her to go and buy milk and food for the child. 
The, she went to the X-ray department where the hospital’s social worker came into 
contact with her and summoned her for a dressing down:   
Then she went to see the social worker because she was actually intoxicated 
when she brought the child here. The Brewelskloof social worker picked that 
up when she went to the X-ray department, so she wanted to see this 
participant…And [the social worker] said, “you know what, it’s very 
irresponsible to do that”. 
What we can see through this incident is not only a darker side of the social world within 
which TB finds traction to that depicted in Chapters 6 and 7. It also highlights the difficult 
position of those who face situations like the above and the ambiguities of whose 
responsibility it is to intervene. Dayna’s position, consistent with the way in which 
SATVI frames participants – as responsible, autonomous individuals – was that it was 
not the institute’s place. Only the state social worker was deemed have the authority to 
intervene in the situation. However, such disinterestedness was not easy for the 
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fieldworkers, who assumed the mother was planning to spend the money on more alcohol 
and thus, out of concern for the baby, wanted to convey the importance of spending it on 
milk. Being in a position to intervene but not having the authority to do so was a difficult 
thing to accept for many of SATVI’s staff, and the line was often crossed in response to 
challenging situations.  
Post-Referral Management of Patients 
We have begun to see a conception of SATVI’s entanglement in primary healthcare 
provision in which participants, often motivated by money, were subjected to active 
surveillance technologies and made visible to the state the moment that TB (or otherwise) 
was identified, thus extending their reach into community settings. The assumption so 
far, however, is that participants, upon being diagnosed promptly took the referral letters 
to the clinics for treatment. Many, if not most, did exactly this. As Liz, one of SATVI’s 
nurses, observed: “Most of them really did go. Because if you go there [the clinic] a day 
or two later and you’re looking for more participants, you will ask, ‘did so and so come?’, 
and the sister said ‘yes’”. However, it was a far from uncommon occurrence that 
participants did not attend, particularly when the diagnosis entailed exclusion from the 
study, which was the case for TB. In this section, I show the kinds of interactions and 
allocations of responsibly that occurred between SATVI and government clinic staff – 
especially those who worked together previously in the clinics – in these instances where 
participants seemed to be more resistant to undergoing the transition from participant to 
patient. 
 Perhaps not by coincidence, it tended to be those among SATVI’s nurses who had 
previously worked in the government clinics who had the least trust in participants that 
they would attend the clinics and could cite the most examples to support this. As we saw 
earlier, study coordinator Monique said that she was very careful to make sure that they 
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did not “carry” participants (or the mothers of infant participants) so as to “make them 
responsible” if a diagnosis was made. However, she in fact had a highly sceptical view 
of what participants did with the referral letters:      
We give them a letter, because the monitor will ask for proof. But TB 
participants will throw that letter in the bin. Ignorance, I think. It happened a 
lot with our babies, dying of TB, after being discharged from the CV ward 
with five days of TB treatment. And then when that treatment is done, after 
five days, the mother played innocent. Quite a few of them. Quite, a few of 
them. 
Similar stories were true of adults and adolescents too. Their beliefs as to why they did 
not attend the clinics varied. Monique above cited “ignorance”. However, one of the most 
commonly cited reasons was that there was a difference between a diagnosis made at 
SATVI and at a government clinic. The majority of instances in which TB was diagnosed 
in a government clinic was when the individual was so sick that they were actively 
looking for treatment. Participants diagnosed at SATVI, by contrast, were not necessarily 
seeking medical attention for a sickness, especially once they had passed screening, had 
been vaccinated and were involved in the follow-up stages. In the previous chapter, we 
saw that being part of a vaccine trial could mean a lot to people and even be a life-
changing experience. Then, all of a sudden, they were handed a TB diagnosis, often at 
such an early stage that they were not even feeling especially unwell, were excluded from 
the trial and had to brave the much-maligned government clinic system. In this sense, 
there was a ‘gap’ between diagnosis and treatment that was not only institutional but also 
of a different social substance to when people were diagnosed in a clinic.  
 Who was responsible for ensuring that participants bridged the ‘gap’? SATVI’s 
responsibility for following up on clinic referrals depended substantially upon the 
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condition diagnosed and whether or not it entailed exclusion. In terms of TB, which in 
vaccine trials entailed exclusion, SATVI were required by protocol to continue following 
up their participants for a period of time post-diagnosis. In the case of infant trials (such 
as the trial of MVA85A), infants with TB were followed up until the end of the trial like 
all others. But for adult trials, the protocols were often more vaguely worded, involving 
a shorter period of follow-up to check that they had started and were continuing with 
treatment. While they do check, however, SATVI were not responsible for ensuring 
treatment compliance. Sovereign responsibility theoretically resided solely with the 
government clinics. Yet it became clear that, when it actually came to concrete instances 
of participants not attending their clinic, SATVI’s nurses, particularly those who had 
previously worked in the government clinics, frequently felt compelled to step over the 
‘line’ between where their formal responsibly ended and where that of the clinics began.  
 To see why, it is worth reminding ourselves of what life was like for the TB room 
nurses. Confined behind the walls of the clinics, they were swamped with seemingly 
endless streams of patients, often irritated because of the thankless challenge of steering 
several hundred individuals through a long course of antibiotics. A referral letter faxed 
through from SATVI did not mean much if the patient did not actually show up in person 
– it was “faceless”, as Sister du Plessis put it – and their ability to chase these elusive 
individuals up was contingent upon the limited powers of the home-based carers (see 
Chapter 4). Well aware that of this situation, SATVI’s nurses felt wholly responsible for 
making sure that this “faceless” participant was placed in front of a TB nurse by using 
their mobility in community settings to locate the individual in question. This usually 
involved liaising with the clinics to confirm they could be seen that day. For instance, I 
asked Dayna how often she drew upon her informal contacts in the clinics and the 
purposes for which she used them: 
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Yes, a lot! Especially with their problem patients and our problem patients. If 
we know that this is a problem patient, especially with the HIV story and TB 
patients that doesn’t take his medication. “I have a patient here, please can 
you see him today, because this is a runner”. I will tell [Sister du Plessis] this 
is a difficult person, you don’t get him, I managed to track him down, can you 
squeeze him in?” She will say “yes I can squeeze him in”.  
Note the kind of language used here: “problem patient” (rather than ‘responsible’ 
participant), “runner” (rather than compliant health-seeker) and “track him down” (rather 
than letting him go to the clinic of his own volition). This was, indeed, the same language 
used by the government clinic nurses themselves that we saw in Chapter 4, especially in 
their more exasperated moments. It struck me that, when managing participants who 
violated the abstract imagining of the SATVI-clinic referral relationship and thus 
triggered the governmental stereotype of the irresponsible TB patient, research nurses 
partially reverted back to their roles as agents of the state, taking on the responsibility for 
ensuring that participants commenced treatment beyond that which was legitimate as a 
distanced researcher. It was nurses who just happened to be in different institutional 
settings, one group with command over resources appropriated from research to further 
the common end of ensuring that patients started their TB treatment. Sovereign 
responsibility was thus extended over the research context in moments of public health 
urgency.     
 Importantly, this feeling of mutual responsibility was shared by the government 
clinic staff themselves. For they felt able to contact SATVI for help if there was a patient 
who they were having problems locating in the community – even, in fact, when they 
were not a participant. The facility manager of Worcester CDC, for instance, perceived 
SATVI as a resource that they could “use”: “We can even use them. If you need 
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something you can just tell them, okay, bring that patient”. Moreover, they were 
conscious that SATVI’s fleet of vehicles and superior access to hard-to-reach community 
settings made them more effective than the home-based carers at locating and bringing in 
resistant patients. Sister du Plessis, for example, compared the institute with the carers:   
They [SATVI] go to the house and say, listen what is the problem? And then 
they bring the patient here.  They’ve got transport and they bring them.  
Sometimes the DOTS workers here, the normal DOTS workers, they [the 
NGO] tell them that they mustn’t drive the patients. They are not allowed to 
drive the patients. If you ask [the NGO coordinator], will you please get the 
patient and bring him, then they say they are not supposed to...where SATVI 
on the other hand they drive the patients here. So, if he must begin, he will 
begin.  
When SATVI got involved in the situation, therefore, there was a greater confidence that 
participants would successfully begin treatment. 
 Interestingly, one of the most important advances in the government clinic 
functioning has partially undermined SATVI’s ability to streamline ‘difficult’ 
participants to the TB rooms. As noted in the previous chapter. Worcester CDC and, 
subsequently, the other clinics in which I conducted fieldwork, moved from a system 
where people queued to receive attention that day to an appointment system. In this new 
system, depending upon the severity of the condition one would be given appointment on 
a subsequent day. Dayna, however, suggested that this often made it very difficult, which 
she described using the example of an HIV-exposed infant:  
I had this baby. And I found that this baby never had the immunisations. So, 
I phoned the clinic and I said, listen here, I know this is a runaway mother. I 
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referred the mother, the mother was there, but they said “no we can’t see you, 
we will see you on another day”. So she never want back. And then later on, 
we got the mother again [with the car] and we went and made her sit at the 
clinic, and they said again “no we can’t see you today”. Only at twelve weeks, 
I pushed my way into this system and I said, please see this child! So they 
did, but now this child has been without Nevirapine for six weeks, and then, 
at the end of the day, this child seroconverted to HIV.    
With the stakes being so high, Dayna took it upon herself to speak to one of the primary 
healthcare managers and tried to assert that SATVI were here to “complement” the clinics 
and that, with the caveat that it would not be an everyday occurrence, be allowed in 
“problem” cases to jump the queues. In such cases, as she put it, “we can meet each other 
somewhere in the middle”. Here there is a contest in sovereign responsibility at the 
juncture of two competing imperatives: that of improving the delivery of healthcare for 
many thousands, versus the heightened responsibility felt towards a much smaller 
minority of participants in a clinical trial. This is characteristic of the uneven distribution 
of resources in clinics affected by high-end clinical trials. Nonetheless, it raises questions 
of equity and fairness on the part those who were sitting in the lines that would be 
bypassed by SATVI’s participants (see Angweni et al. 2015). Indeed, from the 
perspective of someone waiting patiently in line, one might even feel more resentful given 
that those seen to be skipping the queues were ones who seemingly did not even want to 
be there.   
Conclusion 
This chapter has completed our exploration of the movement of people through SATVI’s 
trials by focusing on the point at which many were diagnosed with TB or another medical 
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condition and were referred to a government clinic for treatment. Focusing on the status 
transition from ‘participant’ to ‘patient’, I highlighted the ambiguities, complementarities 
and tensions that straddled the border between research and care. At the institutional level, 
the division of responsibilities was clear: participants might have acquired the status of 
‘universal’ human subjects in the game of ‘global’ scientific research, but the state 
remained participants’ rightful healthcare provider (Barsdorf et al. 2010). This division 
was supported wholeheartedly by the research team, especially the nurses who had been 
trained to respect the stringent hierarchies of the health system.  
 Yet no amount of deference or humility could entirely obscure the ways in which 
SATVI stepped over into the work of TB control and primary healthcare provision 
through the ground-level conduct of its vaccine trials. At times, SATVI was perceived to 
have overstepped its authority by the government clinic staff (Angweni et al. 2015). But 
what little resentment the clinic staff harboured was outweighed by the valuable 
contribution SATVI was seen to make to their day-to-day work lives. For SATVI’s 
superior mobility, capacity for active case finding and even their ‘hold’ over Worcester’s 
poor (primarily through money) functioned to extend the reach of the clinics into hard-
to-reach community settings, enabling them to exert greater control and influence in the 
areas where TB holds greatest traction. In fact, SATVI’s trials partially fulfilled the 
nostalgic sense of longing for the degree of community presence and control that had 
been largely stripped from the government clinics since the end of apartheid (see Chapter 
4).   
 Yet at the same time, questions and contestations over sovereign responsibility 
emerged in the process of connecting participants to healthcare, especially in the 
occurrence that participants seemed more resistant to making the transition from 
‘participant’ to ‘patient’. Who was responsible, for what and for how long? The line had 
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to be continuously managed, by nurses in particular, who had to juggle their sense of 
responsibility for participants with their valuable contacts and allegiances with the clinics. 
For the most part, SATVI and government clinic staff found ways to collaborate in order 
to bridge the ‘gap’ engendered by the research environment between diagnosis and 
treatment. However, it was not always straightforward, with the imperatives of providing 
healthcare for the majority running into tension with the concentrated responsibility felt 
towards individuals in trials. This chapter thus contributes towards our understandings of 
‘collaborative partnerships’ in global health and how responsibility is allocated and 
enacted on the ground.     
 While the focus this chapter and Chapter 7 are not identical, they offer two different 
and competing narratives of what and who is to blame for the current state of the TB 
epidemic and SATVI’s emergent healthcare role in relation. From one perspective, 
SATVI appears as a ‘first point of care’ of sorts for citizens who feel that they have been 
wronged by their government. From another, the institute appears as a high-resource 
agent of surveillance and control, extending the reach of the state into the TB ‘hotspots’ 
and the elusive bodies contained therein. As I mentioned in the introduction to this 
chapter, it is not my position that either version is ‘correct’ or closer to the ‘truth’. Rather, 
the fact that SATVI manifests so differently depending upon the perspective testifies to 
just how messy and divisive the TB epidemic. Moreover, it highlights power of TB 
discourse to shift blame away from the structural determinants of disease and on to 
impoverished individuals. These two versions of SATVI’s emergent healthcare role 
reflect the proverbial angel and devil that sit on the shoulders of Worcester’s 
impoverished coloured residents and the perpetual struggle between them that this thesis 
has sought to capture. As Jenson (2008, p. 8) puts this, the struggle between people’s 
“everyday sense of being themselves as persons who live normal and moral lives on the 
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one hand, and on the other the colouredness, sustained by the full gamut of stereotypical 
framing and definition”.
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Conclusion: 
Rethinking Carina’s Choice 
This thesis opened with the story of Carina and the ‘brave choice’ that she made to enrol 
her baby into one of SATVI’s TB vaccine trials. The comic provided a good device to 
begin my thesis because it encapsulated many aspects of the socioeconomic, 
epidemiological and cultural context that we encountered in the preceding chapters. This 
includes poverty, unemployment, a huge burden of infectious disease (especially TB), 
gangsterism, a heavy reliance upon under-resourced government healthcare facilities and 
a strained relationship between the clinics and the residents that they serve. The comic 
also reveals the way in which ‘global’ science and ethics imagines the relationship 
between SATVI and its study community. This relationship is one in which SATVI’s 
staff might be an active presence in the Breede Valley – driving around, recruiting and 
monitoring trial participants, and occasionally making appearances in government 
facilities – but all the while neutral, distanced observers, representing but not intervening 
upon the local situation.  
 The chapters set out to describe, firstly, the TB epidemic – its magnitude, 
challenges and discursive framings – into which SATVI’s trials have been inserted. 
Secondly, they sought to show how SATVI’s trials have become entangled in the Breede 
Valley’s socioeconomic and healthcare landscape through the ground-level conduct of its 
TB vaccine trials. I have thus attempted to view the significance of the trials in people’s 
lives not simply as providing access to scarce resources for bare survival in the new 
biopolitical order of global health (Geissler et al. 2008; Rottenburg 2009; Kamuya et al. 
2014; Nguyen 2011, 2015). Rather, I have tried to bring into view a broader a more fine-
grained appreciation of the spectrum of roles, imperatives and subject positions with 
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which people in Africa approach, interpret and appropriate clinical trials. In particular, 
building upon a number of insightful ethnographic studies conducted in Cape Town, I 
show that SATVI has been creatively read into people’s attempts to craft lives that they 
consider to be valuable, moral and respectable in conditions that have been rendered 
extremely precarious by centuries of racialised domination, exclusionary policies and 
stereotyping (Salo 2003; Jensen 2008; F. Ross 2010, 2015). In order to reiterate and 
reflect upon the findings in the preceding chapters, this conclusion revisits some of the 
scenes from Carina’s Choice in order to show how far we have come from the depiction 
of medical research with which this thesis opened. Using the comic, I divide my 
reflections into four sections: ‘TB, Gangsters and Nurses’; ‘Carina’s Brave Choice’; 
‘From Misconceptions to Moral Economy’; and ‘The Limits of Hope’. The final section 
offers directions for future ethnographic research both with SATVI and in the broader 
field of TB-related science.  
TB, Gangsters and Nurses 
The Kleynhans family – comprised of Carina, Cookie, Tupac, Veronica and Vernon – 
experiences some of the challenges associated with impoverished living that hardened 
into the stereotype of the ‘coloured problem family’ during the colonial and apartheid 
regimes (Jensen 2008). Vernon is unemployed; the family possess very little money; 
Cookie’s father is nowhere to be seen; and Tupac is vulnerable to entering a gang if he 
has not already. Jensen (2008) argues that a central figure in ‘coloured’ townships is that 
of the skollie (thug), which is ambiguous in the sense that he both undermines positive 
identities and is the figure against which people stake their own claims to morality and 
respectability. Accordingly, the central character in Carina’s Choice for our purposes is 
arguably not Carina but rather Tupac.  
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 Jensen’s insightful analysis, however, does not extend so far as the landscape of 
health seeking and delivery, which is one reason that Tupac’s cough and his visit to the 
clinic is especially revealing. At first, there is hesitancy in the house to recognise TB as 
a possibility, and Vernon’s strong response to suggestion hints at the stigma surrounding 
the disease and people’s hesitancy to attend a clinic to be diagnosed. More significantly, 
at the clinic Tupac is uncooperative with the uniformed government nurse, and in one 
telling image (below) he is facing away from her, arms folded in defiance, while the nurse 
stands with hands on her hips, berating him. A we saw in Chapter 4, this captures the way 
that government clinic staff viewed the challenges of the TB epidemic. That is, people 
appear to be unresponsive to the new post-apartheid governmentality premised upon 
‘patient responsibility’ (Compion 2008) and as a result there is a ‘gap’ between the clinic 
and home, with a feeling of little control or influence in low-income suburbs where the 
disease continues to spread unabated. 
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It is for this reason that I have introduced the ‘problem TB patient’, a figure overlapping 
with but not identical to the skollie. The problem patient is engendered by the ways in 
which TB discourse and the language of ‘patient responsibility’ focuses attention upon 
individual behaviour while deflecting attention away from structural determinants of 
disease (Farmer 2000; Compion 2008; Harper 2006; Harper 2010). He is, perhaps most 
vividly, captured in the flyer composed by Sister du Plessis (Chapter 4, p. 99). Yet, as we 
saw in Chapter 6, the problem TB patient is further moralised and reified in the popular 
imagination, closely associated with notions of ‘dirt’ – not only dirty places but also dirty 
people and dirty practices, including smoking, alcoholism and drug abuse (Abney 2011). 
I have suggested that this stereotypical figure features prominently in the ways that people 
frame themselves as ‘responsible’ health seekers as well as moral and respectable 
individuals more generally.  
 The context into which SATVI’s trials have been inserted is therefore a complex, 
unstable and divided post-apartheid setting in which TB is far more than a brute fact. 
From the perspective of the government clinics, SATVI has ‘locked in’ to precisely the 
low-income, gangster-ridden community settings that they struggle so much to exert 
control any control over. From the perspective of residents themselves, the institute has 
become entwined in people’s attempts to craft ordinary, respectable lives on the 
peripheries of social and economic life, in the mist of and often in response to skollies, 
‘problem patients’ and the ‘dirty’ lifestyles with which they are both associated. To 
characterise the everyday hardships in which TB is entwined, I have tentatively use the 
term ‘abjection’, the starting point in the useful schema around which a number of the 
chapters (5, 6 and 7) were constructed empirically to make sense of the meaning and 
significance of SATVI’s trials in people’s lives. That is, the movement from abject to 
object to subject (Simpson & Sariola 2013).   
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Carina’s ‘Brave Choice’ 
While Tupac is in the consultation room with the nurse, Carina is approached by Mandisa 
– one of SATVI’s fieldworkers – who introduces the institute and the trial for which they 
are currently recruiting (below). Carina’s lack of familiarity with SATVI’s work reflects 
the way that ethical guidelines construe clinical trials as isolated events that take place 
between predetermined enrolment and end points, rather than as cumulative and 
embedded in people’s collective memories (Geissler et al. 2008; Kelly 2011; Geissler & 
Molyneux 2011). In reality, as this thesis has shown, it is actually harder to find people 
who are not familiar with SATVI’s work, given the volume and variety of vaccine trials 
that have been conducted since 2001. “SATVI – something for all the family” was how 
one researcher jokingly expressed the fact one can find entire families – such as the 
Kleynhans’– who have been involved in the institute’s research in one form or another 
over the last fifteen years.    
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After having the trial explained to her, Carina is asked to make a ‘brave choice’ to enrol 
Cookie into the trial for the ‘greater good’ of a new TB vaccine. Now the language of 
choice, and its close relationship with the bioethical ideal of autonomy, has arguably been 
the primary sticking point for anthropological critique. This is because of its associations 
with neoliberalism in healthcare (Fisher 2009) and, in particular, the way it deflects 
attention away from the relations of inequality between researchers and study populations 
and reduces what is ‘ethical’ to clear communication, participant rights and minimising 
the possibility of ‘undue inducement’ (Geissler et al. 2008; Petryna 2009; Kingori 2013). 
This thesis has offered a different take on the language of ‘choice’, ‘autonomy’ and 
‘greater good’. In Chapter 3, we saw that considerable work went into building the 
capacity and conditions for the social relations of research against the backdrop of a 
deeply entrenched culture of medical paternalism. Yet the inverted power relationship 
between researchers and participants brought about by the trial environment was 
interpreted largely positively by both participants and staff (cf. Sariola & Simpson 2011). 
Chapter 5 showed how SATVI’s fieldworkers saw their roles in the trials as important 
because they were able to make people feel valued, included and capable of doing 
something good, which takes on particular significance given peoples’ fears of being 
considered weggooi mense (throw-away people). Chapter 7, moreover, argued that one 
of the most important reasons why SATVI was valued as a health space was that they felt 
they were treated with respect, as equals and as being included in decision-making 
process in contrast to the perceived indignities, stereotyping and authoritarianism of the 
government clinics.  
 Drawing attention to the positive uptake of the ideal of the autonomous, choosing 
human subject around which research relations gravitate is not to suggest that it is a 
universal, nor that it has a fixed or stable referent. In fact, it is precisely because it was a 
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novelty for many to be treated as such that it had tangible effects, the positivity of which 
becomes appreciable in light of how they arrived into the category of ‘universal’ human 
subject from a position as abjects-cum-objects. In the rush to show what the neoliberal 
language of ‘autonomy’ and ‘choice’ obscures (Fisher 2007; Mol 2008), we easily lose 
sight of what it might mean to be treated as autonomous, moral and altruistic in conditions 
that strip away the possibilities for self-worth. Whether or not this was an attainable 
reality is a matter that is discussed further on.  
From Misconceptions to Moral Economy  
Bioethics, as mentioned above, tends to assume that the category of the human subject is 
universal and fixed. But within the more dialogical relationship engendered by the 
research environment, both participants and research staff were bringing their own values, 
beliefs and ideas of proper personhood to bear on what it meant to be a human subject 
and how this subjectivity was connected to the science. Chapters 5 and 6 in particular 
suggested that, in the same moment that trials protocols were shaping participants as 
measurable and commensurable objects, for those on the ground the all-important site of 
knowledge and intervention was the subject, the moral agent – even the soul. It is for this 
reason that the moral dimensions of TB – especially its symbolic associations with ‘dirt’ 
and ‘dirty practices’ – were not stripped away by the trial protocols. Rather, they were 
refracted through and indeed amplified by the trials’ everyday practices and routines, as 
people projected their self-perceptions and moral aspirations onto the category of the 
human subject.  
 The way that many participants interpreted the science and their roles in it as 
participants are easily placed into the bioethical category of ‘misconception’, which 
brings us to the final scene in Carina’s Choice. At Cookie’s first birthday party, a man 
voices his suspicions about SATVI’s work (below). He firstly suggests that the study 
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vaccines might actually give people TB and, secondly, questions the purposes to which 
SATVI are putting Cookie’s blood (Leach, Fairhead & Small 2006). But these are quickly 
dismissed as ‘misconceptions’ by the better-informed people at the party, and in the end 
the man comes to see he was mistaken. While I did not encounter too many suspicions in 
interviews, blood nonetheless featured prominently in people’s understandings, with 
many people expressing their participation in terms of donations of ‘clean blood’. Chapter 
6 argued that the idiom of clean blood should not be viewed as a mere misconception but 
rather as a tangible, symbolically rich interpretation that is grounded in the day-to-day 
rhythms of the trials and people’s highly-moralised understandings of TB. Blurring the 
distinction between object and subject, it defies the passive disposition to sickness that 
makes them scientifically valuable from a bio-scientific perspective, reflecting the desire 
to be set apart from rather than representative of a ‘high-burden’ community. In some 
cases, participation could catalyse drastic transformations in outlook and lifestyle, with 
profound social effects beyond the confines of the trials (Brives 2013).  
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Observing a vaccine trial run by British MRC in The Gambia, Geissler and colleagues 
(2008) argued that the moral economy of truth and objectivity prized by science had to 
coexist with another on the ground, involving “material contact and substantial 
transactions, notably of blood and medicine”. The sharp resistance beyond the 
requirements of trial protocols to practices and lifestyles considered to be ‘dirty’ points 
towards a different kind moral economy surrounding trial participation. This moral 
economy incorporates values such as respectability, cleanliness, ‘good’ lifestyles and 
responsibility and can be seen as partially defined in opposition to the symbolic 
associations between TB and ‘dirt’. It is no less situated than the moral economy 
identified by Geissler and colleagues. But it does, I believe, draw our attention beyond 
the material dimensions of trial participation to a broader spectrum of imperatives and 
subject positions with which people approach and attribute significance to clinical 
research. Insofar as this thesis can be read as a critique of bioethics, it is therefore not a 
critique of ‘autonomy’ and the language of ‘choice’. Rather, given the creativity and 
dynamism with which people read SATVI’s trials into their day-to-day lives, this thesis 
critiques the equally problematic category of ‘vulnerability’ that is applied to varying 
degrees to almost all SATVI’s participants. 
 Vulnerability, then, has been treated not as an a priori category referencing 
‘compromised autonomy’, but rather as emergent in practices: experienced, interpreted 
and acted upon in ways not always visible from the abstract perspective of bioethics. In 
the preceding chapters, we saw a variety of ways in which people felt profoundly 
vulnerable: the effects of chronic poverty, disempowerment and racial stereotyping, the 
threat of gang life and violence, the fear of alcoholism, and drug addiction, and the 
perceived indignities of interactions with the state. Whereas bioethicists tend to see the 
principle issues of human subject research as turning on ‘autonomy’, one thing that 
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emerges strongly here is that SATVI is actually one of the only places many people felt 
safe, dignified and respected. The institution was creatively used to avoid certain 
vulnerabilities. It was used as a platform to confront others. But the notion of vulnerability 
as it is used in bioethics tends to frame people as passive, docile and obliging, rather than 
as dynamic, driven and critical individuals navigating complex sociomedical spaces 
(Chambers 1989; Levine et al. 2004; K. Brown 2015). The common phrase, “it’s not 
about the money, it’s about…”, pointed towards an array of canny ways in which people 
were interpreted and using the trials, for instance Leighton, who viewed participation as 
an opportunity for personal growth and transformation amidst instability and 
unpredictability (Chapter 6).  
Chapter 6 inverted the question of vulnerability and turned it back on the trials 
themselves. It asked: if people start transforming their lifestyles in tandem with becoming 
trial participants, could it alter their chances of getting TB and threaten the possibility of 
proving vaccine efficacy? The point of this question is not to challenge the science but 
simply to highlight that people are dynamic, unpredictable and harder to force a frame 
over than the image of vulnerability suggests. Whilst SATVI’s trials are striving towards 
the future good of a new TB vaccine, people are not sitting still in the meantime; they 
have their own hopes and aspirations and use these trials to help further them in ways that 
ethnography is ideally suited to capture.  
The Limits of Hope 
Whilst I have attempted to capture the creativity with which people in impoverished 
environments build lives that they consider to be valuable, moral and respectable, I have 
also kept in view the tensions, contradictions and often futility of these world-building 
efforts. Moreover, I have attempted to do so in a context where life is often desperately 
cruel and unpredictable. Both Jensen (2008) and Ross (2015) draw attention to the 
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“positive imaginative horizons” (F. Ross 2015, p. S99) that the notion of ordentlikheid 
provides, it contains the very structures of dominance that made it available as an emic 
category. In the same way that Jensen (2008) showed that people framed themselves 
respectability by projecting the skollie elsewhere and on to others, there was something 
sad about the way in which participants set their own motives against an imagined 
majority who were perceived as only there ‘for money’ and often to fuel practices that 
were associated with the skollie or ‘problem TB patient’. While such practices are a 
reality in post-apartheid Worcester, I concur with Jensen’s analysis that there is a sense 
in which people were pointing fingers at their own stereotype, reinforcing the very 
relations of inequality that they sought to escape.  
 People’s highly-moralised understandings of TB and the way that these deflect 
attention away from structural determinants (Farmer 2000; Harper 2006; Harper 2010; 
Abney 2011) also set people up for perceived ‘failure’. At the end of Chapter 6, we saw 
hints at people who dropped out of SATVI’s trials. What is especially troubling is that, if 
they were indeed excluded from the trials, then it was certainly not because they had done 
anything ‘wrong’, and yet they appeared to have interpreted the exclusion as a personal 
moral failing, that is, reverting to ‘dirty’ lifestyles. They might not even have been 
excluded at all but simply too ashamed to return. The moral triage enacted by the trials, 
while emancipatory for some, was a source of dejection for others. Moreover, despite 
people’s self-perceptions as responsible health seekers, a TB diagnosis is a daunting 
prospect. It is, moreover, perhaps even more of a struggle to accept given that one moment 
they felt they were a part of something good and where they felt valued and respected, 
and the next they were handed a TB diagnosis, excluded and had to attend a place that 
was perceived as quite the opposite. It was uncanny how quickly the governmental 
stereotype of uncaring, irresponsible bodies resurfaced the moment that people did not 
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attend the clinics for treatment and the approach to patients that were legitimised in 
moments of public health urgency. As Jenson (2008) might argue, ‘defaulting’ was 
almost the default mode in the governmental imagining and was poised and waiting to 
(re)surface. 
 The way that participants were interpreting and acting upon SATVI’s trials 
reflects the way in which people are looking outside of usual and especially state-
affiliated institutions for hope and positive horizons. Yet, most of this was happening 
beyond the visibility of the state and, in fact, from the perspective of the government 
clinic nurses, SATVI took on a very different appearance. There was a degree of 
frustration that, in the same moment SATVI had such ‘hold’ over Worcester’s residents 
– which was attributed to the R150 ‘reimbursements’ – they had such a struggle retaining 
patients. Nonetheless, SATVI was perceived by clinic nurses as an ally to the state in 
controlling TB, extending their reach into hard-to-reach, dangerous community settings 
and control over the elusive, often ‘irresponsible’ people living therein (Chapter 8). As I 
suggested in Chapters 4 and 8, it is not my position that the perspectives of the 
government nurses are ‘wrong’, ‘ignorant’ or belie a lack of ‘care’. But their perspectives 
do show how difficult it is, in the everyday frustration and exhaustion of providing 
healthcare to many thousands of people, to keep in view the structural violence that 
underpins people’s apparent ‘irresponsibility’. It is my hope that this thesis, by 
highlighting the ways in which the TB epidemic is differentially experienced by 
healthcare professionals and residents, will be useful for health authorities as they strive 
to provide a health service that is legitimate and workable in a country still grappling with 
the enduring legacies of apartheid.    
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Shifting Markets and Future Research 
The way that I have described SATVI’s research programme in this thesis might give the 
impression of a stable and constant stream of TB vaccine research. But the reality is, 
markets in TB-related medical research are changing and in ways that do not favour 
SATVI’s particular area of expertise. Fewer efficacy trials are being funded, due in part 
to the realisation that vaccines such as that trialled by SATVI between 2009 and 2012 can 
show such promise in early-phase testing and yet still ‘fail’ when tested on large study 
cohorts. Needing to keep its doors open, SATVI is beginning to run drug trials to “fill the 
void”, as one doctor put it. On the one hand, this is not nearly as fulfilling for SATVI’s 
researchers, whose expertise is in TB vaccines and they have historically had a large role 
in the design of the trials. On the other, it has been suggested that SATVI’s niche in years 
to come might be therapeutic vaccines. That is, vaccines that are administered as part of 
treatment regimens to shorten the treatment process. In this regard, drug trials and related 
studies might be thought of as ‘capacity building’ for therapeutic vaccine trials as research 
conducted in the formative years was capacity building for efficacy trials (Chapter 3).    
 One question that emerges from an anthropological perspective is: what will the 
move towards involving patients with active TB do to perceptions of SATVI’s work in 
the Breede Valley? As we have seen, SATVI has developed a reputation as working with 
healthy people and, more specifically, as being in the business of ‘clean blood’. Not only 
does this mean SATVI participation is not stigmatised but, in fact, as I have shown, the 
institute has become a place associated with moral, respectable personhood, which was 
defined in opposition to associations between TB and ‘dirt’. So, what happens when 
SATVI start involving TB patients? What will this mean for the government clinics now 
that the institute is stepping even further into work that is usually their domain? How will 
research staff engage with the issue of ‘defaulting’ on medication? Will they hold patients 
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accountable and be stern with them? SATVI’s shifting identity and the way that it is 
experienced and interpreted at different levels by the multitude of stakeholders in the 
institute’s research opens up novel and important possibilities for anthropological 
investigation.   
 Looking further outwards, SATVI is one of several large research institutes 
conducting both TB vaccine and TB drug trials in South Africa. Many of these trials are 
in fact multi-sited trials, with the same protocols being implemented in often very 
different sociocultural and epidemiological contexts. Originally, I planned my PhD 
research as being multi-sited, planning in particular to ‘follow’ a large adult early efficacy 
trial through South Africa, in particular the trial that I have referred to as the Adult 
Efficacy Trial. It was decided that this was beyond the scope of a PhD, and I have 
certainly not regretted the depth of analysis that has been enabled by my exclusive focus 
on SATVI. But in order to build further upon my research, a possible next step is to shift 
the level of analysis outwards to incorporate a number of sites, for instance regarding the 
similarities and differences in community perceptions of these research institutes. How is 
the research of these other institutes received by those involved in their ground-level 
conduct? How are the same or similar protocols implemented differently across different 
regional contexts? While anthropology has historically been associated with deep 
immersion in a single, bounded field site, today multi-sited ethnography is widely 
practiced because of the increasingly multi-sited nature of the social phenomena being 
explored (Marcus 1995). Shedding light upon the social fabric and ethical implications 
of TB-related trials arguably means looking towards these broader networks of activity 
in South Africa and across the developing world as they cross both spatial boundaries and 
levels of scale. 
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Appendix 1: 
Carina’s Choice 
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Appendix 2: 
The Rhythms of Study Visits 
Each of the vaccine trials being run at the time of my fieldwork had their own social 
dynamics. These were influenced by a range of factors, including the layout of the vaccine 
clinic, the age range of the study cohort and the size of the trial. Nonetheless, the trial 
protocols entailed similar routines. Below I provide an overview of the trial protocols, 
from screening, to vaccination, to the follow-up process.   
Screening 
The screening visit, which would determine whether people were eligible be enrolled, 
occurred shortly after informed consent had been obtained by a fieldworker at their 
homes. On a day that was convenient for them, they were picked up from their homes by 
one of SATVI’s drivers, and were taken to the trial site at Brewelskloof Hospital and to 
the vaccine clinic where the trial for which they were being screening was being run. The 
screening process involved a wide variety of medical questions, tests and examinations. 
Observations such as height and weight could be taken by fieldworkers wherever there 
was space, often in the corridors. Everything else was performed behind closed doors, the 
bulk of which was performed by a nurse.  
 The nurse took their blood pressure and temperature, questioned them for any TB-
related symptoms and asked a standardised series of questions regarding medical history. 
One of SATVI’s study doctors then followed up on this medical information and also 
conducted a physical examination. Back with the nurse, blood from a finger prick was 
taken for an HIV test (pre- and post-test counselling was conducted by a fieldworker), 
before further blood was drawn for a quantiFERON (TB infection) test and to check for 
liver and kidney function. People were also asked to produce a measure of sputum to 
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check for active TB. All the while, people were informed of what was happening, asked 
whether they were still happy to take part, and given the opportunity to ask questions. 
Finally, they received a R150 ‘reimbursement’ and were driven home again by logistics.   
 For many people, screening was their first and last involvement in the trials. 
Screening failures were particularly high in trials – such as the Adolescent Trial study 
and the Adult Safety Trial – where TB-uninfected people were required. But any number 
of issues that precluded enrolment could emerge during screening. HIV-positive results 
were in the minority, but not uncommon. BMI, blood pressure, TB history – almost any 
concurrent medical condition – might also lead to exclusion depending upon the particular 
criteria of the trial in question. It was not usually until at least a week later, when all blood 
and sputum samples had been analysed in the lab, that people would hear definitively 
(usually by phone but via home visit if needs be) whether they were eligible to be enrolled 
into the study. For those found to have something that required medical attention, they 
were referred to their usual healthcare provider for further diagnostics and potential 
treatment.   
Vaccination 
Those who passed screening were invited back to SATVI for enrolment and vaccination. 
Again, people would be asked whether they were happy to proceed, if they had any 
questions and finally, after some final medical checks, injected with either the study 
vaccine or a placebo. Immediately following vaccination, they were kept at the site for a 
minimum of two hours for observation. If they experienced any adverse events, they 
received immediate medical attention by SATVI’s trial team and, if necessary, they would 
be admitted to Worcester Hospital. Provided they did not experience any adverse events 
at the vaccination visit, participants were driven home again.  
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Follow-up 
From the moment of injection, the long process of evaluating the safety and/or efficacy 
of the study vaccine began. Provided they did not experience any adverse events (AEs) 
at the vaccination visit, participants were driven home again, but would return frequently 
for (‘reimbursed’) follow-up visits, typically at days 7, 28, 84, and every other 84 days 
until the end of the trial (approx. 20 visits in total).  
For safety evaluations, participants were asked to self-monitor at home and make 
a note of any observations in a diary. In addition, as with prior visits, participants were 
informed what was happening, asked whether they had any questions, and if they would 
like to continue. Then they underwent a series of questions, tests, and examinations, often 
but not always including blood draws. Medical issues would frequently emerge during 
the follow-up process, which may or may not have led to exclusion, and referral to their 
healthcare provider where necessary. In efficacy trials (e.g. the Adult Efficacy Trial), 
SATVI were particularly vigilant for signs of active TB disease, because a certain number 
of cases were expected – even desired – in order to show that the study vaccine works. 
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Appendix 3: 
Socioeconomic Indicators and Social Grants 
Socioeconomic indicators – South Africa 
Poverty 53% of people in South Africa lived below the poverty line in 2011, 
as defined by R779 per person per month. 36,37  
Unemployment 26.5% in January 2017. 38 
 
Socioeconomic indicators – Breede Valley Municipality39  
Total Population (2015)  174,198 
Total Households (2015) 46, 963 
Per Capita Income (2011) R25, 923 
High School Pass Rate (2014)  82.1% 
In 2011: 
• 13.7% of households (or 6004 households) lived on less than R400 per month (£23) – 
which is considerably less than the poverty line 
• 17% of households live on less than R800 per month (£47)  
– which is around the poverty line per EACH person)  
• 32% lived on less than R1,630 per month (£96). 
 
                                                 
36 Statistics South Africa (2014) 
37 Although in an independent analysis, (Budlender et al. 2015) suggest that the 2011 
figure should be 63% because they think that the poverty line ought to be defined as 
R1042 per person per month. See also: http://theconversation.com/how-current-
measures-underestimate-the-level-of-poverty-in-south-africa-46704  
38 Statistics South Africa (2017) 
39 Western Cape Government (2015) 
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Social Grants40 
Grant Rand / month Notes 
Child Support Grant 380 [per child] To receive this grant, you must be 
the primary caregiver of a child. The child 
must be under the age of 18 years old 
Foster Child Grant 920 [per foster child] 
Care Dependency Grant 1,600 [per child] Care dependency grant offers help 
to full-time caregivers of a child / children 
with disabilities 
Old-Age Pension 1,600 [per pensioner] over 60 years 
 1,620 [per pensioner] over 75 years 
 
 
  
                                                 
40 Source: https://www.westerncape.gov.za/general-publication/applying-social-welfare-
grant  
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Appendix 4: 
Informed Consent Forms 
(1) Clinical Trial Participant Information Sheet and Consent Form 
(2) SATVI Staff Information Sheet and Consent Form 
 
(3) Healthcare Professional Information Sheet and Consent Form 
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(1) Clinical Trial Participants - Participant Information Sheet 
My name is Justin Dixon. I am a student from the University of Durham in the United 
Kingdom. I am seeking your help with a study I am doing about SATVI’s work in the 
Cape Winelands East district. Please take time to read the following information 
carefully, and take time to consider whether you want to take part in this study or not. 
Please ask me if there is anything that is unclear to you, or if you would like more 
information about the study before making your decision.  
 What is the purpose of this study? 
In this study, I would like to find out about how SATVI helps to improve people’s health 
in the district by researching new vaccines, working with local healthcare centres, and 
improving awareness of TB. This study will last for 12 months, based at SATVI’s field 
project office in Worcester Approximately 135 people, with a variety of ties to SATVI’s 
work, will be invited to take part in total. The study will help SATVI to improve its 
relationship with the community. It will also help to make medical research more 
beneficial to people in South Africa.   
  If you agree to participate, what will you be asked to do?   
I am asking you to take part in my study because you have some knowledge or experience 
of SATVI’s work in the Cape Winelands East district. I would like you to take part in a 
single interview with me at SATVI’s office. During the interview I will ask you about 
your knowledge and experiences of SATVI’s work, about TB, and also about healthcare 
in your community. This will take between 30 and 50 minutes of your time. I will ask 
your permission to tape record the interview. I will use the information you share with 
me during the interview to describe SATVI’s work in articles and reports.     
  Voluntary participation 
Please understand that it is your choice whether to take part or not. There will be no 
penalty if you decide not to take part, and this will not affect your relationship with 
SATVI in any way.  If you agree to take part now, you can choose to interrupt or end 
your participation at any point.   
 Are there any risks or benefits if I take part? 
The questions I ask you are unlikely to cause you any harm or distress. However, if any 
of the questions asked make you feel uncomfortable in any way, you do not have to 
answer them, and I will move on to the next question. In addition, in the unlikely event 
that the need arises, I can refer you to a counselling service for further support about the 
topics raised by in the interview. There are no direct benefits for participating in my study. 
However, you might value the opportunity to discuss your knowledge and experiences of 
SATVI’s work. In addition, your input will be beneficial in the long run for the 
community and others affected by medical research in South Africa.    
 Confidentiality 
In order to make sure that the information you share with me is as confidential as possible, 
the tape recording of your interview will be destroyed once I have written the interview 
down. Also, whenever I use any of the information you share with me during the 
interview, I will not mention your name or any other features that might identify you 
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personally. These conditions will only be broken in the event of an emergency, where 
there is a risk to you or to another person.  
 Further information 
If you have any concerns or questions regarding this study that have not been answered, 
please feel free to contact me: 
Justin Dixon                                                             Michele Tameris                      
Anthropology PhD Student                                   Clinical Researcher 
Phone: 076 516 1489                        or                 Phone: (023) 346 5400                          
Email: justin.dixon@durham.ac.uk                         Email: michele.tameris@uct.ac.za       
 
The full title of the study is “Beyond Protocol: Ethics, Experimentation and Healthcare 
at a Tuberculosis Vaccine Clinical Trial Site in Rural South Africa”. This study has been 
approved by the University of Cape Town Faculty of Health Sciences Human Research 
Ethics Committee, and the University of Durham Department of Anthropology Ethics 
Committee. If you would like to find out more about your rights as a research participant, 
please call: (021) 406 6492.  
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Clinical Trial Participants - Informed Consent Form for Interview 
This form is to show that you have understood what it will mean to help me with this 
study and are happy for me to use information shared during the interview. 
Signing the form will mean that you have agreed to participate in the study entitled 
“Protocol and Beyond: Ethics, Experimentation and Healthcare during Tuberculosis 
Vaccine Trials in South Africa”. 
This means that:  
• The research project has been explained to me and I have had the chance to ask 
questions. 
• I voluntarily agree to take part in the study. 
• I understand that at any time during the interview, I am free to interrupt or end my 
participation without penalty.  
• I understand that my decision whether or not to take part in an interview will not harm 
my relationship with SATVI. 
• I understand that information shared during this interview may be used in articles and 
reports, and I agree to the information being used in this way.  
• I understand that my name and identifying features will not be revealed. 
• If the interview is tape recorded, I understand that the tape recording will be destroyed 
once it has been written down. 
 
Print name of study participant:  ________________________________ 
 
Signature of study participant: ________________________________     
Date: _____________ 
 
 
Print name of person taking consent: 
  ________________________________ 
 
Signature of person taking consent:  ________________________________  
 
Date: _____________ 
 
In the event that the participant is under 18 years of age: 
 
Print name of consenting  
parent/legal guardian:  ________________________________ 
 
Signature of consent of 
parent/legal guardian:  ________________________________    
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Date: ______________ 
(2) SATVI Staff - Participant Information Sheet 
My name is Justin Dixon and I am a researcher from the University of Durham in the 
United Kingdom.  I am seeking your help with a study I am doing about SATVI’s work 
in the Cape Winelands East district. Please take time to read the following information 
carefully, and take time to consider whether you want to take part in this study or not. 
Please ask me if there is anything that is unclear to you, or if you would like more 
information about the study before making your decision.  
 What is the purpose of this study? 
In this study, I would like to find out about how SATVI helps to improve people’s health 
in the district by researching new vaccines, working with local healthcare centres, and 
improving awareness of TB. This study will last for 12 months, based at SATVI’s field 
project office in Worcester. Approximately 135 people, with a variety of ties to SATVI’s 
work, will be invited to take part in total. The study will help SATVI to improve its 
relationship with the community. It will also help to make medical research more 
beneficial to people in South Africa. 
 If You Agree to Participate, What will the Study Involve?   
As someone with an important role within SATVI, I would be thrilled if you agree to be 
an ongoing participant in my study. If you agree to take part, I will arrange times with 
you to spend time with you as you go about your day-to-day work in order to learn more 
about what you do and about your role within SATVI. To aid my memory I will take field 
notes during this time. I would also like you to take part in a small number of interviews 
with me over the course of the year about your work at SATVI and about TB and 
healthcare in the community. If you agree to be interviewed, I will ask your permission 
to tape record and transcribe our conversations. Finally, I will hold some meetings with 
a small number of SATVI’s staff sitting together [a focus group] to discuss SATVI’s 
work. I would be grateful if you would agree to take part in one or more of these during 
the study. I will use the information shared throughout the year to describe SATVI’s 
activities in academic articles and other reports.     
  Voluntary Participation 
Please understand that it is your choice whether to take part in my study or not, and there 
will be no penalty if you decide not to, and this decision will not affect your job at SATVI 
in any way.  Due to the in-depth nature of this study, I will be especially careful to ensure 
that you are comfortable with my presence at all times, and that you do not feel that my 
study is intruding upon your privacy. If there are any aspects of my study that you do not 
wish to take part in, this is perfectly acceptable. 
 
 Are there any risks or benefits if I take part?  
Your participation in my study is unlikely to cause you any harm or distress. However, if 
any part of the study begins to make you feel uncomfortable in any way, you are welcome 
to interrupt or end your participation at any point. During the study, it is likely that I will 
ask you quite a lot of questions, particularly during interviews and focus groups. You do 
not have to answer any of these that make you feel uncomfortable or that you do not wish 
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to answer. In addition, in the unlikely event that the need arises, I can refer you to a 
counselling service for further support about the issues raised by the study. There are no 
direct benefits for participating in this study. However, you might value the opportunity 
to share your knowledge and experiences of SATVI’s work. In addition, your input will 
be beneficial in the long run for SATVI staff, the community, and others involved in 
medical research in South Africa.  
 Confidentiality 
Assuring that the information you share as a participant remains as confidential as 
possible is a key priority. To this end, unless you explicitly ask me to, I will not discuss 
any of the information you share with me during the project with SATVI’s management 
staff. Recorded interview and focus group discussions will be destroyed once the 
recording has been transcribed. In addition, your name and any identifying characteristics 
will not be included in any data or in any academic articles and reports arising from this 
study. Where you share information with me in public spaces I will also do my utmost to 
ensure that conversations are not overheard. In addition, I will encourage those who take 
part in focus groups to respect the confidentiality of information shared during these 
sessions. Confidentiality will only be breached in exceptional circumstances in the event 
of risk to yourself or third parties.  
 Further Information 
If you have any concerns or questions regarding this study that have not been answered, 
please feel free to contact me: 
 
Justin Dixon                                                             Michele Tameris                      
Anthropology PhD Student                                   Clinical Researcher 
Phone: 076 516 1489                        or                 Phone: (023) 346 5400                          
Email: justin.dixon@durham.ac.uk                         Email: michele.tameris@uct.ac.za       
 
The full title of the research project is Beyond: Ethics, Experimentation and Healthcare 
during Tuberculosis Vaccine Trials in South Africa. The protocol has been reviewed and 
approved by the University of Cape Town Faculty of Health Sciences Human Research 
Ethics Committee and in the United Kingdom by the University of Durham Department 
of Anthropology Ethics Committee. If you would like to find out more about your rights 
as a research participant, please call: (021) 406 6492.  
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SATVI Staff - Informed Consent Form  
The purpose of this form is to show that you have understood what it will mean to help 
me in this study and to allow me to use data collected from your involvement. Signing 
the form will mean that you have agreed to participate in the study entitled “Protocol and 
Beyond: Ethics, Experimentation and Healthcare during Tuberculosis Vaccine Trials in 
South Africa”. 
This means that:  
• The research project has been explained to me and I have had an opportunity to ask 
questions. 
• I certify that I am at least 18 years of age. 
• I voluntarily agree to participate in the study. 
• I understand that at any time during the course of the research, I am free to interrupt 
or end my participation without penalty.  
• I understand that this study will last 12 months. 
• I understand that this research involves ongoing observation of everyday practices 
and events. 
• I understand that my decision whether or not to participate will not jeopardise my 
future relations with SATVI. 
• I understand that my name and identifying features will not be revealed in any data or 
any articles and reports. 
• I understand that recorded information will be destroyed once it has been transcribed. 
 
 
Print name of study participant: ________________________________ 
 
Signature of study participant: ________________________________    
 
Date: _____________ 
 
 
Print name of person taking consent: ________________________________ 
 
Signature of person taking consent: ________________________________      
 
Date: _____________ 
 
 
 
(3) Healthcare Professional - Participant Information Sheet 
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My name is Justin Dixon and I am a researcher from the University of Durham in the 
United Kingdom.  I am seeking your help with a study I am doing about SATVI’s work 
in the Cape Winelands East district. Please take time to read the following information 
carefully, and take time to consider whether you want to take part in this study or not. 
Please ask me if there is anything that is unclear to you, or if you would like more 
information about the study before making your decision.  
 What is the purpose of this study? 
In this study, I would like to find out about how SATVI helps to improve people’s health 
in the district by researching new vaccines, working with local healthcare centres, and 
improving awareness of TB. This study will last for 12 months, based at SATVI’s field 
project office in Worcester. Approximately 135 people, with a variety of ties to SATVI’s 
work, will be invited to take part in total. The study will help SATVI to improve its 
relationship with the community. It will also help to make medical research more 
beneficial to people in South Africa. 
 If You Agree to Participate, What will the Study Involve?   
I have asked you to take part in my study because your work as a healthcare professional 
in Cape Winelands East is related to SATVI’s research on TB vaccines in the district. If 
you agree to take part, I will spend time with you as you go about your day-to-day work 
in order to learn more about healthcare in Cape Winelands East and its relationship to 
SATVI’s research. To aid my memory I will take field notes. I would also like to 
interview you about your knowledge and experiences of SATVI’s research, as well as 
about TB and healthcare in the district. If you agree to be interviewed, I will ask your 
permission to tape record and transcribe the proceedings. The length of your involvement 
in the study will depend upon how long you – and other participants – are comfortable 
with my presence at your place of work, and could be staggered over a number of time 
periods. I will use the information shared during this time to describe SATVI’s activities 
in academic articles and other reports.     
  Voluntary Participation 
Please understand that it is your choice whether to take part in my study or not, and there 
will be no penalty if you decide not to. Due to the in-depth nature of this study, I will be 
especially careful to ensure that you are comfortable with my presence at all times, and 
that you do not feel that my study is intruding upon your privacy. If you wish to participate 
in one but not both of the above research activities, this is also perfectly acceptable.  
 Are there any risks or benefits if I take part?  
Your participation in my study is unlikely to cause you any harm or distress. However, if 
any part of the study begins to make you feel uncomfortable in any way, you are welcome 
to interrupt or end your participation at any point. During the study, it is likely that I will 
ask you quite a lot of questions, particularly during interviews. You do not have to answer 
any of these that make you feel uncomfortable or that you do not wish to answer for any 
reason. In the unlikely event that the need arises, I can also refer you to a counselling 
service for further support about issues raised by the study. There are no direct benefits 
for participating in my study. However, you might value the opportunity to discuss your 
knowledge of SATVI’s work and healthcare in the district. In addition, your input will be 
beneficial in the long run for the community and others affected by medical research in 
South Africa.     
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 Confidentiality 
Assuring that the information you share as a participant remains as confidential as 
possible is a key priority. Recorded interview discussions will be destroyed once the 
recording has been transcribed. In addition, your name and any identifying characteristics 
will not be included in any data or in any publications and reports arising from this 
research. Where you share information with me in public spaces I will also do my utmost 
to ensure that conversations are not overheard. Confidentiality will only be breached in 
exceptional circumstances in the event of risk to yourself or third parties.  
 Further Information 
If you have any concerns or questions regarding this study that have not been answered, 
please feel free to contact me: 
Justin Dixon                                                             Michele Tameris                      
Anthropology PhD Student                                   Clinical Researcher 
Phone: 076 516 1489                        or                 Phone: (023) 346 5400                          
Email: justin.dixon@durham.ac.uk                         Email: michele.tameris@uct.ac.za       
 
The full title of the research project is Beyond: Ethics, Experimentation and Healthcare 
during Tuberculosis Vaccine Trials in South Africa. The protocol has been reviewed and 
approved by the University of Cape Town Faculty of Health Sciences Human Research 
Ethics Committee and in the United Kingdom by the University of Durham Department 
of Anthropology Ethics Committee. If you would like to find out more about your rights 
as a research participant, please call: (021) 406 6492.  
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Healthcare Professional - Informed Consent Form  
The purpose of this form is to show that you have understood what it will mean to help 
me in this study and to allow me to use data collected from your involvement. 
Signing the form will mean that you have agreed to participate in the study entitled 
“Protocol and Beyond: Ethics, Experimentation and Healthcare during Tuberculosis 
Vaccine Trials in South Africa”. 
This means that:  
• The research project and my participation have been explained to me and I have 
had an opportunity to ask questions. 
• I certify that I am at least 18 years of age. 
• I voluntarily agree to participate in the study. 
• I understand that at any time during the course of the research, I am free to 
interrupt or end my participation without penalty.  
• I understand that this research involves ongoing observation of everyday practices 
and events. 
• I understand that my decision whether or not to participate will not harm my future 
relations with SATVI. 
• I understand that my name and identifying features will not be revealed in any 
data or any articles and reports. 
• I understand that recorded information will be destroyed once it has been 
transcribed. 
 
Print name of study participant: ________________________________ 
 
Signature of study participant: ________________________________    
 
Date: _____________ 
 
 
Print name of person taking consent: ________________________________ 
 
Signature of person taking consent: ________________________________      
 
Date: _____________ 
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